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The Road Not Taken 
 
Two roads diverged in a yellow wood, 
And sorry I could not travel both 
And be one traveler, long I stood 
And looked down one as far as I could 
To where it bent in the undergrowth; 
 
Then took the other, as just as fair, 
And having perhaps the better claim 
Because it was grassy and wanted wear, 
Though as for that the passing there 
Had worn them really about the same, 
 
And both that morning equally lay 
In leaves no step had trodden black. 
Oh, I kept the first for another day! 
Yet knowing how way leads on to way 
I doubted if I should ever come back. 
 
I shall be telling this with a sigh 
Somewhere ages and ages hence: 
Two roads diverged in a wood, and I, 
I took the one less traveled by, 
And that has made all the difference. 
-Robert Frost 
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GENERAL ABSTRACT 
 
The gastrointestinal tract (GIT) is a diverse ecosystem, and is colonised by a diverse 
array of bacteria, of which bifidobacteria are a significant component. Bifidobacteria 
are Gram-positive, saccharolytic, non-motile, non-sporulating, anaerobic, Y-shaped 
bacteria, which possess a high GC genome content. Certain bifidobacteria possess 
the ability to produce conjugated linoleic acid (CLA) from linoleic acid (LA) by a 
biochemical pathway that is hypothesised to be achieved via a linoleic isomerase. 
CLA has a number of published beneficial effects on the host, for example 
modification of body composition by supplementing CLA to the diet or inhibiting 
cancer by blocking growth and metastatic spread of tumours.  
In Chapter two of this thesis we describe the CLA-producing capabilities of various 
B. breve strains, demonstrating that B. breve NCFB 2258 exhibits the highest level 
of CLA production. Since the gene predicted to encode a so-called myosin cross 
reactive antigen (MCRA) in B. breve NCFB 2258 shows high sequence homology to 
the linoleic acid isomerase of Lactobacillus acidophilus and Lactobacillus reuteri 
PYR8, an insertion mutation in the gene encoding MCRA was constructed to 
investigate its effect on CLA production. However, it was found that the MCRA-
specifying gene is not involved in CLA production in B. breve NCFB 2258, and that 
this gene specifies an oleate hydratase involved in the conversion of oleic acid into 
10-hydroxystearic acid. 
Prebiotics are defined as non-digestible food ingredients that beneficially affect the 
host by selectively stimulating growth and/or activity of one or a limited number of 
bacteria in the colon. Many prebiotics represent oligo- or polysaccharides, which 
specifically target bifidobacteria due to their perceived probiotic effects on this 
xix 
 
bacterial group. There is significant scientific and commercial interest in the 
identification of carbohydrates that can be developed as novel prebiotics with proven 
probiotic efficacy and bacterial target specificity. Key to the development of such 
novel prebiotics is to understand which carbohydrates support growth of 
bifidobacteria and how such carbohydrates are metabolised.  
In Chapter 3 of this thesis we describe the identification and characterisation of two 
neighbouring gene clusters involved in the metabolism of raffinose-containing 
carbohydrates (plus related carbohydrate melibiose) and melezitose by 
Bifidobacterium breve UCC2003, which was used as our model strain and is an 
isolate from a nursling stool. The rafABCD gene cluster, whose transcription is 
specifically induced by growth on raffinose-containing carbohydrates and the related 
carbohydrate melibiose, is predicted to specify a GH family 27 α-galactosidase 
(rafA), a solute binding protein (rafB) and two permease proteins (rafC and rafD). 
The melABCDE gene cluster, transcription of which is specifically induced during 
growth on melezitose, is predicted to specify a solute binding protein (MelA) and 
two permease proteins (MelB and MelC), an α-glucosidase (MelD) belonging to GH 
family 13, and an α-galactosidase/raffinose synthase (MelE) of GH family 36. 
The purified RafA protein was shown to hydrolyse stachyose and raffinose to 
produce sucrose and galactose, while also cleaving melibiose to its monosaccharide 
constituents glucose and galactose. Purified recombinant MelD protein was shown to 
fully hydrolyse melezitose into glucose and fructose, thereby demonstrating that this 
protein has both α-(1 2) and α-(1 3) glucosyl hydrolase activities. The putative α-
galactosidase MelE failed to exhibit hydrolytic activity towards raffinose, stachyose 
or melibiose, however, MelE as well as RafA were shown to exhibit hydrolytic 
activity towards synthetic α-(1 4)- and α-(1 3)-galactobiose. Kinetic studies 
xx 
 
identified that the preferred bond cleaved by MelD is the α-(1 2)-glucosidic linkage 
present in sucrose. In the case of RafA the preferred substrate was melibiose, 
followed by raffinose.  
The fourth chapter of this thesis describes the analysis of transcriptional regulation of 
the raf and mel clusters. From our obtained information, it was concluded that the 
raffinose utilisation system is positively regulated by an activator protein, designated 
RafR, while the gene cluster associated with melezitose metabolism is negatively 
regulated by a LacI-type transcriptional regulator, designated MelR1. A second LacI-
type transcriptional regulator, MelR2, encoded by a gene located immediately 
adjacent the MelR1-encoding gene, was shown to negatively regulate transcription 
of two genes that are positioned between the melABCDE gene cluster and the 
MelR2R1-encoding genes. Through a combination of in silico analysis, DNA/protein 
interaction and primer extension studies we determined that the MelR1 and MelR2 
operator sequences partially overlap with the individual promoter sequences they 
regulate. Similar analyses identified the RafR binding operator sequence as being 
positioned just upstream of the rafB promoter. Furthermore, B. breve UCC2003 was 
shown to preferentially utilise melezitose over raffinose, indicating that this 
bifidobacterial strain operates an as yet unidentified carbon catabolite control 
mechanism.  
In the final experimental chapter two putative rep genes, designated repA7017 and 
repB7017, are identified on the megaplasmid pBb7017 of B. breve JCM 7017, the first 
bifidobacterial megaplasmid to be reported. One of these, repA7017, was subjected to 
an in-depth characterisation. In silico analysis, DNA/protein interaction and primer 
extension identified the transcriptional start site and binding region of the RepA 
protein and led to the hypothesis that this plasmid functions as a theta-type 
xxi 
 
replicating plasmid. The work described in this thesis has resulted in an improved 
understanding of bifidobacterial fatty acid and carbohydrate metabolism, and in the 
latter case also provided detailed insights into the carbohydrate-dependent regulation 
of different gene clusters involved in sugar metabolism. Furthermore, attempts were 
made to develop novel genetic tools, based on the pBb7017 replication functions 
which would facilitate the stable cloning of large DNA fragments, and which would 
represent a significant contribution towards the genetic manipulation of 
bifidobacteria and advance the functional investigation of genomic probiotic 
mechanisms of action.  
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CHAPTER I 
General Introduction 
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1.1 INTRODUCTION 
The gastrointestinal tract (GIT) represents an ecosystem that is colonised by a 
diverse array of bacteria, termed the gut microbiota, which in humans is estimated to 
outnumber the total counts of germ and somatic cells by approximately tenfold, and 
which encompasses approximately 100-fold more genes than the number present in 
the host genome (Bäckhed et al., 2005). Prior to birth the foetus’ gastrointestinal 
tract is considered to be essentially sterile, and the development of the gut microbiota 
commences immediately following birth as a result of contact with elements of the 
mother’s vaginal and faecal microbiota during passage through the birth canal, as 
well as with other environmental microbes (Koenig et al., 2011; Vaishampayan et 
al., 2010).  
The bacterial populations in the GIT can be divided into autochthonous and 
allochthonous bacteria, representing indigenous and transient microbes, respectively 
(Tannock, 2001), of which the former are presumed to be stably colonised in the 
human host (Zoetendal et al., 1998). Determination of the faecal microbiota 
composition of healthy human adults has shown that the majority of microorganisms 
present are members of two distinct phyla, i.e. Firmicutes and Bacteroides (Eckburg 
et al., 2005; Hold et al., 2002). The faecal microbiota is presumed to reflect that of 
the gut itself and possesses a range of metabolic abilities that are otherwise absent in 
the host, and that are therefore considered indispensable for a healthy human 
existence (Savage, 2001). 
The infant gut microbiota is thought to be sustained by specific oligo-saccharides 
present in mother’s milk, and it is during this lactation period that bifidobacteria are 
the most abundant bacterial component of the gut microbiota (Gueimonde et al., 
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2007). Several recent studies on the infant microbiota further reinforced the fact that 
bifidobacteria are predominant in the infant gut as determined by the analysis of 
faecal samples (Ishizeki et al., 2013; Ruiz-Moyano et al., 2013; Turroni et al., 
2012a). The prevalence of bifidobacteria in the infant gut has been linked to 
development and maturation of the immune system, and maintenance of proper gut 
function, although the precise mechanism(s) underlying such activities remain(s) to 
be elucidated (Klaenhammer et al., 2012; Blum & Schiffrin, 2003; Ouwehand, 2007; 
Salminen et al., 2005). 
Heterotrophic bacteria such as bifidobacteria obtain energy from (limited) oxidation 
of organic compounds, and in particular carbohydrates. Oxidation of these 
compounds allows the synthesis of adenosine triphosphate (ATP) as the chemical 
energy source. This literature review will focus on carbohydrate and fatty acid 
metabolism in bifidobacteria. 
1.2 GENERAL FEATURES OF BIFIDOBACTERIA 
Bifidobacteria are Gram-positive, saccharolytic, non-motile, non-sporulating, 
anaerobic bacteria, which exhibit a bifurcated morphology, and possess a high G+C 
genome content (Ventura et al., 2007b). Members of the genus Bifidobacterium are 
part of the phylum Actinobacteria, which is one of the largest phyla in the domain 
Bacteria (Ventura et al., 2007a). Within the Bifidobacterium genus there are 
currently 48 species, many of which fall within six phylogenetic clusters, namely the 
Bifidobacterium pseudolongum, Bifidobacterium pullorum, Bifidobacterium longum, 
Bifidobacterium adolenscentis, Bifidobacterium asteroides and Bifidobacterium 
boum groups (Ventura et al., 2006). Bifidobacteria are present in different ecological 
niches: animal intestine (human, bovine, rabbit, murine, chicken and insect), oral 
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cavity, sewage, blood and food (Turroni et al., 2008; Turroni et al., 2012b; Ventura 
et al., 2007a). They were first isolated over hundred years ago (Tissier, 1900) from 
the faeces of a breast-fed infant and were then named “Bacillus bifidus”. Various 
bifidobacterial strains have been associated with a wide range of health-promoting 
activities, such as strengthening of the intestinal barrier, modulation of the immune 
system and exclusion of pathogens (Fanning et al., 2012; Marco et al., 2006; O'Hara 
& Shanahan, 2007; Turroni et al., 2008; Ventura et al., 2012; Ventura et al., 2014). 
A substantial amount of physiological and molecular biological information is 
available on Bifidobacterium breve UCC2003, an isolate from nursling stool 
(O'Connell Motherway et al., 2011b), which has been demonstrated to metabolise 
various mono-, di-, oligo- and polysaccharides (Maze et al., 2007; O'Connell et al., 
2013b; O'Connell Motherway et al., 2008; O'Connell Motherway et al., 2011a; 
Pokusaeva et al., 2010; Pokusaeva et al., 2011b; Ryan et al., 2005).   
1.2.1 BIFIDOBACTERIAL GENOMES 
According to currently available information thirty one bifidobacterial strains have 
had their genomes sequenced to completion (Table 1.1). The first bifidobacterial 
genome sequenced was that of B. longum (subsp. longum) NCC2705 (Schell et al., 
2002), which was shown to contain a genome with a size of 2.26 Mb. All completely 
sequenced genomes exhibit a GC content of 58-61 %, and range in size from 1.9 to 
over 2.8 Mb, with B. longum subsp. infantis ATCC 15697 possessing the largest 
genome (2.83 Mb) (Table 1.1). In addition to the thirty one completed bifidobacterial 
genome sequences, an additional twelve bifidobacterial draft genome sequences are 
currently listed in the database of the National Centre of Biotechnology Information 
(NCBI; dated December 1, 2013). 
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Species 
Genome 
size 
(Mb) 
GC 
content 
% Genes Proteins Source 
Genbank 
No. Reference 
Bifidobacterium adolescentis ATCC 15703 2.09 59.2 1,702 1,632 Human GIT NC_008618 Unpublished 
Bifidobacterium animalis subsp. lactis V9 1.94 60.5 1,636 1,572 Infant GIT NC_017217 (Sun et al., 2010) 
Bifidobacterium animalis subsp. animalis ATCC 25527 1.93 60.5 1,601 1,538 Human GIT NC_017834 Unpublished 
Bifidobacterium animalis subsp. lactis AD011 1.93 60.5 1,603 1,527 Infant faeces NC_011835 (Kim et al., 2009) 
Bifidobacterium animalis subsp. lactis B420 1.94 60.5 1,625 1,561 Human GIT NC_017866 (Stahl & Barrangou, 2012) 
Bifidobacterium animalis subsp. lactis BB-12 1.94 60.5 1,706 1,642 Human GIT NC_017214 (Garrigues et al., 2010) 
Bifidobacterium animalis subsp. lactis ATCC 27673 1.96 60.6 1,620 1,556 Human GIT NC_022523 (Loquasto et al., 2013) 
Bifidobacterium animalis subsp. lactis BLC1 1.94 60.5 1,607 1,518 Human GIT NC_017216 (Bottacini et al., 2011) 
Bifidobacterium animalis subsp. lactis Bi-07 1.94 60.5 1,661 1,597 Human faeces NC_017867 (Stahl & Barrangou, 2012) 
Bifidobacterium animalis subsp. lactis Bl-04 1.94 60.5 1,631 1,567 Human faeces NC_012814 (Barrangou et al., 2009) 
Bifidobacterium animalis subsp. lactis Bl12 1.94 60.5 1,607 1,518 Human colon NC_021593 (Milani et al., 2013) 
Bifidobacterium animalis subsp. lactis CNCM I-2494 1.94 60.5 1,724 1,660 Human faeces NC_017215 (Chervaux et al., 2011) 
Bifidobacterium animalis subsp. lactis DSM 10140 1.94 60.5 1,628 1,565 Infant GIT NC_012815 (Barrangou et al., 2009) 
Bifidobacterium asteroides PRL2011 2.17 60.1 1,731 1,658 Honeybee NC_018720 (Bottacini et al., 2012) 
Bifidobacterium bifidum BGN4 2.22 62.6 1,902 1,834 Human faeces NC_017999 Unpublished 
Bifidobacterium bifidum PRL2010 2.21 62.7 1,791 1,706 Infant faeces NC_014638 (Turroni et al., 2010) 
Bifidobacterium bifidum S17 2.19 62.8 1,845 1,783 Infant faeces NC_014616 Unpublished 
Bifidobacterium breve ACS-071-V-Sch8b 2.33 58.7 2,011 1,826 Human GIT NC_017218 Unpublished 
Bifidobacterium breve UCC2003 2.42 58.7 1,985 1,854 Infant faeces NC_020517 (Maze et al., 2007) 
Bifidobacterium dentium Bd1 2.64 58.5 2,195 2,127 Dental caries NC_013714 (Ventura et al., 2009) 
Bifidobacterium longum subsp. longum JCM 1217 2.39 60.3 2,009 1,924 Human faeces NC_015067 (Fukuda et al., 2011) 
Bifidobacterium longum subsp. longum JDM301 2.48 59.8 2,035 1,958 Human faeces NC_014169 (Wei et al., 2010) 
Bifidobacterium longum subsp. longum KACC 91563 2.4 59.8 2,350 1,985 Infant faeces NC_017221 (Ham et al., 2011) 
Bifidobacterium longum NCC2705 2.26 60.1 1,799 1,728 Human GIT NC_004307 (Schell et al., 2002) 
Bifidobacterium longum DJO10A  2.39 60.1 2,073 2,001 Human GIT NC_010816 (Lee et al., 2008) 
Table 1.1 Completely sequenced bifibifidobacterial genomes 
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Species 
Genome 
size 
(Mb) 
GC 
content 
% Genes Proteins Source 
Genbank 
No. Reference 
Bifidobacterium longum subsp. infantis ATCC 15697  2.83 59.9 2,588 2,416 Infant GIT NC_011593 (Sela et al., 2008) 
Bifidobacterium longum subsp. infantis 157F 2.41 60.1 2,070 1,999 Infant GIT NC_015052 (Fukuda et al., 2011) 
Bifidobacterium longum subsp. longum BBMN68 2.27 59.9 1,876 1,804 Human GIT NC_014656 (Hao et al., 2011) 
Bifidobacterium longum subsp. longum F8 2.38 59.9 1,743 1,681 Human GIT NC_021008 Unpublished 
Bifidobacterium thermophilum RBL67 2.29 60.1 1,904 1,845 Infant faeces NC_020546 Unpublished 
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1.2.2 BIFIDOBACTERIAL PLASMIDS 
Approximately 20 % of tested bifidobacterial strains contain detectable plasmids, 
which are typically small to medium-sized, ranging from 1.5 kb to 15 kb (Cronin et 
al., 2011; Park et al., 1997a; Sgorbati et al., 1982). Bifidobacterial megaplasmids, 
i.e. extra-chromosomal genetic elements of 100 kb or more in size, have also been 
reported from porcine isolates for certain B. pseudolongum subsp. globosum 
although they have not been characterised further (Simpson et al., 2003). For a 
compilation of completely sequenced bifidobacterial plasmids see Table 1.2 (NCBI; 
dated December 1, 2013). 
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                               Table 1.2 Sequenced bifibifidobacterial plasmids 
Species Plasmid 
Accession 
number Reference 
B. pseudocatenulatum p4M NC_003527.1 (Gibbs et al., 2006) 
B. catenulatum pBC1 NC_007068.1 (Alvarez-Martin et al., 2007) 
B. pseudolongum subp. globosum pASV479 NC_010877.1 (Sangrador-Vegas et al., 2007) 
B. bifidum pBIF10 DQ093580 Unpublished 
 
PB80 NC_011332.1 (Shkoporov et al., 2008) 
B. asteroides pCIBAO89 NC_010908.1 (Cronin et al., 2007) 
 
pAP1 Y11549 Unpublished 
B. breve pCIBB1 NC_002133.1 
(O'Riordan & Fitzgerald, 
1999) 
 
pNBB1 E17316 (Bourget et al., 1993) 
 
pB21A NC_010930.1 (Shkoporov et al., 2008) 
B. kashiwanohense pBBKW-1 AB713428 (Takahata et al., 2013) 
 
pBBKW-2 NC_021876.1 (Takahata et al., 2013) 
B. longum BLNIAS-p2 NC_017222.1 (Ham et al., 2011) 
 
pDOJH10L NC_004252.1 (Lee & O'Sullivan, 2006) 
 
pKJ50 NC_004978.1 (Park et al., 1999) 
 
pNAC2 NC_004769.1 (Corneau et al., 2004) 
 
pB44 NC_004443.1 (Shkoporov et al., 2008) 
 
pTB6 NC_006843.1 (Tanaka et al., 2005) 
 
pKJ36 NC_002635.1 (Park et al., 1997a) 
 
pMG1 NC_006997.1 Unpublished 
 
p6043B NC_010861.1 Unpublished 
 
pBLO1 NC_004943.1 (Schell et al., 2002) 
 
pNAC1 NC_004779 (Corneau et al., 2004) 
 
pNAL8M AM183144.1 (Guglielmetti et al., 2007) 
 
pBIFA24 NC_010164.1 (Park et al., 2008) 
 
p6043A DQ458910 Unpublished 
 
pNAL8L AM183145.1 (Guglielmetti et al., 2007) 
 
pNAC3 NC_004768 (Corneau et al., 2004) 
 
pDOJH10S NC_004253.1 (Lee & O'Sullivan, 2006) 
 
pSPO2 GU256055.1 Unpublished 
 
pMB1 X84655 (Rossi et al., 1996) 
 
pFI2576 NC_011139.1 (Moon et al., 2009) 
 
BLNIAS-p1 NC_017220 (Ham et al., 2011) 
 
p157F-NC1 NC_015053 (Fukuda et al., 2011) 
 
p157F-NC2 NC_015066 (Fukuda et al., 2011) 
 
pBK283 AB495342.1 (Fukiya et al., 2010) 
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1.2.3 THETA TYPE REPLICATION 
Two main types of plasmid replication exist: rolling circle and theta-type replication. 
A factor which distinguishes theta-type replication from the rolling circle mechanism 
is that the former mechanism does not produce single stranded DNA replication 
intermediates. This literature review will focus mainly on theta-type replication, 
which distinguishes three subtypes based on mechanistic differences of the 
replication initiation process. The first of these is dependent on a plasmid-encoded 
replication initiator, the replication or Rep protein, which binds to a series of direct 
repeats, also known as iterons, to form an initiation complex at the origin of 
replication. This complex, in association with DnaA, facilitates the recruitment of a 
DnaB-DnaC protein complex to this plasmid replication origin, resulting in the 
strand opening of an AT-rich DNA region, directly adjacent to the initiation 
complex, thereby initiating leading strand synthesis primed by a DnaG-mediated 
RNA transcript. The organisation and functioning of this replication subtype 
resembles that of the origin of chromosomal replication (OriC) in E. coli (Bramhill 
& Kornberg, 1988).  
The second recognised subtype of theta-type replication initiation is not dependent 
on a plasmid-encoded initiator protein, yet is instead dependent on host DNA 
polymerase I. In this mechanism the initial strand opening event occurs by a strand 
displacement reaction at the origin due to synthesis of an RNA transcript. This RNA 
transcript is processed by Rnase H, and this processed RNA is then used for leading 
strand synthesis which is initially performed by DNA polymerase I, but which is 
replaced by DNA polymerase III holoenzyme for DNA elongation purposes. A 
prime example of this mechanism of replication is that observed for the ColE1 
plasmid (Kingsbury & Helinski, 1970).  
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The third subtype of replication initiation found in theta-type replicons requires host 
DNA polymerase I and a Rep protein, and is the mechanism of choice for ColE2 and 
ColE3 type replicons (Yasueda et al., 1989). In this case the Rep protein binds to the 
replication origin, which is located downstream of the Rep-encoding gene. This 
interaction results in the production of an RNA primer, catalysed by the host RNA 
polymerase, and is responsible for initiation of leading strand synthesis by DNA 
polymerase I (Takechi et al., 1995).  
Following initiation by either of the previously mentioned three mechanisms, theta-
type replication can occur either bidirectionally (Prescott & Kuempel, 1972) or 
unidirectionally (Takechi & Itoh, 1995), with most theta-type plasmids replicating 
unidirectionally. Termination of replication occurs when the replication fork 
composed of the leading strand and lagging strand comes in contact with a 
termination sequence. The termination sites specifically interact with a replication 
terminator protein and this complex halts leading strand synthesis (Mulugu et al., 
2001). 
1.2.4 E. COLI/BIFIDOBACTERIUM SHUTTLE VECTORS  
A number of E. coli/Bifidobacterium shuttle vectors have been constructed to date 
(Table 1.3), and such shuttle vectors are crucially important to facilitate genetic 
manipulation of bifidobacteria. Examples are the pBC1.2 shuttle vector, constructed 
based on the B. catenulatum pBC1-based replicon, and functional in several 
Bifidobacterium species, including B. breve UCC2003 and B. pseudocatenulatum 
M115 (Alvarez-Martin et al., 2007), and the pPKCM1 shuttle vector, which is based 
on a plasmid, pCIBAO89,  from B. asteroides, and which replicates in B. animalis 
subsp. lactis, B. longum NCIMB 8809, B. pseudolongum NCIMB 2244, B. 
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pseudolongum subsp. globosum JCM 5820, B. pseudocatenulatum LMG 10505 and 
B. dentium NCFB 2843 (Cronin et al., 2007).  
Another example is the replicon of the cryptic B. longum plasmid pBLES100, which 
when cloned into the E. coli vector pBR322 generated a shuttle vector pBLES100 
that was capable of transforming B. longum 105-A and 108-A (Matsumura et al., 
1997). Various other examples of successful E. coli/Bifidobacterium shuttle vectors 
have been published (Klijn et al., 2006; Missich et al., 1994; Rossi et al., 1996; 
Rossi et al., 1998; Sangrador-Vegas et al., 2007; Shkoporov et al., 2008), and for 
more information on such E. coli/Bifidobacterium shuttle vectors see Table 1.3. 
Many E. coli/Bifidobacterium shuttle vectors constructed to date have the ability to 
replicate in several bidfidobacterial strains; however, experiments to test the 
replication of some of these plasmids in strains of the Gram positive genera, 
Lactobacillus and Lactococcus, have not produced transformants. For example the 
shuttle vector pDOJHR, which is based on a plasmid found in B. longum DOJH10S, 
was shown to be only capable of replicating in B. longum VMK44, thus exhibiting a 
very limited host range (Lee & O'Sullivan, 2006;) . Another plasmid with a relatively 
limited host range is shuttle vector pPKCM1 which appears to be unable to 
transform L. lactis and it was thus concluded that this plasmid is restricted to certain 
Gram positive bacteria (Cronin et al., 2007) suggesting  that bifidobacterial plasmid 
replication functions may be limited to this genus or perhaps high GC Gram positive 
bacteria.
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Strain origin of plasmid  Cryptic bif 
plasmid 
E.coli vector Name shuttle 
vector 
Transformable strains Reference 
B. catenulatum L48 pBC1 pBIF pBC1.2 B. breve UCC2003 (Alvarez-Martin et al., 2007) 
    B. pseudocatenulatum M115  
B. asteroides pCIBAO89 pBlueCm pPKCm1 B. animalis subsp. lactis, (Cronin et al., 2007) 
    B. longum NCIMB 8809  
    B. longum NCIMB 8809  
    B. pseudolongum NCIMB 2244,  
    B. globosum JCM5820,  
    B. pseudocatenulatum 
LMG10505 
 
    B. dentium NCFB 2843  
B. longum NCC293 pNCC293 pMDY23 pDP870 B. longum NCC2705 (Klijn et al., 2006) 
B. longum DJO10A pDOJH10S pACYC184 pDOJHR B. longum VMK44 (Lee & O'Sullivan, 2006) 
B. longum 105-A pBLES100 pBR322 pBLES100 B. longum 105-A (Matsumura et al., 1997) 
    B. longum 108-A  
B. longum 2577 pRM1 pGEM-5Z7 pRM2 B. longum 2577 (Missich et al., 1994) 
B. longum B2577  pMB1 pBluescriptll KS pDG7 B. animalis MB209 (Rossi et al., 1996) 
 pMB1 pBluescriptII KS pLF5 B. bifidum MB254 (Rossi et al., 1998) 
    B. animalis MB209  
    B. infantis MB263  
    B. longum MB219  
    B. magnum MB267  
  pBluescriptII KS pCLJ15 B. bifidum MB254 (Rossi et al., 1998) 
    B. animalis MB209  
    B. infantis MB263  
Table 1.3 E. coli/Bifidobacterium shuttle vectors constructed to date 
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Strain origin of plasmid Cryptic bif 
plasmid 
E. coli vector Name shuttle 
vector 
Transformable strains Reference 
    B. longum MB219  
    B. magnum MB267  
  pBluescriptII KS pSPEC1 B. bifidum MB254 (Rossi et al., 1998) 
    B. animalis MB209  
    B. infantis MB263  
    B. longum MB219  
    B. magnum MB267  
B. pseudolongum subsp.globosum DPC479 pASV479 pBluescriptII KS pASV480 B. breve NCIMB 8807 (Sangrador-Vegas et al., 2007) 
B. longum pB44 pE194 pSUW1/114 B. biﬁdum ATCC15696 (Shkoporov et al., 2008) 
   pSUW53/114 B. biﬁdum ATCC15696 (Shkoporov et al., 2008) 
  pUC19E pSUW64/123 B. biﬁdum ATCC15696 (Shkoporov et al., 2008) 
    B. breve UCC2003  
B. biﬁdum pB80 pBluescript II KS pEESH80 B. breve UCC2003 (Shkoporov et al., 2008) 
   pCESH80 B. breve UCC2003 (Shkoporov et al., 2008) 
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1.3 PROBIOTICS, PREBIOTICS AND SYNBIOTICS 
Probiotics are defined as live microbial food ingredients that have a beneficial 
impact on human health (Salminen et al., 1998). The term probiotic is based on two 
Greek words, meaning ‘for life’, and the concept of probiotics evolved at the turn of 
the 20th century due to a hypothesis put forward by the Russian scientist Elie 
Metchnikoff (Bibel, 1988). He believed that Bulgarian peasants lived long and 
healthy lives due to the fact that they consumed fermented milk products.   
Bifidobacteria are commercially exploited as health-promoting or probiotic 
ingredients in certain functional foods due to their perceived role in preventing 
disease and enhancing gastrointestinal health. The reported beneficial effects that 
specific strains of bifidobacteria may elicit on the host include, among many others, 
(i) inhibition of pathogens through acetate production which is thought to improve 
intestinal defence by preventing the passage of pathogenic bacteria from the gut 
lumen to the blood (Fukuda et al., 2011), (ii) alleviation of lactose intolerance by 
consumption of a combination of Lactobacillus casei Shirota and B. breve Yakult 
(Almeida et al., 2012), and (iii) reduction of serum cholesterol levels by the 
administration of a cocktail of bifidobacteria (Bordoni et al., 2013).   
Various microbes other than bifidobacteria have been associated with probiotic 
activities. For example, it was recently shown that Lactobacillus reuteri DSM 
17938, in conjunction with rehydration therapy, is efficient in the treatment of acute 
diarrhoea (Francavilla et al., 2012). Propionibacterium freudenreichii has also been 
indicated as a probiotic strain because of its immunomodulatory and growth-
promoting effects in pigs (Cousin et al., 2012).  
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The search for new (bifidobacterial) probiotics is on-going (for reviews see (Collado 
et al., 2012; Jankovic et al., 2010; Quigley, 2010)). For example, in a recent study 
four bifidobacterial strains (B. longum 51A, B. breve 1101A, B. pseudolongum 
1191A and B. bifidum 1622A), isolated from faeces of healthy children, were 
compared based on their growth rates, aerotolerance, antagonistic activity against 
pathogens, antimicrobial susceptibility profile and cell wall hydrophobicity (Souza et 
al., 2013). Based on these analyses B. longum 51A was shown to possess the best 
potential for probiotic use as it did not appear to contain any antibiotic resistance 
determinants, while it exhibited the highest growth rate and the best ability to 
produce antagonistic substances against a range of pathogenic microorganisms 
(Souza et al., 2013). 
The term prebiotic was first coined nearly twenty years ago (Gibson & Roberfroid, 
1995). These authors defined prebiotics as “non-digestible food ingredients that 
beneficially affect the host by selectively stimulating the growth and/or activity of 
one or a limited number of bacteria in the colon”. Synbiotics are defined as “a 
mixture of probiotics and prebiotics that beneficially affects the host by improving 
the survival and implantation of live microbial dietary supplements in the 
gastrointestinal tract, by selectively stimulating the growth and/or by activating the 
metabolism of one or more limited number of health-promoting bacteria and thus 
improving host welfare” (Gibson & Roberfroid, 1995). 
It has been demonstrated that the proliferation of gut-derived probiotic bacteria such 
as bifidobacteria is selectively stimulated by various dietary carbohydrates, which 
for this reason are considered to be prebiotics (Macfarlane et al., 2008). Various 
human clinical trials have been performed to analyse the efficacy of prebiotics. For 
example, regular ingestion of lactulose (10 g per day) was shown to result in an 
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increase in bifidobacterial numbers present in the faecal microbiota of participants, 
while having little or no effect on total bacterial populations (Tuohy et al., 2002). 
Similarly, ingestion of ‘Vivinal’ galacto-oligosaccharides (GOS; 2 g twice daily) 
was demonstrated to significantly increase population levels of bifidobacteria in 
faecal samples of subjects over 50 (Walton et al., 2012), while polydextrose was 
shown to result in a decrease in numbers of Bacteroides species, and a numerical 
increase in representatives of Lactobacillus and Bifidobacterium species (Jie et al., 
2000). Furthermore, lactitol (ingested twice a day, total daily dose of 10 g) in 
conjunction with the administration of the probiotic Lactobacillus acidophilus 
NCFM (daily dose of 2 × 1010 cells) was also shown to result in an increase in 
bifidobacterial levels (Bjorklund et al., 2012). 
1.4 CARBOHYDRATE METABOLISM IN BIFIDOBACTERIA 
The normal human diet contains a non-digestible (i.e. resistant to human hydrolytic 
enzymes) carbohydrate fraction, and these non-digestible dietary components 
include plant cell wall polysaccharides, such as arabinan and a particular starch 
fraction, also known as resistant starch, (as it reaches the large intestine without 
being broken down) (Grabitske & Slavin, 2009; Lattimer & Haub, 2010; Topping & 
Clifton, 2001). It has been estimated that approximately 20-60 g of dietary 
carbohydrates reach the colon daily, having escaped or being insensitive to digestion 
by host enzymes (Cummings & Macfarlane, 1991; Silvester et al., 1995). Non-
digestible carbohydrates present in the diet not only have a profound effect on the 
composition of the human GIT microbiota, but also influence the total bacterial load 
in the gut and the concentration of associated metabolic products (Stephen et al., 
1987). 
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As mentioned above, bifidobacteria operate a unique hexose metabolism, the so-
called bifid-shunt, a metabolic pathway that employs the signature enzyme fructose-
6-phosphate-phosphoketolase (F6PPK), converting a range of monosaccharides to 
mainly acetic and lactic acid ((Scardovi & Trovatelli, 1965) see Fig. 1.1). This 
pathway provides bifidobacteria an advantage over other bacteria in that it allows the 
production of more energy in the form of ATP from carbohydrates than alternative 
fermentative pathways present in other bacteria such as lactic acid bacteria. The 
bifidobacterial pathway yields 2.5 ATP molecules from 1 molecule of fermented 
glucose, as well as 1.5 molecules of acetate and 1 molecule of lactate (Palframan et 
al., 2003), although this lactate to acetate ratio may vary depending on the carbon 
source and growth phase, while it is also species dependent (Palframan et al., 2003). 
Approximately 8 % of the average bifidobacterial genome is dedicated to 
carbohydrate metabolism, and half of these genes are putatively responsible for 
carbohydrate uptake, which occurs mainly by means of ATP-binding cassette 
transporters (ABC-type transporters). Just twenty five genes present on the genome 
of B. bifidum PRL2010 were predicted to encode components of transport systems 
dedicated to carbohydrate uptake (Turroni et al., 2012c), and it was observed that in 
comparison to other bifidobacteria (with the exception of B. animalis subsp. lactis 
Bb12) this strain appears to be able to metabolise only a small number of 
carbohydrates. Of these twenty five genes, eight represented members of the ABC-
type transport family for carbohydrates such as fructose, glucose, ribose, galactose 
and turanose.  
In addition to ABC-type carbohydrate transporters, bifidobacteria also employ 
proton motive force-driven permeases, proton symporters, and 
phosphoenolpyruvate-dependent phosphotransferase systems (PEP-PTSs) for 
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carbohydrate internalisation (Maze et al., 2007; Pokusaeva et al., 2011a; Schell et 
al., 2002). The PEP-PTS system is only found in bacteria (although not in all 
bacteria), being responsible for the transport and phosphorylation of various 
carbohydrates, while also playing a crucial role in the global regulation of 
carbohydrate metabolism and various other physiological processes (Postma et al., 
1993). PEP is used both as an energy source as well as a phosphoryl donor, where a 
phosphoryl group of PEP is transferred via four proteins to the membrane 
components of the PTS, forming the PTS phosphorylation cascade (Deutscher et al., 
2006). A more comprehensive discussion of PEP-PTS systems and their role in 
global regulation, and their presence in bifidobacteria will follow in the next section. 
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Figure 1.1 Schematic representation of carbohydrate degradation through the “bifid shunt” in bifidobacteria. Abbreviations: AckA, acetate 
kinase; Adh2, aldehyde-alcohol dehydrogenase 2; Aga, α-galactosidase; Agl, α-glucosidase; Bgl, β-glucosidase; GalE1, UDP-glucose 4-
epimerase; GalK, galactokinase; GalM, galactose mutarotase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase C; GlkA, glucokinase; Gnt, 
6-phosphogluconate dehydrogenase; Gpi, glucose 6-phosphate isomerase; Frk, fruktokinase; F6PPK, fructose-6-phosphoketolase; FucI, L-fucose 
isomerase; FucK, L-fuculose kinase; FucA, L-fuculose-1P aldolase; FucO, lactaldehyde reductase; Ldh2, lactate dehydrogenase; LNBP, lacto-N-
biose phosphorylase; Pgk, phosphoglyceric kinase; Pgm, phosphoglucomutase; Pfl, formate acetyltransferase; Rk, ribokinase; R5PI, ribose-5-
phosphate isomerase; R5PE, ribulose-5-phosphate epimerase; Tal, transaldolase; Tkt, transketolase; TpiA, triosephosphate isomerase; UgpA, 
UTP-glucose-1-phosphate uridylyltransferase; XPPKT, xylulose-5-phosphate/fructose-6-phosphate phosphoketolase; XylA, xylose isomerase; 
XylB, xylulose kinase; Zwf2, glucose-6-phosphate 1-dehydrogenase; Pi, phosphate (based on a figure from a previous review (Pokusaeva et al., 
2011a)). 
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1.4.1 PEP-PTS SYSTEM AND CATABOLITE REPRESSION 
In many bacteria the carbohydrate flux going through a PEP-PTS system regulates 
the activity of other non-PTS systems. This regulation is based on the availability of 
a preferred carbon source in the growth medium, which indirectly inhibits the 
expression or activity of proteins involved in the utilisation or uptake of other 
available carbon sources, a global regulatory process commonly referred to as carbon 
catabolite repression (CCR) (Postma et al., 1993; Saier & Ramseier, 1996). In a 
recent study by Sela et al., (2012), their findings supported the idea of a carbon 
catabolite repression system being in operation in B. longum subsp. infantis ATCC 
15697. A mixture of six low molecular weight human milk oligosaccharides 
(HMOs) induced the transcription of Blon_2335, which encodes a GH95 family α-
fucosidase, while it repressed transcription of Blon_0248 and Blon_0426, which 
represent two GH29 family α-L-fucosidases. It was hypothesised that this repression 
was due to lacto-N-tetraose as, when cells were grown on this substrate, transcription 
of Blon_0248 and Blon_0426 was also repressed. Similarly, a lactose-over-glucose 
preference was observed in B. longum NCC2705 (Parche et al., 2006). In this case 
transcription of glcP, which encodes a glucose transporter, is repressed in the 
presence of lactose. 
Further examples of catabolite repression have been described for B. breve 
UCC2003. In the case of ribose metabolism by this bifidobacterial strain it was 
observed that transcription of the ribose cluster is decreased by two fold when the 
culture in grown in a mixture of glucose and ribose (Pokusaeva et al., 2010). 
Furthermore, transcription of the fos operon of B. breve UCC2003, involved in 
oligofructose metabolism, was observed to be induced in the presence of 
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oligofructose or sucrose, but shown to be repressed in the presence of a mixture of 
glucose and sucrose, or fructose and sucrose (Ryan et al., 2005). 
In terms of bifidobacterial PEP-PTS systems, four complete PEP-PTS systems were 
predicted to be encoded by the B. breve UCC2003 genome (Maze et al., 2007), more 
than most other analysed bifidobacterial genomes. For example B. longum subsp. 
longum DJO10A (Lorca et al., 2007) and B. longum subsp. longum NCC2705 
(Parche et al., 2007) both encode just one PEP-PTS system, while B. animalis subsp. 
lactis (Barrangou et al., 2009) does not appear to encode a single PEP-PTS system. 
The finding that some bifidobacteria do not possess a PEP-PTS system, combined 
with the notion that specific regulatory proteins required for CCR in other bacteria 
appear to be absent in bifidobacteria (unpublished data), indicated that bifidobacteria 
must control CCR via an as yet unknown regulatory mechanism. As has been shown 
in various reports, transcription of the genes encoding proteins involved in the 
metabolism of a specific carbohydrate is regulated. For example, a recently 
published transcriptome analysis of B. animalis subsp. lactis Bl-04 reported on 
carbohydrate-dependent induction by eleven oligosaccharides and the consequent 
identification of genetic loci involved in the uptake and metabolism of these 
saccharidic compounds (Andersen et al., 2013). Other examples will be discussed 
below, together with the identified regulatory mechanisms. 
1.4.2 LACI AND ROK MEDIATED REPRESSION SYSTEMS 
LacI-mediated repression was first characterised for the lac operon in E. coli (Jacob 
& Monod, 1961). The lac operon consists of three genes lacZ, lacY and lacA, which 
encode a β-galactosidase, a lactose permease and a transacetylase, respectively. In 
the absence of lactose, the repressor protein also known as LacI binds to target 
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sequences called operator sequences, which prevents the RNA polymerase from 
transcribing the genes present in the operon. When lactose is present as the main 
source of energy, some of the lactose is converted into allolactose, which, by its 
physical association with LacI, changes the conformation of this repressor and 
prevents LacI binding to its cognate operator sequences, thereby allowing 
transcription of the lac operon. LacI/GalR family regulators share similar structures 
and regulate transcription in a similar manner (Wintjens & Rooman, 1996). 
LacI/GalR family regulators are composed of both DNA-binding and regulatory 
domains, the latter possessing two pivotal roles: (i) to receive and transmit the signal 
via effector binding, and (ii) to mediate homodimer formation/disassembly. 
Various members of the LacI/GalR family have been identified in bifidobacteria and 
in several cases their role in carbohydrate-dependent regulation of gene expression 
has been demonstrated. An example of LacI-type mediated transcriptional control in 
bifidobacteria is the galACDEGR locus of B. breve UCC2003, which is involved in 
utilisation of galactan, a plant-derived polysaccharide. The galA gene encodes a 
galactanase which degrades the galactan polymer predominantly into 
galactotriose/biose, galC, galD and galE, which specifies a presumed ABC-type 
uptake system for the GalA-produced galacto-oligosaccharides, galG encodes a β-
galactosidase, while galR encodes a LacI-type DNA-binding protein. Transcription 
of the galCDEG operon and the monocistronic galA is controlled by GalR, and it 
was observed that this LacI-type repressor responds to the carbohydrate effector 
galactobiose: in the absence of galactobiose, GalR binds to its operator sites thereby 
blocking transcription of the gal genes, while in the presence of this effector GalR is 
unable to bind to these DNA sequences (O'Connell Motherway et al., 2011a). 
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Other such carbohydrate metabolic systems regulated by LacI-type transcriptional 
repressors would be that of cellodextrin and ribose metabolism in B. breve 
UCC2003. Cellodextrin utilisation by B. breve UCC2003 requires the products of the 
cldEFGC gene cluster (Pokusaeva et al., 2011b). The cldE, cldF and cldG genes 
encode a putative cellodextrin-binding protein and two cellodextrin permease 
proteins, respectively, while cldC specifies a β-glucosidase. Through electrophoretic 
mobility shift assay (EMSA) analysis it was shown that this cluster is negatively 
regulated by a LacI-type regulator encoded by cldR. Ribose metabolism by B. breve 
UCC2003 involves the gene products of the rbsACBDK gene cluster. The rbsA, rbsC 
and rbsB genes, encode the ribose uptake system. A putative ribose mutarotase is 
encoded by rbsD and a putative ribokinase is encoded by the rbsK gene. Similar to 
the cld cluster, the transcription of the rbs cluster was shown to be negatively 
regulated by a dedicated LacI-type regulator encoded by rbsR (Pokusaeva et al., 
2010).  
Repressor open reading frame kinase (ROK) regulators were originally described 
approximately twenty years ago and include transcriptional repressors, sugar kinases 
and as yet uncharacterised open reading frames (Titgemeyer et al., 1994). ROK 
repressors and kinases can be distinguished based on their N-terminal sequence: 
ROK kinases possess a conserved N-terminal ATP-binding motif, while ROK 
repressors contain an additional N-terminal DNA-binding domain and a C-terminal 
sugar-binding domain (Titgemeyer et al., 1994). The ROK protein family is 
characterised by the presence of the PF00480 domain that belongs to the Actin-
ATPase clan in the Pfam database (Punta et al., 2012). Mlc from E. coli is a ROK 
transcriptional repressor which controls the expression of genes encoding enzymes 
of the phosphotransferase system (PTS), the Mlc ROK repressor from E. coli also 
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controls the transcription of malT, which is the global activator of the mal regulon 
(Schiefner et al., 2005). The latter study describes the first structure of a ROK family 
protein. Examples of regulators in this family that have been characterised are NagC 
from E. coli (Plumbridge, 2001; Plumbridge et al., 1993), XylR from Bacillus 
subtilis (Dahl et al., 1994; Scheler & Hillen, 1994) and CsnR from Streptomyces 
lividans (Dubeau et al., 2011). 
1.4.3 GLYCOSYL HYDROLASES (GHs) IN BIFIDOBACTERIA 
GHs (EC 3.2.1.-) are a widespread group of enzymes which hydrolyse the glycosidic 
bond between two or more monosaccharides, or between a carbohydrate and a non-
carbohydrate moiety (Cantarel et al., 2009). The first three digits of the assigned EC 
number indicate enzymes that hydrolyse O-glycosyl linkages, whereas the last 
number indicates the substrate and sometimes reflects the molecular mechanism. 
Classification of GHs into families is based on amino acid sequence similarities and 
was devised in 1991 (Henrissat, 1991). GHs which exhibit significant sequence 
similarities to each other were assigned to a particular GH family. Typically, 
hydrolysis of the glycosidic bond is catalysed by two amino acid residues of the 
enzyme to provide a general acid (proton donor) and a nucleophile/base (Davies & 
Henrissat, 1995). Classification of glycoside hydrolases is available at 
http://www.cazy.org/Glycoside-Hydrolases.html (Cantarel et al., 2009).  
Humans do not possess enzymes required for the degradation of prebiotic 
carbohydrates, e.g. fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), 
xylo-oligosaccharides, inulin, arabinoxylan and lactulose (Guarner & Malagelada, 
2003). Gut commensals such as bifidobacteria utilise GHs to degrade dietary 
carbohydrates, although other enzyme activities, such as polysaccharide lyases and 
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carbohydrate esterases, may also be utilised (Flint et al., 2012; Pokusaeva et al., 
2011a). For a full list of putative glycosyl hydrolases present in currently sequenced 
bifidobacteria, see Tables 1.4-1.4.4 (CAZY; dated December 1, 2013). It is not 
possible to cover all characterised or predicted carbohydrate-degrading enzymes 
from bifidobacteria in any significant detail, and therefore in the following sections 
we will focus on a number of representative GH that are mostly related to the 
metabolism of plant-derived carbohydrates. 
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EC Number Enzyme name       
3.2.1.21 β-glucosidase/β-D-glucoside glucohydrolase GH1/3 2 3 3 4 3 
3.2.1.23 β-galactosidase GH1/2/35/42 2 2 5 4 4 
3.2.1.10 Oligo-1,6-glucosidase GH13 1 1   2 1 
3.2.1.20 α-glucosidase GH4/13/31/63/97 3 1  1 1 
2.4.1.7 Sucrose phosphorylase GH13/57/119 1 1 1 1 1 
3.2.1.1 α-amylase/neopullalanase GH13/57  1 4 1 2 
2.4.1.18 α-1,4-glucan branching enzyme GH13/57 1   3 3 1 
3.2.1.68 Glycogen operon protein GH13 2    2 
3.2.1.54 Cyclo-maltodextrinase GH13/57 1     
3.2.1.26 β-fructosidase GH32 1  2 1  
3.2.1.18 Sialidase  GH33/34/83   2   
Table 1.4 Bifdobacterial glycosyl hydrolases 
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3.2.1.22 α-galactosidase  GH4/27/36/57/97 2 2 1 2 3 
3.2.1.24 α-mannosidase GH31/38/47/92 3 1 2 2  
2.4.1.25 4-α-glucanotransferase GH13/57/77 2 2 2 2 2 
3.2.1.96 Endo-β-N-acetyl glucosinaminidase GH18/73/85/111   1 1  
3.2.1.52 β -N-acetylglucosaminidase GH20/84/85 1 1 3 1  
3.2.1.140 Lacto-N-biose phosphorylase GH20/112  1  2  
3.2.1.52 β -N-acetyl hexosaminidase GH3/20 3   1 1 
3.2.1.55 α-L-Arabinosidase/arabinofuranisidase GH3/43/51 10 4 1 5 2 
3.2.1.37 β-xylosidase GH1/3/30/39/43/52/116 1 5  3 1 
3.2.1.41 Pullulanase GH13  1   2 
3.2.1.17 1,4- β -N-acetylmuramidase GH25/108   4 1 2 
3.2.1.25 β-mannosidase GH1/2/5     1 
3.2.1.177 α-xylosidase GH31 1   2  
3.2.1.8 Endo-1,4-βxylanase GH5/8/10/11/30/43/51 1  1 3  
3.2.1.17 Putative phage lysin  GH25    1  
3.2.1.53 β-N-acetyl galactosaminidase GH101    1  
3.2.1.93 Trehalose-6-phosphate hydrolase GH13  1   1 
3.2.1.89 Arabinogalactan-endo-1,4-β-galactosidase GH53 1 1  1  
3.2.1.51 α-L-fucosidase  GH29     2     
3.2.1.58 Glucan-1,3-β-glucosidase GH3/5/17 1   1 1   
3.2.1.97 Endo-α-N-acetylgalactosaminidase GH109   1   
3.2.1.75 Glucan-endo-1,6-β-glucosidase GH5/30     1 
5.4.99.15 Malto oligosyl trehalose synthase GH13  1   1 
NA Unknown GH5 1 1 1 1  
NA Unknown GH13 1 1  3  
NA Unknown GH23 3 3  2 2 
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NA Unknown GH30 1   1 1 
NA Unknown GH43 2 1  2  
NA Unknown GH101 1     
NA Unknown GH112 1  1   
NA Unknown GH121 1   1  
NA Unknown GH125 1 1  1  
NA Unknown GH127 2 1  2 1 
NA Unknown GH129 1 1 1 1  
NA Unknown GH120  1    
NA Unknown GH32  1    
NA Unknown GH95   1   
NA Unknown NC*   1   
NA Unknown GH65    1  
NA Unknown GH94     1 
NA Unknown GH25 1  2 1  
Total   56 40 46 62 38 
NC* indicates Not Characterised 
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EC Number Enzyme name        
3.2.1.74 Cellodextrinase GH1/5/9     1  
3.2.1.21 β-glucosidase/β-D-glucoside glucohydrolase GH1/3 2 3 3 6 3  
3.2.1.23 β-galactosidase GH1/2/35/42 5 4 4 6 10 5 
3.2.1.10 Oligo-1,6-glucosidase GH13   1 1       
3.2.1.20 α-glucosidase GH4/13/31/63/97 3 1 1  7 1 
2.4.1.7 Sucrose phosphorylase GH13/57/119 1 2 2 1 1 1 
3.2.1.1 α-amylase/neopullalanase GH13/57 2 2 3 6 3  
2.4.1.18 α-1,4-glucan branching enzyme GH13/57 1 1 1 1 1 1 
3.2.1.68 Glycogen operon protein GH13     2  
3.2.1.54 Cyclomaltodextrinase GH13/57     1 1 
3.2.1.14 Chitinase GH18/19/48    1 1  
3.2.1.45 Glucosylceramidase GH3/30 1 2 2  1  
3.2.1.26 β-fructosidase GH32 1   2 2  
3.2.1.18 Sialidase  GH33/34/83    1 1 2 
Table 1.4.1 Bifdobacterial glycosyl hydrolases 
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3.2.1.22 α-galactosidase  GH4/27/36/57/97 3 3 3 1 2 2 
3.2.1.24 α-mannosidase GH31/38/47/92    2 3  
3.2.1.89 Endogalactanase GH53     1  
2.4.1.230 Kojibiose phosphorylase GH65    1   
2.4.1.25 4-α-glucanotransferase GH13/57/77 2 2 2 2 2 1 
3.2.1.96 Endo- β-N-acetyl glucosinaminidase GH18/73/85/111     1  
3.2.1.52 β-N-acetylglucosaminidase GH20/84/85    1   
3.2.1.140 Lacto-N-biose phorylase GH20/112     1 2 
3.2.1.52 β -N-acetyl hexosaminidase GH3/20 1 1 1  2 5 
3.2.1.55 α -L-Arabinosidase/arabinofuranosidase GH3/43/51 3 1 2   1 
3.2.1.37 β -xylosidase GH1/3/30/39/43/52/116 1 3 2    
3.2.1.41 Pullulanase GH13 1 4 3 1   
3.2.1.17 1,4-β-N-acetylmuramidase GH25/108 2 2    1 
3.2.1.25 β-mannosidase GH1/2/5       
3.2.1.177 α-xylosidase GH31       
3.2.1.8 Endo-1,4-β-xylanase GH5/8/10/11/30/43/51  1 1 2  1 
3.2.1.93 Trehalose-6-phosphate hydrolase GH13   2    
3.2.1.68 Isoamylase GH13   2    
3.2.1.89 Arabinogalactan-endo-1,4-β-galactosidase GH53    1   
2.4.1.211 1,3-β-galactosyl-N-acetylhexosamine phosphorylase GH112    1   
3.2.1.86 6-phospho-β-glucosidase GH1      1 
3.2.1.51 α-L-fucosidase  GH29           2 
3.2.1.35 Hyalurononglucosaminidase GH84      3 
3.2.1.50 α-N-acetylglucosaminidase GH89      1 
3.2.1.58 Glucan-1,3-β-glucosidase GH3/5/17         1   
3.2.1.97 Endo-α-N-acetylgalactosaminidase GH109      1 
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2.4.1.20 Cellibiose phosphorylase GH94  1     
2.4.1.25/3.2.1.33 Glycogen debranching Enzyme GH13 2 2  1  2 
3.2.1.40 α-L-rhamnosidase GH78/106 1      
3.2.1.78 Mannon-endo-1,4-β-mannosidase GH2/5 1  1    
3.2.1.16 Trehalose synthase GH13  1     
NA Unknown GH5    2 1  
NA Unknown GH13 1   2  1 
NA Unknown GH23 2 2 2  2  
NA Unknown GH30 1      
NA Unknown GH43      1 
NA Unknown GH125    1 1  
NA Unknown GH127 1 1 1    
NA Unknown GH129     1 1 
NA Unknown GH95    1 1  
NA Unknown NC    1 1  
NA Unknown GH65     1  
NA Unknown GH94   1    
NA Unknown GH2    1   
NA Unknown GH33      1 
NA Unknown GH36    1   
NA Unknown GH25   2 3  3 
NA Unknown GH53       
Total   38 40 42 49 55 41 
NC* indicates Not Characterised 
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EC Number Enzyme name        
3.2.1.21 β-glucosidase/β-D-glucoside glucohydrolase GH1/3 2  13 5 1 3 
3.2.1.23 β-galactosidase GH1/2/35/42 5 4 11 7 1 5 
3.2.1.10 Oligo-1,6-glucosidase GH13     2 1 2 1 
3.2.1.20 α-glucosidase GH4/13/31/63/97 1 1 5 3 2 3 
2.4.1.7 Sucrose phosphorylase GH13/57/119 1 1 2 1 1 2 
3.2.1.1 α-amylase/neopullalanase GH13/57 1 1 1 3 1 1 
2.4.1.18 α-1,4-glucan branching enzyme GH13/57 1 1 1 1 1   
3.2.1.68 Glycogen operon protein GH13 3 1 2 2   
3.2.1.54 Cyclomaltodextrinase GH13/57 1 1     
3.2.1.14 Chitinase GH18/19/48     1  
3.2.1.45 Glucosylceramidase GH3/30   1 1   
3.2.1.26 β-fructosidase GH32   1 2 2  
Table 1.4.2 Bifdobacterial glycosyl hydrolases 
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3.2.1.18 Sialidase  GH33/34/83 2 2     
3.2.1.22 α-galactosidase  GH4/27/36/57/97 1  6 3 2 3 
3.2.1.24 α-mannosidase GH31/38/47/92    1  2 
3.2.1.89 Endogalactanase GH53   2    
2.4.1.25 4-α-glucanotransferase GH13/57/77 1 1 2 2 2  
3.2.1.96 Endo-β-N-acetyl glucosinaminidase GH18/73/85/111  3     
3.2.1.52 β-N-acetylglucosaminidase GH20/84/85 1 2     
3.2.1.140 Lacto-N-biose phosphorylase GH20/112 3 2     
3.2.1.52 β-N-acetyl hexosaminidase GH3/20 5 1  1   
3.2.1.55 α-L-Arabinosidase/arabinofuranosidase GH3/43/51 1 1 4 6 1 3 
3.2.1.37 β-xylosidase GH1/3/30/39/43/52/116   5 3  4 
3.2.1.41 Pullulanase GH13   2 2 4  
3.2.1.17 1,4-β-N-acetylmuramidase GH25/108 2 1 2 1 1  
3.2.1.25 β-mannosidase GH1/2/5   2    
3.2.1.177 α-xylosidase GH31   1 1  1 
3.2.1.8 Endo-1,4-β-xylanase GH5/8/10/11/30/43/51 1 1 3 2  3 
3.2.1.93 Trehalose-6-phosphate hydrolase GH13     1  
3.2.1.86 6-phospho- β -glucosidase GH1  1    1 
3.2.1.51 α-L-fucosidase  GH29   1 1     1 
3.2.1.50 α-N-acetylglucosaminidase GH89 1      
3.2.1.58 Glucan-1,3-β-glucosidase GH3/5/17     2 2 1   
3.2.1.97 Endo-α-N-acetylgalactosaminidase GH109 1      
3.2.1.4 cellulase/endo-1,4-β-glucanase GH5/8   2  2  
3.2.1.86 6-phospho-β-glucosidase GH1/4  1    1 
3.2.1.67 1,4-α-galacturonidase GH28      1 
3.2.1.11 Pectinesterase GH28      1 
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2.4.1.20 Cellibiose phosphorylase GH94   1    
2.4.1.25/3.2.1.33 Glycogen debranching Enzyme GH13     2  
3.2.1.40 α-L-rhamnosidase GH78/106   1    
3.2.1.75 Glucan-endo-1,6-β-glucosidase GH5/30       
3.2.1.78 Mannon-endo-1,4-β mannosidase GH2/5   1 1   
3.2.1.139 α-glucoronidase GH4/67      1 
3.2.1.16 Trehalose synthase GH13     1  
3.2.1.111 α-L-fucosidase 1,3/4 GH29/95 1      
3.2.1.51 α-L-1,2-fucosidase GH29/95 1      
NA Unknown GH5      1 
NA Unknown GH13  3 1 1   
NA Unknown GH23 2 1 2 2  1 
NA Unknown GH30      3 
NA Unknown GH43 1 1 2   1 
NA Unknown GH101  1     
NA Unknown GH125   1    
NA Unknown GH127   2 1   
NA Unknown GH129 1 1     
NA Unknown GH120    1   
NA Unknown GH32       
NA Unknown GH95  1     
NA Unknown NC*   1    
NA Unknown GH65      1 
NA Unknown GH2   1 1   
NA Unknown GH123 1 1     
NA Unknown GH3 1 1     
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NC* indicates Not Characterised 
 
 
 
 
 
 
NA Unknown GH110 1 1     
NA Unknown GH33  1     
NA Unknown GH1    1   
NA Unknown GH105      1 
NA Unknown GH115      2 
NA Unknown GH25   1  2 1 
Total   43 39 87 58 31 48 
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EC Number Enzyme name        
3.2.1.21 β-glucosidase/β-D-glucoside glucohydrolase GH1/3 2 4 3 3 4 3 
3.2.1.23 β-galactosidase GH1/2/35/42 2 4 5 4 4 4 
3.2.1.10 Oligo-1,6-glucosidase GH13 1 1 1 1 1 1 
3.2.1.20 α-glucosidase GH4/13/31/63/97 1 1 1 1 1 1 
2.4.1.7 Sucrose phosphorylase GH13/57/119 2 2 2 1 2 1 
3.2.1.1 α-amylase/neopullalanase GH13/57 1 3 2 1 3 1 
2.4.1.18 α-1,4-glucan branching enzyme GH13/57 1 1 1 1 1 2 
3.2.1.68 Glycogen operon protein GH13 2 1  2 1  
3.2.1.45 Glucosylceramidase GH3/30   2   2 
3.2.1.26 β-fructosidase GH32      1 
Table 1.4.3 Bifdobacterial glycosyl hydrolases 
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3.2.1.22 α-galactosidase  GH4/27/36/57/97 3 3 3 3 3 3 
2.4.1.25 4-α-glucanotransferase GH13/57/77 2 2 2 2 2 2 
3.2.1.52 β-N-acetylglucosaminidase GH20/84/85      2 
3.2.1.52 β-N-acetyl hexosaminidase GH3/20 1  1 1  1 
3.2.1.55 α-L-Arabinosidase/arabinofuranosidase GH3/43/51 2 2 1 2 2 1 
3.2.1.37 β -xylosidase GH1/3/30/39/43/52/116 1 1 3 1 1 3 
3.2.1.41 Pullulanase GH13 1 2 4 2 1 4 
3.2.1.17 1,4-β-N-acetylmuramidase GH25/108 1 1 1 2 2  
3.2.1.25 β-mannosidase GH1/2/5 2 1  2 1  
3.2.1.8 Endo-1,4-β-xylanase GH5/8/10/11/30/43/51 1  1    
3.2.1.93 Trehalose-6-phosphate hydrolase GH13 1      
3.2.1.4 Cellulase/endo-1,4-β-glucanase GH5/8 1      
2.4.1.20 Cellibiose phosphorylase GH94 1  1   1 
2.4.1.25/3.2.1.33 Glycogen debranching Enzyme GH13  1 2  1 2 
3.2.1.75 Glucan-endo-1,6-β-glucosidase GH5/30 1 1  1 1  
3.2.1.78 Mannon-endo-1,4-β-mannosidase GH2/5      1 
1.8.1.9 Unknown NC 1 1  1 1  
3.2.1.16 Trehalose synthase GH13   1 1   
NA Unknown GH13 1   1  1 
NA Unknown GH23 2 1 2 2 1 1 
NA Unknown GH30  1  1 1  
NA Unknown GH127 1 1 1 1 1 1 
NA Unknown GH94  1  1   
NA Unknown GH25  2   1 1 
Total   35 38 40 38 36 40 
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EC Number Enzyme name       
3.2.1.21 Glucosidase/β-D-glucoside glucohydrolase GH1/3 2 3 2 3 3 
3.2.1.23 β-galactosidase GH1/2/35/42 3 4 3 7 4 
3.2.1.10 Oligo-1,6-glucosidase GH13   2 2   2 
3.2.1.20 α-glucosidase GH4/13/31/63/97 3 3 2  2 
2.4.1.7 Sucrose phosphorylase GH13/57/119 1 1 2 1 1 
3.2.1.1 α-amylase/neopullalanase GH13/57 4  1 6 3 
2.4.1.18 α-1,4-glucan branching enzyme GH13/57 1 1 1 1 1 
3.2.1.54 Cyclomaltodextrinase GH13/57  1    
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3.2.1.26 β-fructosidase GH32  1 1 2  
3.2.1.22 α-galactosidase  GH4/27/36/57/97 3 2 3 3 3 
3.2.1.24 α-mannosidase GH31/38/47/92 2 2  3  
2.4.1.25 4-α-glucanotransferase GH13/57/77 2 2 2 2 2 
3.2.1.52 β-N-acetylglucosaminidase GH20/84/85 1 1  2  
3.2.1.140 lacto-N-biose phosphorylase GH20/112 1  1  1 
3.2.1.52 β -N-acetyl hexosaminidase GH3/20  1 1  2 
3.2.1.55 Α-L-Arabinosidase/arabinofuranosidase GH3/43/51 3 4 7 5 5 
3.2.1.37 β-xylosidase GH1/3/30/39/43/52/116 3 5  4 4 
3.2.1.41 Pullulanase GH13 2  1   
3.2.1.17 1,4-β-N-acetylmuramidase GH25/108 1 1    
3.2.1.177 α-xylosidase GH31   1 1  
3.2.1.8 Endo-1,4-β-xylanase GH5/8/10/11/30/43/51   2 2 1 
3.2.1.93 Trehalose-6-phosphate hydrolase GH13 1 1    
3.2.1.68 Isoamylase GH13  1    
3.2.1.89 Arabinogalactan endo-1,4-β-galactosidase GH53  1 1 1 1 
3.2.1.50 α-N-acetylglucosaminidase GH89 1     
3.2.1.58 Glucan-1,3-β-glucosidase GH3/5/17     1 1 1 
3.2.1.81 β-agarase GH16/50/86/118    1  
3.2.1.97 Endo-α-N-acetylgalactosaminidase GH109   1  1 
3.2.1.88 β-arabinosidase GH   1       
3.2.1.4 Cellulase/endo-1,4-β-glucanase GH5/8 1 1    
3.2.1.31 β-glucuronidase GH1/2/79   1 1  
2.4.1.25/3.2.1.33 Glycogen debranching Enzyme GH13  1 2 3 2 
3.2.1.16 Trehalose synthase GH13  1   1 
3.2.1.111 α-L-fucosidase 1,3/4 GH29/95    1  
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NC* indicates Not Characterised 
 
NA Unknown GH5 1 1  1  
NA Unknown GH13 4 1 4 1 3 
NA Unknown GH23 2 3 2  3 
NA Unknown GH30 2  2 1 1 
NA Unknown GH43 8 2 8 3 3 
NA Unknown GH101 1     
NA Unknown GH112  1  1  
NA Unknown GH121 1 1   1 
NA Unknown GH125 1 1  1  
NA Unknown GH127 2 1 1 1 2 
NA Unknown GH129  1 1 1 1 
NA Unknown GH120  1    
NA Unknown GH32     1 
NA Unknown GH95    1  
NA Unknown NC   1 1  
NA Unknown GH3 2  1   
NA Unknown GH25    2  
NA Unknown GH53 1     
Total   60 54 58 64 55 
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1.4.4 BIFIDOBACTERIAL α-GALACTOSIDASES 
Several putative and characterised α-galactosidases have been identified in 
bifidobacteria (71 in total based on Tables 1.4-1.8), of which most are very similar 
(belonging to GH family 36) and involved in the same carbohydrate metabolic 
pathway. This commonly occurring GH family 36 bifidobacterial α-galactosidase, is 
involved in the breakdown of raffinose family oligosaccharides (RFOs) (Martínez-
Villaluenga & Gómez, 2007; O'Connell et al., 2013b; Trojanova et al., 2006; Turroni 
et al., 2012c). This common α-galactosidase has been characterised in several 
bifidobacteria; for example the α-galactosidase produced by B. breve 203, was 
demonstrated to be capable of hydrolysing the α-(1 6) linkages of melibiose (Zhao 
et al., 2008). More recently (and presented in this thesis) an α-galactosidase from B. 
breve UCC2003 (and nearly identical to that characterised for B. breve 203) was 
characterised, which was observed to hydrolyse the α-(1 6) bonds in stachyose and 
raffinose to produce sucrose and galactose, and cleave melibiose to generate glucose 
and galactose. This enzyme also showed hydrolytic activity against synthetic α-(1
4) and α-(1 3)-galactobiose therefore exhibiting a rather broad substrate range 
(O'Connell et al., 2013b). 
Other examples of α-galactosidases characterised in bifidobacteria are those found in 
B. longum (Garro et al., 1994; Hirayama et al., 2012), B.adolescentis DSM 20083 
(Leder et al., 1999; Van Laere et al., 1999) and B. bifidum NCIMB 41171 (Goulas et 
al., 2009). Interestingly, an α-galactosidase belonging to GH family 110 was 
identified in B. bifidum JCM 1254, that was shown to be capable of hydrolysing α-(1
3)-linked galactose bonds present in branched blood group B antigen, while also 
hydrolysing group B human salivary mucin and erythrocytes (Wakinaka et al., 
2013). This study would suggest that the α-galactosiase enzyme RafA presented in 
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this study may also possess the ability to degrade these very complex carbohydrates 
through cleavage of specific α-galactose moieties.  
1.4.5 BIFIDOBACTERIAL β-GALACTOSIDASES 
A significant number of putative and characterised β-galactosidases have been 
identified in bifidobacteria (128 in total based on Tables 1.4-1.8), of which many are 
very similar (belonging to GH family 2 and 42, with several also classified as GH 
families 1 and 35). β-galactosidases represent the best studied bifidobacterial GHs 
which have been characterised in a range of bifidobacteria, such as B. angulatum 
(Rabiu et al., 2001), B. adolescentis (Hinz et al., 2004), B. bifidum (Hattori & 
Taylor, 2009; Jorgensen et al., 2001; Moller et al., 2001), B. longum (Hsu et al., 
2007; Li et al., 2014; Rossi et al., 2000), B. longum subsp. infantis (Hung & Lee, 
2002; Moller et al., 2001; Viborg et al., 2013; Yoshida et al., 2012), B. 
pseudolongum (Rabiu et al., 2001), and B. breve (O'Connell Motherway et al., 2013; 
Yi et al., 2011), to name but a few. 
The identified β-galactosidases identified in bifidobacteria have been shown to 
hydrolyse different substrates. For example, three β-galactosidases from B. bifidum 
were shown to hydrolyse the β-(1 4)-galactosidic bonds in lactose (Jorgensen et 
al., 2001), while a similar substrate specificity was observed for a β-galactosidase 
from B. adolescentis (Hinz et al., 2004). More recently a distinct hydrolytic ability 
was observed in the case of three β-galactosidases from B. longum subsp. infantis 
ATCC 15697, namely Bga42A, Bga42B, and Bga42C (Viborg et al., 2013). Bga42A 
was observed to prefer the β-(1 3)-galactosidic linkage found in certain HMOs, as 
well as other β-(1 3)- and β-(1 6)-galactosides attached to a glucose or galactose. 
In contrast, Bga42B very efficiently hydrolyses galactosyllactose, galactobiose and 
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galactotriose, which possess β-(1 4)-galactosidic linkages, while the substrate 
specificity of Bga42C resembled that of Bga42B, though with a lower specific 
activity. 
Not only have several β-galactosidases been shown to hydrolyse glycosidic bonds of 
different substrates, they have also been demonstrated perform glycosyl transfer 
reactions to synthesise GOS from lactose (Rabiu et al., 2001). The latter reactions 
require unnatural conditions: at a lactose concentration ranging from 30 % to 40 % 
(wt/wt), under these conditions GOS yields of 24.7 to 47.6% can be achieved (Hsu et 
al., 2007; Rabiu et al., 2001).  
1.4.6 BIFIDOBACTERIAL α-GLUCOSIDASES 
Quite a high number of α-glucosidases (50 in total based on the data presented in 
Tables 1.4-1.8) (most of which belong to GH families 13 or 31, although members of 
GH families 4, 63 and 97 have also been identified) have been either putatively 
identified or characterised in the genomes of various bifidobacterial species and 
strains. In B. adolescentis DSM 20083 two α-glucosidase-encoding genes (aglA and 
aglB) belonging to GH family 13 were characterised. Recombinant AglA 
demonstrated specificity for α-1,6 bonds, while AglB demonstrated specificity for α-
(1 2/ α-1 3/α-1 4/α 1,6) bonds, although with a preference for α-(1 4) (van 
den Broek et al., 2003). 
Similarly, two α-glucosidases-encoding genes, agl1 and agl2, were identified in B. 
breve UCC2003 (Pokusaeva et al., 2009). The corresponding products, Agl1 and 
Agl2, were shown to exhibit hydrolytic activity towards the α-glucosidic linkages 
present in panose, isomaltose, isomaltotriose, and in four sucrose isomers, namely 
palatinose, trehalulose, turanose, and maltulose, while also hydrolysing such bonds 
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in trehalose and, to a lesser extent, nigerose. In this instance the substrates of 
preference for both enzymes were panose, isomaltose, and trehalulose, representing 
α-(1 6) and α-(1 1) glucosidic linkages. Recently, a third α-glucosidase encoded 
by B. breve UCC2003 was characterised (presented in this thesis), which was shown 
to hydrolyse melezitose into glucose and fructose, thereby demonstrating that this 
protein has both α-(1 2) and α-(1 3)-glucosyl hydrolase activities. This protein 
was furthermore observed to hydrolyse sucrose and turanose to glucose and fructose 
(O'Connell et al., 2013b). Other α-glucosidases are predicted to be encoded by B. 
breve UCC2003, indicating that this strain encodes additional specificities that allow 
this strain to access other carbohydrate substrates with α-glucosidic linkages. 
1.5 DE NOVO MICROBIAL BIOSYNTHESIS OF FATTY ACIDS IN 
ESCHERICHIA COLI 
In this thesis we have studied the biosynthesis of certain unusual fatty acids. First, 
we will in broad terms discuss biosynthesis of fatty acids by Gram negative bacteria 
(E. coli), complemented with some additional information on this metabolic process 
in a high GC Gram positive bacteria (Streptomyces coelicolor). Fatty acids are 
generally soluble in organic compounds and are found in tissues of plants, animals 
and microorganisms, particularly when they are linked to glycerol molecules in the 
form of lipids (Christie, 2003). The typical molecular structure of a fatty acid is a 
straight, even-numbered chain of carbons terminated by a carboxyl group at one end. 
These fatty acids can take one of two forms, either being saturated when the fatty 
acid contains no double bonds, or being unsaturated implying that the fatty acid 
contains one or more double bonds in either cis or trans conformation (NB. in the cis 
conformation, hydrogen atoms are on the same side of the double bond, whereas in 
the trans conformation, they are on opposite sides) (Christie, 2003).  
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De novo fatty acid biosynthesis represents a crucial metabolic pathway in all living 
organisms. Fatty acid synthesis can be achieved via so-called type I or type II 
pathways. The main difference separating these two biosynthetic pathways is the 
way in which the fatty acid biosynthetic machinery is encoded. In the case of the 
type II system, which exists primarily in bacteria and plants, the enzymatic steps 
required for fatty acid biosynthesis are represented by individual proteins that are 
expressed by separate genes (White et al., 2005). In contrast, type I systems, which 
are mainly found in eukaryotes, carry all enzymatic activities required for fatty acid 
biosynthesis on one or two large polypeptide chains (Schweizer & Hofmann, 2004). 
Fatty acid biosynthesis has been studied in considerable detail in E. coli (Chan & 
Vogel, 2010; Rock & Cronan, 1996). For de novo (saturated) fatty acid production 
the fatty acid biosynthesis process begins with the carboxylation of acetyl-CoA into 
malonyl-CoA using acetyl-CoA carboxylase (Polakis et al., 1974, Fig. 1.2 A, step 1). 
Malonyl-CoA-ACP transacylase, specified by the FabD protein, transfers malonyl-
CoA to ACP (Acyl carrier protein), which is a cofactor protein that covalently binds 
all fatty acyl intermediates (Ruch & Vagelos, 1973) (Fig. 1.2 A, step 2). The formed 
malonyl-ACP then combines with an acetyl-CoA group by means of a condensation 
reaction that is catalysed by β-oxoacyl synthase III, also designated FabH, to form β-
oxobutyryl-ACP (Tsay et al., 1992) (Fig. 1.2 A, step 3). Following this step, the β-
oxoacyl-ACP is reduced by an NADPH-dependent β-oxoacyl reductase, designated 
FabG, into β-hydroxyacyl-ACP (Alberts et al., 1964) (Fig. 1.2 A, step 4). The 
hydroxy group is removed by one of two β-hydroxyacyl dehydratases, represented 
by FabA (Birge et al., 1967; Kass et al., 1967; Leon & Bloch, 1967) or FabZ 
(Mohan et al., 1994), which converts the chain into a trans-2-enoyl group (Fig. 1.2 
A, step 5). This leads to the reduction of the double bond in an NADH-dependent 
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reaction by an enoyl-reductase, designated FabI (Weeks & Wakil, 1968) (Fig. 1.2 A, 
step 6). Acyl-ACP bound by a saturated acyl chain extended by two carbon units is 
produced at this point. This cycle may also be initiated by FabB or FabF (Fig. 1.2 A, 
step 7).  
De novo production of unsaturated fatty acids (Chan & Vogel, 2010) follows in 
many ways the same biosynthetic pathway used for saturated fatty acid production as 
described above. The first step in the production of these acyl chains is facilitated by 
the fabA gene product, a β-hydroxyacyl dehydratase, which catalyses both a 
dehydration as well as an isomerisation reaction. FabA converts β-hydroxydecanoyl-
ACP into trans-2-decenoyl-ACP (Fig. 1.2 B, step 1) via a dehydration reaction and 
subsequently isomerises this fatty acyl intermediate trans-2-decenoyl-ACP to cis-3-
decenoyl-ACP (Fig. 1.2 B, step 2) (Birge et al., 1967; Kass et al., 1967; Leon & 
Bloch, 1967). Subsequently, the cis-3-decenoyl group undergoes a condensation 
reaction with another malonyl-ACP group, yielding cis-5-dodecenoyl-ACP (Fig. 1.2 
B, step 3), where the two added carbon groups are introduced closest to the carbonyl 
carbon. This reaction is catalysed by the second essential enzyme for unsaturated 
fatty acid synthesis, β-oxoacyl synthase I or FabB (Garwin et al., 1980a; Garwin et 
al., 1980b). This is then followed by the same elongation steps as for saturated fatty 
acid synthesis (Fig. 1.2 B, step 4 and 1.2A steps 1-7).  
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 Figure 1.2 De novo microbial biosynthesis of fatty acids in E. coli of (Panel A) saturated fatty acids (ACC represents acetyl CoA carboxylase) 
and (Panel B) unsaturated fatty acids (adapted from (Chan & Vogel, 2010). 
A. B. 
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1.5.1 DE NOVO MICROBIAL BIOSYNTHESIS OF FATTY ACIDS IN  
STREPTOMYCETES 
Although there is a paucity of information related to fatty acid biosynthesis in 
bifidobacteria, some relevant information is available from the Gram positive, high 
GC content Streptomyces. It was originally speculated that fatty acid synthesis in 
Streptomyces functioned as a type I system which is mainly present in yeast and 
mammalian cells (Revill et al., 1995; Rossi & Corcoran, 1973). However, it was 
later realised that this was incorrect when a type II system for fatty acid biosynthesis 
was discovered in Streptomyces (Revill et al., 1995; Summers et al., 1995). In 
contrast to E. coli which produces mainly straight chain fatty acids and functions 
specifically with acetyl-CoA (Tsay et al., 1992), species of Streptomyces most often 
produce branched fatty acids and can synthesise fatty acids employing other short 
chain fatty acids, such as isobutyryl-CoA and methylbutyryl-CoA, as well as acetyl-
CoA, as feeding materials for this biosynthetic pathway (Han et al., 1998). 
The acpP gene product of Streptomyces coelicolor has been proven to function as an 
acyl carrier protein due to its ability to compensate for an E. coli mutant deficient in 
fatty acid synthesis (Revill et al., 1996). Similarly, a gene which encodes FabD, 
specifying the malonyl-CoA-ACP transacylase, was identified in Streptomyces 
glaucescens, and shown to be able to complement an E. coli mutant carrying a 
dysfunctional fabD (Summers et al., 1995). This S. glaucescens fabD gene was also 
shown to be active in the presence of acyl carrier proteins from E. coli and S. 
glaucescens (Florova et al., 2002). The β-oxoacyl synthase III enzyme or FabH has 
also been identified in Streptomycetes through complementation of an S. coelicolor 
mutant carrying a mutated fabH gene. Interestingly, the presence of fabH from E. 
coli in this S. coelicolor mutant converted this complemented strain to the production 
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of mainly (86 %) straight chain fatty acids as opposed to the normal branched chain 
fatty acids (Li et al., 2005). Fatty acid synthesis in E. coli and S. coelicolor both 
show similarity in their mechanisms and therefore one would speculate that these 
two models are an apt example of how fatty acid biosynthesis would occur in 
bifidobacteria.  
1.6 CONJUGATED LINOLEIC ACID 
In this thesis the focus is specifically on linoleic acid (LA) which cannot be 
synthesised by humans and is a polyunsaturated fatty acid (PUFA) that is present in 
animals, plants and microorganisms (Gill & Valivety, 1997). Conjugated linoleic 
acid (CLA), ﬁrst identiﬁed over 25 years ago (Ha et al., 1987), is the collective term 
used to describe a group of PUFA that exist as positional and geometric 
stereoisomers of octadecadienoic acid. Unsaturated fatty acids are divided into 
mono-unsaturated fatty acids (MUFA), i.e. fatty acids that contain just a single 
double bond, and PUFA, which possess more than one double bond (Christie, 2003).  
Many of the fatty acids can be synthesised by humans; however, there is one 
particular group of essential PUFA, which the human body cannot produce, and 
which include omega-3 and omega-6 fatty acids. Examples are LA, an omega-6 fatty 
acid essential for building the water barrier in the skin (Zheng et al., 2011), and α-
linolenic acid, an omega-3 fatty acid and a precursor for eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), both representing fatty acids that exhibit a 
range of health benefits such as anti-inflammatory activity (for a review see (Wall et 
al., 2010)). Twenty eight different CLA isomers have so far been identified, of 
which the most abundant is the cis-9 trans-11 (c9, t11) isomer, representing 
approximately 80 % of total CLA in food products. CLA is found naturally in 
ruminant food products, for example lamb, beef and dairy, due to the process of 
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biohydrogenation of LA by specific bacteria in the rumen (Bhattacharya et al., 
2006).  
CLA has attracted a considerable amount of attention due to its purported health 
benefits. Interest in CLA grew when Pariza and his colleagues discovered the anti-
carcinogenic properties of both raw and grilled ground beef, where active 
compounds were identified as four isomers of LA (Pariza, 1997). These findings 
were extended when it was shown that certain isomers of CLA reduce carcinogenesis 
and body fat (Ogawa et al., 2005). Interest in CLA as a weight loss treatment has 
intensified in recent years, since it was first discovered that CLA ingestion can 
modulate body fat composition (Park et al., 1997b). In a recent study the 
supplementation of CLA over a 12 week period in overweight obese Chinese 
subjects resulted in lower obesity indices (Chen et al., 2012). 
Prebiotics compounds have been shown to not only stimulate the increased presence 
of probiotic bacteria, but have also been linked to modulating the amount of 
conjugated linoleic acid produced by certain commensal bacteria (Druart et al., 
2013). In vitro experiments have shown that isolated human gut bacteria have the 
ability to convert polyunsaturated fatty acids such as LA into conjugated PUFA such 
as CLA. It has been observed that feeding mice a diet that is high in LA coupled with 
supplementation with prebiotic carbohydrates increases the in vivo production of 
CLA by the murine gut microbiota (Druart et al., 2013). 
1.6.1 MICROBIAL BIOHYDROGENATION 
PUFAs are produced in the rumen by certain bacteria in ruminant animals. These 
ruminant animals are fed forage, which is a good source of LA and linolenic acid, 
while seed oils used to concentrate feed are also high in linoleic acid. It has been 
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hypothesised that following ingestion these dietary lipids undergo hydrolysis of the 
ester linkages by microbial lipases, this being a prerequisite for the second step, i.e. 
the biohydrogenation of fatty acids. Fatty acids are then released into the rumen, 
adsorbed on to feed particles and hydrogenated or integrated into bacterial lipids 
(Harfoot & Hazlewood, 1997; Jenkins et al., 2008). The process of biohydrogenation 
involves conversion of dietary LA to CLA (c9, t11) by a bacterial enzyme known as 
linoleic acid isomerase (LAI). CLA can then be further reduced via a reductase to 
form vaccenic acid, which is then thought to be reduced to stearic acid (Fig. 1.3). 
Endogenous synthesis also occurs simultaneously in the animal’s own tissues, the 
reduction of CLA to vaccenic acid is believed to be the rate limiting step in the 
reduction of CLA to stearic acid, which causes the build-up of vaccenic acid in the 
tissues where endogenous synthesis occurs via ∆9 desaturase enzyme (Griinari et al., 
2000) (Fig. 1.3). Butyrivibrio fibrisolvens was the first bacterium shown to perform 
the process of biohydrogenation of fatty acids (Polan et al., 1964). CLA was shown 
to be produced as an intermediate of this process (Kepler et al., 1966). 
In recent years a number of other bacteria belonging to the genera 
Propionibacterium, Lactobacillus and Bifidobacterium have been reported to convert 
LA into CLA when grown in either synthetic media or milk (Barrett et al., 2007). 
The biohydrogenation process is believed to be similar to that performed by 
ruminant bacteria (Lin et al., 2002), although CLA may undergo further 
isomerisation due to the fact that the resulting CLA product is not reduced or 
adsorbed (Coakley et al., 2003). It has been hypothesised that the process of CLA 
production by bifidobacteria may contribute to the positive effects of these bacteria 
in the GIT (Coakley et al., 2006). 
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It has also been hypothesised that the conversion of free LA to CLA may function as 
a detoxification mechanism in bacteria as free LA has been shown to inhibit growth 
of CLA-producing bacteria (Jiang et al., 1998). The bent structure of LA may 
interfere with the bacterial membrane and when free LA is conjugated the resulting 
fatty acid strain becomes straight chain fatty acid, thereby decreasing the fluidity of 
the membrane, which may also have a positive effect on stress resistance (Weber et 
al., 1994). 
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                Figure 1.3 Microbial biohydrogenation (adapted from (Bauman et al., 2000). 
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1.6.2 LINOLEIC ACID ISOMERASE 
The bacterial enzyme that is known to be involved in the conversion of LA to c9, t11 
CLA is the linoleic acid isomerase (LAI; EC 5.3.1.5). This enzyme was first isolated 
from Butyrivibrio fibrisolvens (Kepler et al., 1966; Kepler et al., 1970) and it was 
concluded from these studies that this isomerase is membrane bound, that it 
demonstrates a substrate requirement for cis-9,cis-12 diene systems and a free 
carboxyl group (as present in LA) (Kepler et al., 1970). The LAI from 
Propionibacterium acnes which isomerises LA to t10, c12 CLA has been expressed 
in bacteria, yeast and tobacco seeds (Hornung et al., 2005; Rosberg-Cody et al., 
2007). A gene encoding the LAI from P. acnes was cloned and overexpressed in 
Lactococcus lactis and E. coli, resulting in between 30-50  % conversion rates of LA 
to t10, c12 CLA (Rosberg-Cody et al., 2007).   
More recently the LAI enzymes from P. acnes, Lb. reuteri and Lb. acidophilus have 
also been expressed in E. coli (Luo et al., 2013). In this study they achieved 
purification of an active protein which has proven difficult previously to purify and 
subsequently had the ability to test different parameters of the enzyme in order to 
achieve optimal activity (Luo et al., 2013). It has been shown that lactobacilli 
expressing LAI from P. acnes can modulate the fatty acid composition of host 
adipose tissue in mice (Rosberg-Cody et al., 2011b). A recombinant Lactobacillus 
paracasei NFBC 338 derivative expressing the LAI from P. acnes was tested in 
order to see if it had an effect on fatty acid composition of different mouse tissues. 
The result showed a 4-fold increase in t10, c12 CLA in adipose tissue of mice as 
compared to those which received the non-CLA producing strain. The liver of the 
mice which received the recombinant strain also showed a 2.5-fold increase in the 
level of t10, c12 CLA as compared to the control strain. 
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1.6.3 CLA PRODUCTION BY BIFIDOBACTERIA 
In a study performed by (Coakley et al., 2003) the ability to convert LA to CLA by 
Lactobacillus, Lactococcus, Pediococcus and Bifidobacterium was assessed. The B. 
breve strain NCFB 2258 was shown to be the most efficient in converting free LA to 
CLA, as it was demonstrated to convert 65 % of linoleic acid to the c9, t11 CLA 
isomer. In a subsequent study the anti-proliferative characteristics of c9, t11 and t9, 
t11 obtained from B. breve NCFB 2258 CLA production was tested on two colon 
cancer cell lines resulting in both showing anti-proliferative affect with t9, t11 being 
the most potent (Coakley et al., 2006). B. breve DPC 6330, an isolate from a faecal 
sample from an elderly patient, showed high CLA-producing ability among the 
isolates tested (Barrett et al., 2007). More recently 17 bifidobacterial strains were 
tested for LA to CLA bioconversion and of the 17 strains 11 were capable of LA to 
CLA bioconversion (O'Connell et al., 2013a).  
1.6.4 MYOSIN CROSS REACTIVE ANTIGEN 
Myosin cross reactive (MCRA-like) proteins show over 50 % sequence similarity to 
the LAI from Lb. acidophilus and Lb. reuteri PYR8 (Rosson et al., 2001). The first 
MCRA protein (MW ~67 kDa) was identified in Streptococcus pyogenes, while 
screening for antigens recognised by acute rheumatic fever sera (Kil et al., 1994). 
The MCRA protein of S. pyogenes M49 was recently shown to represent a flavin 
adenine dinucleotide (FAD) enzyme which acts as a fatty acid hydratase (Volkov et 
al., 2010), catalysing the conversion of oleic acid into 10-hydroxystearic acid (Joo et 
al., 2012). 
The MCRA-like protein from B. breve has recently been characterised as an FAD-
dependent fatty acid hydratase with a role in stress protection (Rosberg-Cody et al., 
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2011a). The MCRA gene from B. breve NCFB 2258 was expressed in L. lactis and 
Corynebacterium glutamicum, and the recombinant protein was then tested for 
enzymatic activity using the fatty acid substrates palmitoleic, oleic and LA. The 
bifidobacterial MCRA was shown to catalyse the conversion of these fatty acids to 
10-hydroxy fatty acids. Other MCRA proteins have been characterised recently in 
hosts such as Lactobacillus rhamnosus LGG, Lb. plantarum ST-III, Lb. acidophilus 
NCFM and B. animalis subsp. lactis BB-12. These MCRA proteins were expressed 
in E. coli, and in all four cases the resulting recombinant E. coli strains catalysed the 
conversion of LA and oleic acid to 10-hydroxy derivatives (Yang et al., 2012). In 
both cases purified proteins were used. 
As mentioned previously MCRA-like proteins show over 50 % sequence similarity 
to the LAI from Lb. acidophilus and Lb. reuteri PYR8 (Rosson et al., 2001). The 
microbial production of CLA was elucidated using washed cells of Lb. acidophilus 
AKU 1137 (Ogawa et al., 2001) and involves the production of hydroxy fatty acids 
as precursor to formation of CLA. This study speculated that hydroxyl fatty acid 
production is the first step in CLA formation. When such hydroxy fatty acids are 
isolated and introduced to the washed cells of Lb. acidophilus AKU 1137, 
conversion to CLA isomers was shown to take place (Ogawa et al., 2001). It was 
therefore concluded that CLA formation by Lb. acidophilus AKU 1137 involves two 
steps: hydration of LA to 10-hydroxy-18:1, and the subsequent dehydration and 
isomerisation of these hydroxy fatty acids to the c9, t11 CLA and t9, t11 CLA 
isomers. Based on this context it was hypothesised that the MCRA plays an 
important role in CLA production. 
However, more recently (and presented in this thesis) it was observed that when an 
insertion mutant was created in the MCRA-encoding gene of B. breve NCFB 2258, 
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no effect on CLA production was observed, demonstrating that the MCRA-encoding 
gene does not play a role in CLA production by B. breve (O'Connell et al., 2013a). 
The MCRAUCC2003 insertion in B. breve UCC2003 did however affect its hydratase 
activity, as its ability to produce 10-hydroxy fatty acids from oleic acid was severely 
reduced. 
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1.7 CONCLUSION 
Discovery of novel, efficient and clinically proven prebiotics is an important field of 
product development for the food industry. Investigations on what carbohydrates can 
be utilised by bifidobacteria and the identification of the metabolic pathways 
involved will provide clues as to the identity of novel prebiotics. Through 
transglycosylation reactions it may also be possible to develop novel compounds 
utilising bifidobacterial GHs. Genome sequencing has allowed the identification of 
many putative GH-encoding genes in bifidobactreia, and much research is still to be 
done to fully explore and exploit these carbohydrate-active enzymes. 
Bifidobacteria have the ability to produce CLA which has been associated with many 
health benefits such as anti-tumour and weight loss activities. Genome sequencing 
and putative characterisation of genes has provided further insights into the 
metabolic process of fatty acid metabolism of bifidobacteria. However, the precise 
mechansism of CLA production by bifidobacteria is still elusive and further research 
has to be performed in order to fully elucidate this mechanism. It is also important to 
develop genetic tools capable of genetically manipulating bifidobacteria such as E. 
coli/bifidobacterial shuttle vectors as bifidobacteria are notoriously difficult to 
manipulate and there is a paucity of genetic tools available for this purpose. 
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1.7.1 THESIS OUTLINE 
Chapter I (above) is a general introduction of this thesis which covers carbohydrate 
metabolism and fatty acid metabolism specifically in bifidobacteria. 
Chapter II describes the identification and characterisation of a bifidobacterial oleate 
hydratase and its role in stress tolerance. 
Chapter III reports the identification and characterisation of two clusters of B. breve 
UCC2003 involved in raffinose-like sugars and melezitose utilisation. 
Chapter IV deals with the regulation of the gene clusters involved in the utilisation of 
raffinose-like sugars and melezitose utilisation by B. breve UCC2003. 
Chapter V aims to characterise the replication function of a novel bifidobacterial 
megaplasmid and attempts to create a shuttle vector. 
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2.1 ABSTRACT 
Bifidobacteria are common commensals of the mammalian gastrointestinal tract. 
Previous studies have suggested that a bifidobacterial myosin cross reactive antigen 
(MCRA) protein plays a role in bacterial stress tolerance, while this protein has also 
been linked to the biosynthesis of conjugated linoleic acid (CLA) in bifidobacteria. 
In order to increase our understanding on the role of MCRA protein in bifidobacteria 
we created and analysed an insertion mutant of the MCRA-encoding gene of B. 
breve NCFB 2258. Our results demonstrate that the MCRA protein of B. breve 
NCFB 2258 does not appear to play a role in CLA production yet is an oleate 
hydratase, which contributes to bifidobacterial solvent stress protection. 
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2.2 INTRODUCTION 
Bifidobacteria are Gram positive, non-motile, non-sporulating, anaerobic rods which 
possess a high G+C genome content, and belong to the phylum Actinobacteria and 
the family Bifidobacteriaceae (Ventura et al., 2004; Ventura et al., 2007). 
Bifidobacteria were first isolated more than a century ago (Tissier, 1900), and 
naturally inhabit the gastrointestinal tract of humans and other mammals, being 
particularly abundant in breast-fed infants (Turroni et al., 2008; Turroni et al., 2012). 
Bifidobacteria have been claimed to maintain gastrointestinal health (Tannock, 
1997), and are therefore used as a health-promoting or probiotic bacterial ingredients 
in certain functional foods (Stanton et al., 2005). Their reported beneficial effects on 
the host include inhibition of pathogens, alleviating lactose intolerance, enhancing 
natural immunity and reducing serum cholesterol (Leahy et al., 2005; Liu et al., 
2007; Ventura et al., 2012) 
Bifidobacteria have been shown to convert oleic acid (OA) to 10-hydroxystearic acid 
(10-HSA) (Rosberg-Cody et al., 2011a). OA is a mono-unsaturated fatty acid that 
occurs naturally in vegetable oils (Joo et al., 2012), and is reported to confer a range 
of health benefits including the inhibition of adrenoleukodystrophy (ALD), a 
metabolic disorder that leads to demyelination in the central and peripheral nervous 
system (Perusi et al., 1999), and reduction in blood pressure (Terés et al., 2008). 
Microbial hydration of an unsaturated fatty acid was first reported for Pseudomonas 
sp. 3266 (now known as Elizabethkingia meningoseptica), which was shown to 
possess the ability to convert OA to 10-HSA (Wallen et al., 1962). However, the 
isolation and biochemical characterisation of the enzyme responsible for this 
conversion, the oleate hydratase, was not reported until relatively recently (Bevers et 
al., 2009). The latter authors also showed that expression of the E. meningoseptica 
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OA hydratase, was strongly up-regulated when this bacterium was grown in the 
presence of 0.3 % OA. Unsaturated fatty acids such as OA have been shown to be 
toxic to many bacteria (Raychowdhury et al., 1985), which is probably due to the 
disruptive effect of these hydrophobic compounds on the bacterial membrane 
(Greenway & Dyke, 1979), combined with their inhibitory action on enoyl-ACP 
reductase (FabI) and thus fatty acid biosynthesis (Zheng et al., 2005). The hydration 
of unsaturated fatty acids is therefore hypothesised to represent a detoxification 
mechanism in bacteria to aid survival in environments rich in unsaturated fatty acids 
(Volkov et al., 2010).  
The first MCRA protein (MW ~ 67 kDa) was identified in Streptococcus pyogenes, 
while screening for antigens recognised by acute rheumatic fever sera. Its amino acid 
sequence did, at that time, not exhibit similarity to any streptococcal protein with a 
known function, although it was found to be conserved among pathogenic groups A, 
C, and G of Streptococci (Kil et al., 1994). The MCRA protein of Streptococcus 
pyogenes M49 was recently shown to represent a flavin adenine dinucleotide (FAD) 
enzyme which acts as a fatty acid hydratase (Volkov et al., 2010). This latter 
enzymatic activity catalyses the conversion of OA into 10-hydroxystearic acid, the 
role of the FAD-binding residues present in this and other (predicted) fatty acid 
hydratases/MCRA-like proteins are not fully understood (Joo et al., 2012).  
MCRA-like proteins show over 50% sequence similarity to the linoleic acid 
isomerase (LAI) from Lactobacillus acidophilus and Lb. reuteri PYR8 (Rosson et 
al., 2001). LAI catalyses the conversion of linoleic acid (LA, a dienoic unsaturated 
fatty acid) to cis-9 trans-11 (c9,t11) conjugated linoleic acid (CLA). CLA is the 
collective term used to describe a group of polyunsaturated fatty acids that exist as 
positional and geometric stereoisomer’s of octadecadienoic acid (Mulvihill, 2001). 
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Twenty eight different CLA isomers have been identified, of which the most 
abundant is the c9,t11 isomer, representing approximately 80 % of total CLA in food 
products. CLA is found naturally in ruminant food products, for example lamb, beef 
and dairy, due to the process of biohydrogenation of LA in the rumen (Bhattacharya 
et al., 2006). The LAI protein is a membrane-bound enzyme which was first isolated 
from Butyrivibrio fibrisolvens (Kepler et al., 1970). Subsequently, the crystal-
structure of an LAI from Propionibacterium acnes was solved (Liavonchanka et al., 
2006) and the reaction mechanism characterised (Liavonchanka et al., 2009). 
It was recently suggested (Rosberg-Cody et al., 2011a) that the MCRA-like protein 
produced by bifidobacteria is responsible for the first step of a two-step CLA 
production process in which hydroxy-fatty acids act as intermediates in the 
production of CLA (Ogawa et al., 2001). In the latter study, the gene encoding the 
MCRA-like protein from B. breve NCFB 2258 was cloned, sequenced and expressed 
in two heterologous hosts (Lactococcus and Corynebacterium), and the recombinant 
proteins assessed for enzymatic activity against fatty acid substrates. It was 
demonstrated that heterologous expression of this bifidobacterial MCRA in 
Lactococcus and Corynebacterium resulted in increased amounts of hydroxy-fatty 
acids in the culture medium. It was also observed that these recombinant hydroxy-
fatty acid-producing cells were more resistant to heat and solvent stress as compared 
to their non-recombinant, wild type controls. 
The aim of the current study was to investigate the biological function of the 
MCRA-like protein in Bifidobacterium breve. The obtained results show that the B. 
breve MCRA-like protein functions as an oleate hydratase, which plays a role in 
stress tolerance in bifidobacteria, though it does not appear to play a role in CLA 
production in B. breve.  
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2.3 MATERIALS AND METHODS 
Bacterial strains, plasmids and culture conditions  
Bacterial strains and plasmids used in this study are detailed in (Table 2.1). 
Bifidobacterial strains were routinely cultured in either de Man Rogosa and Sharpe 
medium (MRS; Difco™, BD, Le Pont de Claix, France) supplemented with 0.05 % 
cysteine-HCl, or reinforced clostridial medium (RCM; Oxoid Ltd. Basingstoke, 
England). Bifidobacterial cultures were incubated at 37oC under anaerobic 
conditions which were maintained using an anaerocult oxygen depleting system with 
an atmosphere of 5% CO2 - 5% H2 - 90% N2 (Merck, Darmstadt, Germany) in an 
anaerobic chamber. Escherichia coli strains were cultured in Luria-Bertani broth 
(LB) (Sambrook et al., 1989) at 37oC with agitation. Where appropriate, growth 
media contained erythromycin (Em; 100 µg ml-1 for E. coli), tetracycline (Tet; 10 µg 
ml-1 for E. coli and B. breve) or kanamycin (Km; 50 µg ml-1 for E. coli).  
Nucleotide sequence analysis  
Sequence data were obtained from the Artemis-mediated (Rutherford et al., 2000) 
genome annotations of the B. breve UCC2003 genome (O'Connell Motherway et al., 
2011b). Database searches were performed using non-redundant sequences 
accessible at the National Centre for Biotechnology Information internet site 
(http://www.ncbi.nlm.nih.gov) using Blast (Altschul et al., 1990; Altschul et al., 
1997). Sequence assembly, verification and analysis were performed using the 
Seqman and Seqbuilder programs of the DNASTAR software package (DNASTAR, 
Madison, WI, USA v10.1.2).  
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DNA manipulations  
Chromosomal DNA was isolated from bifidobacteria as previously described 
(O'Riordan & Fitzgerald, 1999). Minipreparation of plasmid DNA from E. coli was 
achieved using the Qiaprep spin plasmid miniprep kit (Qiagen GmBH, Hilden, 
Germany). Procedures for DNA manipulations were performed essentially as 
previously described (Sambrook et al., 1989). Restriction enzymes and T4 DNA 
ligase were used according to the supplier’s instructions (Roche Diagnostics, Bell 
Lane, East Sussex, UK). Synthetic single stranded oligonucleotide primers used in 
this study (Supplementary table S2.1) were synthesised by MWG Biotech AG 
(Ebersberg, Germany). Standard PCRs were performed using TaqPCR mastermix 
(Qiagen GmBH, Hilden, Germany), B. breve colony PCRs were performed using 
reddymix extensor PCR mastermix (Thermo scientific, Waltham, USA), and both of 
these PCR procedures were performed according to manufacturer’s instructions 
using a biometra T3000 thermocycler (Biometra, Goettingen, Germany). PCR 
amplicons were purified using the Qiagen PCR purification kit (Qiagen GmBH, 
Hilden, Germany). Electroporation of plasmid DNA into E. coli or B. breve NCFB 
2258 was performed as previously described (Maze et al., 2007; Sambrook et al., 
1989). The correct orientation and integrity of all constructs was verified by DNA 
sequencing, performed at MWG Biotech (Ebersberg, Germany).  
Construction of B. breve insertion mutant 
 B. breve NCFB 2258 is highly transformable achieving transformation efficiencies 
comparable to those achieved with B. breve UCC2003 and it was observed that 
methylation of plasmid DNA in E. coli pNZ-MBbrI-MBbrII allows homologous 
recombination to be achieved in B. breve NCFB 2258. An internal fragment of the 
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putative MCRA-encoding gene Bbr_1293 (472 bp) was amplified by PCR using B. 
breve UCC2003 chromosomal DNA as template and primer combination 
MCRAFhd3 and MCRARxba1 (Table 3). B. breve UCC2003 sequence was used to 
design all primers as the B. breve NCFB 2258 genome sequence is unavailable. The 
generated PCR product was ligated to pORI19, an Ori+ RepA- integration plasmid 
(Law et al., 1995), using HindIII and XbaI restriction sites that were incorporated 
into the primers for the MCRA amplicons and introduced into E. coli EC101 by 
electroporation. Recombinant E. coli EC101 derivatives containing pORI19-based 
constructs were selected on LB agar containing Em, and supplemented with X-gal 
(5-bromo-4-chloro-3-indolyl-D-galactopyranoside) (40 g ml-1) and 1 mM IPTG.  
The expected genetic structure of the recombinant plasmid, designated pORI19-
MCRA (pORI19 containing an internal 472 bp fragment of the MCRA-encoding 
gene), was confirmed by restriction mapping prior to subcloning of the Tet resistance 
antibiotic cassette, tetW, from pAM5 (Alvarez-Martin et al., 2007) as a SacI 
fragment into the unique SacI site of pORI19-MCRA.  
The orientation of the tetracycline (Tet) resistance gene in the resulting plasmid, 
designated pORI19-tet-MCRA, was determined by restriction analysis. The plasmid 
was subsequently introduced into E. coli EC101 pNZ-MBbrI-MBbrII and 
transformants were selected based on Cm and Tet resistance. Methylation of the 
plasmid complement of the obtained transformants in EC101 pNZ -MBbrI-MBbrII 
was confirmed by their observed resistance to PstI restriction (O'Connell Motherway 
et al., 2009). The methylated pORI19-tet-MCRA plasmid was introduced into B. 
breve NCFB 2258 by electroporation, with subsequent selection for tetracycline 
resistance on RCA plates supplemented with Tet. The methylated pORI19-tet-420 
plasmid (O'Connell Motherway et al., 2011a) was introduced into B. breve NCFB 
111 
 
2258 by electroporation, with subsequent selection for tetracycline resistance on 
RCA plates supplemented with Tet.  
Insertion mutants resulting from site specific homologous recombination were 
initially confirmed by colony PCR targeting the tetracycline resistance gene tetW. 
This was followed by a second confirmatory PCR adopting a tetW-based primer, 
either forward or reverse depending on the orientation of tetW, in combination with a 
primer specific for each targeted gene to confirm integration at the correct 
chromosomal position. In this case a product would only be obtained if the correct 
gene disruption had been achieved. 
Rapid analysis method for conjugated linoleic acid production 
The ability of isolates to convert free linoleic acid to CLA was assayed by incubating 
cultures in mMRS (Watson et al., 2013) broth supplemented with free linoleic acid 
(0.5 mg ml-1) (Sigma-Aldrich, Steinheim, Germany) at 37°C for 72 h, with 
subsequent assessment of the fatty acid profile using a rapid detection method for 
CLA production (Barrett et al., 2007). A standard curve (Barrett et al., 2007) 
demonstrated that an increase in the CLA concentration (from 0 to 0.05 mg ml-1) 
coincided with a linear increase (R2 = 0.9985) in absorbance for the c9,t11 CLA 
isomer up to an absorbance of 2.1. Therefore, the CLA concentrations in culture 
supernatants with an absorbance at 233 nm less than or equal to 2.1 could be 
calculated from the linear trend line of the standard curve using the equation y = 
43.431x + 0.0053. 
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Gas liquid chromatography (GLC) method for conjugated linoleic acid production 
The ability of isolates to convert free linoleic acid to CLA was assayed by incubating 
cultures in mMRS broth supplemented with free linoleic acid (0.5 mg ml-1) at 37°C 
for 72 h. Fatty acids were extracted from four grams of the fermented sample 
following addition of 0.75 mg of the internal standard tridecanoic acid (Sigma-
Aldrich, Steinheim, Germany). Two millilitres of isopropanol (Labscan, Bangkok, 
Thailand) and four millilitres of n-hexane (Labscan, Bangkok, Thailand) were added 
to the sample followed by vortexing for two minutes. Following centrifugation at 
2,197 xg for 5 minutes the resulting clear upper layer was removed to a clean glass 
tube and evaporated by heating at 45oC under a steady flow of nitrogen. Extracted 
fatty acids were converted to fatty acid methyl esters (FAMEs) by acid catalysed 
methylation using 4 % methanolic HCl (Supleco, Pennsylvania, USA) at 60oC for 20 
minutes and analysed by GLC analysis (Coakley et al., 2003; Stanton et al., 1997). 
Determination of hydratase activity  
Determination of hydratase activity was performed as previously published 
(Rosberg-Cody et al., 2011a), with the following modification: before extraction 
bacterial cells were ground into a fine powder under liquid nitrogen using a beat mill 
from Retsch (Haan, Germany) and stored at -80°C. GC/MS-analysis was then 
performed as indicated in a previous publication (Volkov et al., 2010). 
Stress tolerance 
B. breve NCFB 2258-MCRA and B. breve NCFB 2258-420, which carries a 
mutation in a gene previously shown to encode a β-galactosidase (control) 
(O'Connell Motherway et al., 2011a), were grown to OD600 nm 0.4 - 0.5, prior to 
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stress. Solvent tolerance was determined on addition of ethanol (final concentration 
16 %; v/v), after 180 minutes ten microliter volumes of serially diluted samples were 
spotted in triplicate on reinforced clostridial agar plates. Plates were incubated for 48 
hours at 37oC anaerobically. Spots containing between 3 and 30 colony forming 
units (CFU) were counted and the average was used to calculate the number of CFU 
per millilitre. The values presented are averages of triplicate experiments 
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2.4 RESULTS 
Analysis of CLA production by various Bifidobacterium species  
The ability of various strains of bifidobacteria to convert LA to CLA was analysed 
using a rapid spectrophotometer-based method (Barrett et al., 2007). Of the 17 
bifidobacterial strains tested 11 strains were capable of LA to CLA bioconversion. B. 
longum strains KJOC1, KJOC2, UCC2 and UCC3, and B. breve strains UCC1 and 
UCC2003 did not appear to produce appreciable amounts of CLA from free LA. 
Due to the fact that the spectrophotometer-based method merely gives an estimation 
of CLA content, a more accurate gas liquid chromatography (GLC) method (Coakley 
et al., 2003) was adopted. Our results demonstrate that B. breve NCFB 2258 was the 
strain with the highest CLA (c9,t11) conversion capability, which was in keeping 
with the rapid spectrophotometer results in terms of high and low CLA producers 
(Table 2.2). However, B. breve UCC2003 and B. breve NCIMB 8807 were shown to 
exhibit different CLA production capabilities even though B. breve UCC2003 is a 
clonal isolate of B. breve NCIMB 8807 (Sheehan et al., 2007). Upon close 
examination B. breve NCIMB 8807 was shown to gradually lose its CLA-producing 
capability upon repeated sub-cultivation (results not shown). Although the reasons 
for this unstable CLA-production phenotype are not clear, other CLA-producing 
strains used in this study did not exhibit such behaviour. 
Identification and analysis of a B. breve UCC2003 myosin cross reactive encoding 
gene / MCRAUCC2003 
A gene designated MCRAUCC2003, predicted to encode a protein with similarity to 
other myosin cross reactive antigen (MCRA) proteins was identified from the 
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annotation of the genome sequence of B. breve UCC2003 (O'Connell Motherway et 
al., 2011b). At protein level, the predicted product of MCRAUCC2003 is almost 
identical (99 % identity) to predicted MCRAs encoded by homologs on the genomes 
of Bifidobacterium breve CETC 7263 (Genbank accession number ADY18551.1), 
DSM 20213 (Genbank accession number ZP_12586529.1), ACS-071-V-Sch8b 
(Genbank accession number ZP_06596910.1), while also displaying high levels of 
identity (80-99%) to annotated MCRA-encoding genes from a range of other 
bifidobacteria. An exception to this is found for MCRA homologs on the genomes of 
B. animalis subsp. lactis HN019 (Genbank accession number ZP 02963377) and B. 
animalis subsp. animalis ATCC 25527 (Genbank accession number YP 
006279649.1), where just 68% identity is observed compare to MCRAUCC2003. The 
apparently monocistronic MCRAUCC2003 (1,878 bp) on the B. breve UCC2003 
genome corresponds to a deduced protein of 625 amino acids (Mw ~ 70.5 kDa), and 
is located upstream of a ribosomal RNA (rRNA) operon and downstream from a 
gene predicted to encode a 2,5-diketo-D-gluconic acid reductase A (Fig. 2.1) 
A mutation in the MCRA-like gene does not affect CLA production in B. breve 
NCFB 2258 
As mentioned above, MCRA-like proteins exhibit over 50 % sequence similarity to 
LAI from Lactobacillus acidophilus and Lb. reuteri PYR8 (Rosson et al., 2001), 
which have been implicated in the conversion of LA to c9,t11 CLA. It was recently 
also suggested (Rosberg-Cody et al., 2011a) that these MCRA-like proteins are 
responsible for the first step of a proposed two-step CLA production process in 
which hydroxy-fatty acids act as intermediates in the production of CLA (Ogawa et 
al., 2001). In order to determine if the MCRA-encoding gene is involved in CLA 
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production, an insertion mutant was created in the MCRA-encoding gene, designated 
here as MCRANCFB2258, of B. breve NCFB 2258 after which the CLA production 
capability of the mutant strain was analysed. Based on the rapid spectrophotometer 
method of (Barrett et al., 2007), the B. breve NCFB 2258-MCRA insertion mutant 
was shown to produce the same amount of CLA as the parent strain B. breve NCFB 
2258, and this result was verified by GLC analysis (Table 2.2). These data 
convincingly demonstrate that the MCRA-encoding gene does not play a role in 
CLA production by B. breve NCFB 2258, at least under the conditions tested. 
Effect of the MCRA insertion mutation on hydratase activity of B. breve NCFB 
2258 
Bifidobacteria have been shown to exhibit hydratase activity, which allows such 
bacteria to convert oleic acid into 10-hydroxyoctadecanoic acid otherwise known as 
10-hydroxystearic acid (10-HSA) (Rosberg-Cody et al., 2011a). In order to test if 
hydratase activity was affected in B. breve NCFB 2258-MCRA carrying a mutation 
in MCRANCFB2258, this strain was subjected to a hydratase activity test as previously 
described (Volkov et al., 2010). In contrast to the control strain B. breve NCFB 
2258-420, which carries an insertion in Bbr_0420, previously characterised as an β-
galactosidase (O'Connell Motherway et al., 2011a), the insertion mutant B. breve 
NCFB 2258-MCRA did not exhibit hydratase activity above the threshhold detection 
level (Fig. 2.2), thus substantiating the hypothesis that the MCRANCFB2258 gene 
product acts as a hydratase that converts oleic acid into 10-HSA.  
MCRA insertion mutation affects the stress tolerance of B. breve NCFB 2258  
Heterologous expression of the B. breve NCFB 2258 MCRA protein in Lactococcus 
and Corynebacterium had previously been shown to cause increased stress tolerance 
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to 3 % (v/v) butanol (Rosberg-Cody et al., 2011a). These findings suggest that a 
mutation in this gene in B. breve NCFB 2258 would consequently lead to increased 
sensitivity to certain stressful conditions. In order to test this assumption, B. breve 
NCFB 2258-MCRA and B. breve NCFB 2258-420 (control) were grown to an 
OD600 nm of between 0.4 and 0.5, prior to exposure to solvent stress, which was 
achieved by the addition of ethanol (final concentration 16 %; v/v). The obtained 
results show that the B. breve NCFB 2258-MCRA insertion mutant is indeed more 
sensitive to solvent stress than the control strain B. breve NCFB 2258-420 in the 
presence of ethanol (Fig. 2.3). 
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2.5 DISCUSSION 
The aim of the current study was to investigate the biological function of the 
MCRA-encoding gene of B. breve in the hydration of oleic acid into 10-
hydroxystearic acid and its possible role in CLA production. We showed that various 
bifidobacterial strains have different CLA production capabilities with B. 
breve NCFB 2258 and B. breve JCM 7017 producing high levels of CLA (Coakley 
et al., 2003; Hennessy et al., 2009; Rosberg-Cody et al., 2004) while the tested B. 
longum strains did not produce measurable amounts of CLA from LA, a feature 
common among B. longum strains (Ewaschuk et al., 2006; Rosberg-Cody et al., 
2004). Interestingly, analysis of the CLA-producing capability of B. breve NCIMB 
8807 showed that this strain lost this ability during repeated sub-cultivation, a 
phenomenon that has not been reported previously. 
In this study we demonstrated that the MCRA-encoding gene from B. breve NCFB 
2258 is an oleate hydratase, which is responsible for the breakdown of oleic acid to 
10-hydroxystearic acid. MCRA-encoding genes from various bacteria, including 
bifidobacteria, have been associated with hydratase activity (Bevers et al., 2009; 
Rosberg-Cody et al., 2011b; Volkov et al., 2010; Yang et al., 2012). The MCRA-
like protein has been implicated in the first step of CLA production, an assumption 
which is based on the finding that CLA production from LA by L. acidophilus is 
presumed to be a two-step process in which hydroxy fatty acids act as intermediates 
in the production of CLA (Ogawa et al., 2001). This hypothesised mechanism of 
bacterial CLA production was based on the finding that washed cells of the strain Lb. 
acidophilus AKU 1137 were shown to rapidly convert hydroxy fatty acids to their 
respective CLA isomers. Therefore CLA production by Lb. acidophilus was 
proposed to involve hydration of LA to 10-hydroxy-18:1, followed by the 
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dehydration and isomerisation of hydroxy fatty acids to c9,t11 CLA. It is evident in 
this study that the MCRA-encoding gene of B. breve NCFB 2258 is not involved in 
CLA production and that bifidobacteria follow a different biochemical route to 
achieve LA to CLA conversion. It is also interesting to note that this MCRA gene is 
present in B. longum strains which do not produce CLA such as in this case KJOC1. 
In relation to solvent stress, B. breve NCFB 2258-MCRA was shown to be more 
sensitive to 16 % ethanol (v/v) as compared to the control strains B. breve NCFB 
2258 and B. breve NCFB 2258-420. In a previous study (Rosberg-Cody et al., 
2011b) increased stress tolerance to butanol was observed when B. breve NCFB 
2258  MCRA was heterologously expressed in L. lactis and C. glutamicum. Ethanol 
was chosen as an alternative membrane stress to butanol as similarities exist in how 
microbes respond to these membrane stress-invoking compounds (Liu & Qureshi, 
2009). The effects of ethanol are a result of dielectric, polar and hydrogen bond 
interactions with the surface groups of the membrane and membrane proteins, 
ethanol therefore has the same effects as butanol (Jones, 1989). Previous studies 
have suggested that MCRA proteins play a role in stress tolerance within the 
gastrointestinal tract. Deletion of the MCRA-encoding gene in L. acidophilus was 
shown to result in a strain that exhibited reduced growth in the presence of lactate, 
acetate and salt, which is consistent with a reduced membrane integrity (O'Flaherty 
& Klaenhammer, 2010).  
Ethanol and butanol are short chain alcohols and bacteria respond to these 
compounds in a similar manner through changes in membrane fatty acid 
composition, structure and membrane fluidity (Liu & Qureshi, 2009). In Gram 
negative bacteria exposure to ethanol leads to disruption of cell membrane integrity 
and structure which leads to cell death. Ethanol-tolerant phenotypes in some E. coli 
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strains are known to result from adaptive changes in the composition of the 
membrane fatty acids with fatty acid length changing from 16 to 18 carbons, while 
other changes in the composition of the cell envelope may also confer tolerance (Liu 
& Qureshi, 2009).  
The mechanism underlying Gram positive bacterial tolerance to organic solvents has 
not been studied extensively (Torres et al., 2011), and have been speculated to be 
due to the induction of a general stress regulon (Sardessai & Bhosle, 2002), 
production of organic solvent-emulsifying or deactivating enzymes (Moriya et al., 
1995) and/or an active solvent efflux pump (Inoue & Horikoshi, 1991; Moriya et al., 
1995). Unsaturated fatty acids are toxic for many bacteria due to their detrimental 
effect on the cytoplasmic membrane and it has been hypothesised that MCRA 
ensymes may provide a detoxification mechanism by the hydration of unsaturated 
fatty acids (Volkov et al., 2010). This detoxification activity may also apply to the 
bifidobacterial MCRA proteins and may represent a physiological adaptation to the 
colonic environment. 
Collectively our results demonstrate that the MCRA-like protein encoded by B. 
breve NCFB 2258 is an oleate hydratase, which plays a role in stress tolerance in 
bifidobacteria, while it does not appear to have a role in LA to CLA conversion by B. 
breve. The actual metabolic pathway of CLA production in bifidobacteria is thus still 
elusive and our future research efforts will aim to uncover the genetic elements 
involved in this bioconversion. 
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2.7 TABLES AND FIGURES 
Table 2.1 Bacterial strains and plasmids used in this study 
 
JCM: Japan Collection of Microorganisms; NIZO: Nizo Food Research; LMG: 
Belgian coordinated Collection of Microorganisms; NCFB: National Collection of 
Food Bacteria; NCIMB: National Collection of Industrial and Marine Bacteria; 
NCTC: National Collection of Type Cultures; UCC: University College Cork 
Culture Collection. 
Strain/ plasmid Relevant characteristics Reference or source 
E.coli strains   
EC101-pNZ-
M.Bbrll+Bbr111 
EC101 harbouring pNZ8048 derivative 
containing bbrllM and bbrlllM 
(MaryO’Connell-
Motherway et al., 2009) 
EC101 
 
Cloning host, repA+ kmr (Law et al., 1995) 
B.breve strains 
UCC2003 
NCIMB 8807 
NCFB 2257 
NCTC 11815 
NCFB2258 
NCIMB 8815 
JCM 7017 
UCC2005 
UCC2007 
NIZO658 
LMG 13208 
UCC1 
 
Isolate from a nursling stool 
Isolate from a nursling stool 
Isolate from infant intestine 
Isolate from infant intestine 
Isolate from infant intestine 
Isolate from infant faeces 
Isolate from human faeces 
Isolate from human faeces 
Isolate from human faeces 
Isolate from a nursling stool 
Isolate from infant intestine 
Isolate from human faeces 
 
(Maze et al., 2007) 
NCIMB 
NCFB 
NCTC 
NCFB 
NCIMB 
JCM 
UCC 
UCC 
NIZO 
LMG 
UCC 
NCFB2258-
MCRA 
NCFB2258-420 
 
B.longum Strains 
UCC2 
UCC3 
KJOC1 
KJOC2 
 
pORI19-tet-MCRA insertion mutant of  
2258 
pORI19-tet-420 insertion mutant of  
2258 
 
Isolate from human faeces 
Isolate from human faeces 
Isolate from infant faeces  
Isolate from infant faeces  
This study 
This study 
 
UCC 
UCC 
UCC 
UCC 
Plasmids   
pORI19 
pAM5 
 
Emr , repA- , ori+ , cloning vector 
pBC1-puC19-Tcr 
 
(Law et al., 1995) 
(Alvarez-Martinet al., 2007) 
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 Table 2.2 Bioconversion of linoleic acid to CLA by bifidobacterial strains 
* Values represent the average of two independent experiments 
   CLA converted from 0.5mg ml-1 linoleic acid* 
Strain Species Source c9,t11 S.D % Converted 
Bifidobacterium breve  UCC2003 Isolate from a nursling stool 0.008 0.001 1.73 
 NCIMB 8807 Isolate from a nursling stool 0.085 0.011 17.16 
 NCFB 2257 Isolate from infant intestine 0.027 0.006 5.54 
 NCTC 11815 Isolate from infant intestine 0.148 0.011 29.64 
 NCFB 2258 Isolate from infant intestine 0.245 0.021 49.0 
 NCIMB 8815 Isolate from infant faeces 0.077 0.021 15.54 
 JCM 7017 Isolate from human faeces 0.229 0.027 45.90 
 UCC2005 Isolate from human faeces 0.179 0.033 35.88 
 UCC2007 Isolate from human faeces 0.054 0.003 10.84 
 Nizo 658 Isolate from a nursling stool 0.083 0.004 16.70 
 LMG 13208 Isolate from infant intestine 0.055 0.00 11.16 
 UCC1 Isolate from human faeces 0.005 0.000 1.05 
 NCFB 2258-MCRA This study 0.213 0.002 42.60 
Bifidobacterium longum      
 UCC2 Isolate from human faeces 0 0 0 
 UCC3 Isolate from human faeces 0 0 0 
 KJOC1 Isolate from infant faeces 0 0 0 
 KJOC2 Isolate from infant faeces 0 0 0 
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Figure 2.1 Schematic representation of the comparison of the myosin cross reactive antigen encoding gene, MCRAUCC2003, from B. breve 
UCC2003 to other sequenced B. breve (O'Connell Motherway et al., 2009). 
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 Figure 2.2 The ability of B. breve NCFB 2258-MCRA and B. breve NCFB 2258-
420 (control) to convert oleic acid to 10-hydroxystearic acid was assayed by 
incubating cultures in MRS broth which contains 1% oleic acid at 37°C for 16 h, 
with subsequent assessment of the fatty acid profile.  
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Figure 2.3 B. breve NCFB 2258-MCRA and B. breve NCFB 2258-420 (control) grown in the absence and presence of ethanol 16% (v/v). Log 
phase cells were grown to  an OD600 nm of 0.4 - 0.5, prior to stress of  ethanol 16% (v/v), after 180 minutes cultures were spot plated, incubated 
at 37oC for 48hrs anaerobically this was followed by viable cell counts. The values represent the average of three independent experiments with 
standard error. *P <0.001 
127 
 
2.8 SUPPLEMENTARY MATERIAL 
Table S2.1 Oligonucleotide primers used in this study 
Purpose Primer Sequencea Size 
Amplification of MCRA internal fragment 
from B. breve UCC2003 to create mutant 
MCRAFhd3 
MCRARxba1 
TGCATCAAGCTTCGATGACGAGGTGCTGAAC 
TGCGCATCTAGACAGCCGCCGTTGGTGATG 
 
472bp 
Confirmation of MCRA integration in B. breve 
NCFB 2258 
 
Confirmation of 420 integration in B. breve 
NCFB 2258 
MCRA -confirm 
Tetwsal1F 
 
420-confirm 
Tetsal1F 
CTACAGCAGCGGCAACTATG 
TCAGCTGTCGACATGCTCATGTACGGTAAG 
 
GTTGCTACTCCCTCTGACTCTCC 
TCAGCTGTCGACATGCTCATGTACGGTAAG 
3.5KB 
 
 
3.2KB 
 
 
Confirmation of tetw integration in B. breve 
NCFB 2258 
 
Tetwsal1F 
Tetwsal1R 
 
TCAGCTGTCGACATGCTCATGTACGGTAAG 
GCGACGGTCGACCATTACCTTCTGAAACATA 
2.2KB 
a Sequences of restriction enzyme sites are indicated in bold 
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3.1 ABSTRACT 
Members of the genus Bifidobacterium are common inhabitants of the 
gastrointestinal tract of humans and other mammals, where they ferment many diet-
derived carbohydrates that cannot be digested by their host. To extend our 
understanding of bifidobacterial carbohydrate utilisation, we investigated the 
molecular mechanisms by which eleven strains of Bifidobacterium breve metabolise 
four distinct α-glucose and/or α-galactose-containing oligosaccharides. Here we 
demonstrate that all B. breve strains examined possess the ability to utilise raffinose, 
stachyose and melibiose. However, the ability to metabolise melezitose was not 
ubiquitous for all tested B. breve strains. Transcriptomic and functional genomic 
approaches identified a gene cluster dedicated to the metabolism of α-galactose-
containing carbohydrates, while an adjacent gene cluster, dedicated to the 
metabolism of α-glucose-containing melezitose, was identified in strains able to use 
this carbohydrate. 
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3.2 INTRODUCTION 
Bifidobacteria are Gram positive, saccharolytic, non-motile, non-sporulating, 
anaerobic rods which possess a high GC genome content, and belong to the phylum 
Actinobacteria and the family Bifidobacteriaceae (Miyake et al., 1998; Ventura et 
al., 2007b). The first representatives of the genus Bifidobacterium were isolated 
more than a century ago (Tissier, 1900), and these bacteria naturally inhabit the 
gastrointestinal tract of humans and other mammals, being particularly abundant in 
breast-fed infants (Turroni et al., 2008; Turroni et al., 2012a). Certain bifidobacterial 
strains have been claimed to promote and maintain gastrointestinal health (Tannock, 
1997) and are therefore used as health-promoting or probiotic bacterial ingredients in 
certain functional foods (Stanton et al., 2005). Their reported beneficial effects on 
the host include, among others, inhibition of bacterial and viral pathogens, 
alleviating lactose intolerance, enhancing natural immunity and reducing serum 
cholesterol (Leahy et al., 2005; Liu et al., 2007; Ventura et al., 2012).  
As saccharolytic microorganisms, bifidobacteria degrade various oligosaccharides 
and polysaccharides into their monosaccharide constituents, which are then shuttled 
into a specific hexose fermentation pathway called the fructose-6-phosphate 
phosphoketolase pathway or bifid-shunt (Scardovi & Trovatelli, 1965). Species- or 
strain-specific proliferation of commensal bifidobacteria is presumed to be 
stimulated by particular dietary carbohydrates, which are for this reason termed 
prebiotic substances (Macfarlane et al., 2008). The term prebiotic was first coined in 
1995 (Gibson & Roberfroid, 1995), when it was defined as “non-digestible food 
ingredients that beneficially affect the host by selectively stimulating the growth 
and/or activity of one or a limited number of bacteria in the colon”. Up to 8 % of the 
coding capacity of a bifidobacterial genome is dedicated to carbohydrate 
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metabolism, of which half are considered to be responsible for carbohydrate uptake, 
mainly via ATP binding cassette (ABC) transporters, although proton motive force-
driven permeases, proton symporters, and phosphoenolpyruvate-dependent 
phosphotransferase systems (PEP-PTSs) may also be employed for this purpose 
(Maze et al., 2007; Pokusaeva et al., 2011a; Schell et al., 2002). A range of glycosyl 
hydrolases, enzymes that hydrolyse a specific glycosidic bond between the 
monosaccharidic moieties of certain oligo- and polysaccharides, allow bifidobacteria 
to grow on dietary and host-derived carbohydrates present in the gastrointestinal 
tract (Pokusaeva et al., 2011a).  
Certain bifidobacterial strains have previously been shown to grow on soymilk-
derived α-galacto-oligosaccharides, such as raffinose [α-D-Galp-(1 6)-α-D-Glcp-(1
2)-β-D-Fruf], stachyose [α-D-Galp-(1 6)-α-D-Galp-(1 6)-α-D-Glcp-(1 2)-β-
D-Fruf] and melibiose [α-D-Galp-(1 6)-α-D-Glcp] (Garro et al., 1999; Minami et 
al., 1983; Yazawa et al., 1978). Stachyose and raffinose (sugars of the so-called 
raffinose family, which also includes verbascose) are present in a wide variety of 
plants (French, 1954), while the related sugar melibiose (though not a member of the 
raffinose family) is also found in many plants, being particularly abundant in 
soybean roots and stems (Rehms & Barz, 1995). To metabolise such α-galacto-
oligosaccharides bifidobacteria require α-galactosidase enzyme activity, which has 
been identified and characterised in five bifidobacterial species, B.bifidum JCM 1254 
(Wakinaka et al., 2013) B. adolescentis (Leder et al., 1999; Van Laere et al., 1999), 
B. bifidum (Goulas et al., 2009), B. breve (Zhao et al., 2008) and B. longum subsp. 
longum (Garro et al., 1994; Hirayama et al., 2012).  
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Raffinose utilisation and its transcriptional regulation have been characterised in 
more detail in Escherichia coli than in bifidobacteria. In E. coli, raffinose is actively 
transported into the cell using a dedicated raffinose permease (encoded by rafA), 
after which raffinose is hydrolysed into sucrose and galactose by an α-galactosidase 
(specified by rafB), followed by hydrolysis of the sucrose into glucose and fructose 
by a sucrose hydrolase, which is encoded by rafD (Aslanidis et al., 1989).  
Various α-glucosidases are produced by Bifidobacterium sp. (Pokusaeva et al., 2009; 
van den Broek et al., 2003), such as the enzymes encoded by agl1 and agl2, which 
were previously identified and characterised in B. breve UCC2003 (Pokusaeva et al., 
2009). These two enzymes, both members of glycosyl hydrolase (GH) family 13 
which mainly represents enzymes with α-(1 6)-glucosidase activity (EC 3.2.1.10), 
were shown to exhibit hydrolytic activity towards panose, isomaltose, isomaltotriose, 
as well as four sucrose isomers, palatinose, trehalulose, turanose and maltulose, 
while they were also shown to partially degrade trehalose and nigerose. The 
preferred substrates for the Agl1 and Agl2 enzymes were shown to be panose, 
isomaltose, and trehalulose, carbohydrates that contain either an α-(1 6)-glucosidic 
bond (present in panose and isomaltose) or an α-(1 1)-glucosidic bond (present in 
trehalulose) (Pokusaeva et al., 2009). 
Melezitose [α-D-Glcp-(1 2)-β-D-Fruf-(3 1)-α-D-Glcp] is an α-glucose-containing 
trisaccharide found in honeydew and manna, which are sugar-rich liquid and solid 
deposits, respectively, associated with leaves and branches of various trees and 
shrubs (Bacon & Dickinson, 1957). Although it was initially believed that melezitose 
is an oligosaccharide that is naturally present in various plants (Hudson, 1946), it 
was later concluded that certain insects are responsible for melezitose production as 
this sugar is absent from the tree sap used by such insects to form honeydew (Bacon 
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& Dickinson, 1957). To the best of our knowledge no information is available on 
how (bifido)bacteria metabolise melezitose.  
In the current study, we describe the identification of two adjacent gene clusters, mel 
and raf, present in the genome of B. breve UCC2003 which are involved in the 
metabolism of melezitose and raffinose-family/related sugars, respectively. 
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3.3 MATERIALS AND METHODS 
Bacterial strains, plasmids and culture conditions  
Bacterial strains and plasmids used in this study are detailed in (Table 3.1). 
Bifidobacteria were routinely cultured in either de Mann Rogosa and Sharpe medium 
(MRS; Difco™, BD, Le Pont de Claix, France), supplemented with 0.05 % cysteine-
HCl, or reinforced clostridial medium (RCM; Oxoid Ltd. Basingstoke, England). 
Carbohydrate utilisation by bifidobacterial strains was examined in modified de 
Mann Rogosa and Sharpe Medium (mMRS) prepared from first principles (De Man 
et al., 1960), devoid of a carbohydrate source. Prior to inoculation, the mMRS 
medium was supplemented with cysteine-HCl (0.05 % w/v) and a particular 
carbohydrate source (1 % w/v). The carbohydrates used were raffinose, stachyose, 
melezitose, melibiose and glucose (all purchased from Sigma-Aldrich, Steinheim, 
Germany). Bifidobacterial cultures were incubated at 37oC under anaerobic 
conditions which were maintained using an Anaerocult oxygen depleting system 
(Merck, Darmstadt, Germany) in an anaerobic chamber. Lactococcus lactis strains 
were cultivated in M17 broth containing 0.5 % glucose (Terzaghi & Sandine, 1975) 
at 30oC. E. coli strains were cultured in Luria-Bertani broth (LB) (Sambrook et al., 
1989) at 37oC with agitation. Where appropriate, growth media contained 
chloramphenicol (Cm; 5µg ml-1 for L. lactis, 10 µg ml-1 for E. coli, and 2.5 µg ml-
1 for B. breve), erythromycin (Em; 100 µg ml-1 for E. coli), tetracycline (Tet; 10 µg 
ml-1 for E. coli or B. breve) or kanamycin (Km; 50 µg ml-1 for E. coli).  
In order to determine bacterial growth profiles and final optical densities, 5 ml of 
freshly prepared mMRS medium including a particular carbohydrate (see above) was 
inoculated with 50 µl (1 %) of a stationary phase culture of a particular B. breve 
strain. Un-inoculated mMRS was used as a negative control. Cultures were 
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incubated anaerobically at 37oC for 16 hours, and the optical density at 600 nm 
(OD600) was determined during this period at 30 minute intervals using a 
Powerwave™ microplate spectrophotometer (BioTek Instruments, Inc. USA) in 
conjunction with Gen5™ Microplate Software for Windows. 
Nucleotide sequence analysis 
 Sequence data was obtained from the Artemis-mediated (Rutherford et al., 2000) 
genome annotations of B. breve UCC2003 (O'Connell Motherway et al., 2011b). 
Database searches were performed using non-redundant sequences accessible at the 
National Centre for Biotechnology Information (NCBI) 
(http://www.ncbi.nlm.nih.gov) using the basic local alignment search tool (BLAST) 
(Altschul et al., 1990; Altschul et al., 1997). Sequence verification and analysis were 
performed using the Seqman and Seqbuilder programs of the DNASTAR software 
package (DNASTAR, Madison, WI, USA v10.1.2).  
DNA manipulations 
 Chromosomal DNA was isolated as previously described (O'Riordan & Fitzgerald, 
1999). Minipreparation of plasmid DNA from E. coli, B. breve or L. lactis was done 
using the Qiaprep spin plasmid miniprep kit (Qiagen GmBH, Hilden, Germany). For 
B. breve or L. lactis an initial lysis step was incorporated into the plasmid isolation 
procedure by resuspending cells in lysis buffer supplemented with lysozyme (30 mg 
ml-1) followed by incubation at 37oC for 30 minutes. Procedures for DNA 
manipulations were performed essentially as described previously (Sambrook et al., 
1989). Restriction enzymes and T4 DNA ligase were used according to the 
supplier’s instructions (Roche Diagnostics, Bell Lane, East Sussex, UK). Synthetic 
single stranded oligonucleotide primers used in this study are detailed in 
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(Supplementary table S3.1), and were synthesised by Eurofins (Ebersberg, 
Germany). Standard PCRs were performed using TaqPCR mastermix (Qiagen 
GmBH, Hilden, Germany), in a Biometra T3000 thermocycler (Biometra, 
Goettingen, Germany). PCR products were visualised by EtBR staining following 
agarose gel electrophoresis (1%). B. breve colony PCRs were performed as 
described previously (O'Connell Motherway et al., 2009). PCR fragments were 
purified using the Qiagen PCR purification kit (Qiagen GmBH, Hilden, Germany). 
Electroporation of plasmid DNA into E. coli was performed as previously described 
(Sambrook et al., 1989). Electrotransformation of B. breve UCC2003 (Maze et al., 
2007) and L. lactis (Wells et al., 1993) was performed according to published 
protocols. The correct orientation and integrity of all plasmid constructs (see also 
below) were verified by DNA sequencing, performed at Eurofins (Ebersberg, 
Germany).  
Construction of B. breve insertion mutant strains 
Internal fragments of Bbr_1856 (designated here as melE) (421 bp, representing 
codons 242 through to 383 out of the 620 codons of this gene), Bbr_1857 
(designated melD) (456 bp, representing codons 92 through to 244 out of the 556 
codons of this gene), Bbr_1860 (designated melA) (331 bp, representing codons 230 
through to 341 out of the 441 codons of this gene), Bbr_1867 (designated rafB) (394 
bp, representing codons 95 through to 226 out of the 429 codons of this gene), 
Bbr_1869 (designated rafA) (474 bp, representing codons 319 through to 477 out of 
the 771 codons of this gene) were amplified by PCR using B. breve UCC2003 
chromosomal DNA as template and the oligonucleotide primer combinations 
1856fHd3 and 1856rxba1, 1857fHd3 and 1857rxba1, 1860fHd3 and 1860rxba1, 
1867fHd3 and 1867rxba1, and 1869hd3 and 1869Rxba1, respectively. Each of the 
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generated PCR products was ligated to pORI19, an Ori+ RepA- integration plasmid 
(Law et al., 1995), using HindIII and XbaI restriction sites that were incorporated 
into the primers for the melE, melD, melA, rafB and rafA fragment-encompassing 
amplicons and introduced into E. coli EC101 by electroporation. Recombinant E. 
coli EC101 derivatives containing pORI19 constructs were selected on LB agar 
containing Em, and supplemented with X-gal (5-bromo-4-chloro-3-indolyl-D-
galactopyranoside) (40 g ml-1) and 1 mM IPTG.  
The expected genetic structure of each of the resulting recombinant plasmids, 
pORI19-melE (pORI19 containing an internal 421 bp fragment of the melE gene), 
pORI19-melD (pORI19 containing an internal 456 bp fragment of the melD gene), 
pORI19-melA (pORI19 containing an internal 331 bp fragment of the melA gene), 
pORI19-rafB (pORI19 containing an internal 394 bp fragment of the rafB gene) and 
pORI19-rafA (pORI19 containing an internal 474bp fragment of the rafA gene), was 
confirmed by restriction mapping and sequencing prior to subcloning of the Tet 
resistance antibiotic cassette, tetW, from pAM5 (Alvarez-Martin et al., 2007) as a 
SacI fragment into the unique SacI site in each of the pORI19 derivatives. The 
orientation of the tetracycline resistance gene in each of the resulting plasmids, 
pORI19-tet-melE, pORI19-tet-melD, pORI19-tet-melA, pORI19-tet-rafB and 
pORI19-tet-rafA (naming is consistent with the names of their predecessor plasmids, 
see above, to which the ‘-tet-’ designation was added), was determined by restriction 
analysis. The plasmids were subsequently introduced into E. coli EC101 pNZ-
MBbrI-MBbrII in order to achieve methylation, and transformants were selected 
based on Cm and Tet resistance. Methylation of the plasmid complement of the 
obtained transformants in EC101 pNZ-MBbrI-MBbrII was confirmed by their 
observed insensitivity to PstI restriction (O'Connell Motherway et al., 2009). 
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Plasmid preparations of methylated pORI19-tet-melE, pORI19-tet-melD, pORI19-
tet-melA, pORI19-tet-rafB and pORI19-tet-rafA were then introduced into B. breve 
UCC2003 by electroporation with subsequent selection for transformants on RCA 
plates supplemented with Tet. Insertion mutants resulting from site-specific 
homologous recombination were initially confirmed by colony PCR targeting the 
tetracycline resistance gene tetW, followed by a second confirmatory PCR adopting a 
tetW-based primer, either forward or reverse depending on the orientation of tetW, in 
combination with a primer specific for each targeted gene to confirm integration at 
the correct chromosomal position. In this case, a product would only be obtained if 
the correctly positioned gene disruption had occurred. 
Analysis of global gene expression using B. breve DNA microarrays 
 Global gene transcription patterns were determined by microarray analysis during 
growth of B. breve UCC2003 on raffinose, stachyose, melibiose, melezitose or 
sucrose, and these transcriptomes were compared to that obtained from cells that had 
been grown on ribose as the sole carbohydrate source. All biological replicates were 
hybridised using a dye-swap strategy. DNA-microarrays containing oligonucleotide 
primers representing each of the 1864 annotated genes on the genome of B. breve 
UCC2003 were designed by and obtained from Agilent Technologies (Palo Alto, 
Ca., USA). Methods for cell disruption, RNA isolation, RNA quality control, 
complementary DNA synthesis and labelling were performed as described 
previously (Zomer et al., 2009). Labelled cDNA was hybridised using the Agilent 
Gene Expression hybridisation kit (part number 5188-5242) as described in the 
Agilent Two-Color Microarray-Based Gene Expression Analysis v4.0 manual 
(G4140-90050). Following hybridisation, microarrays were washed in accordance 
with Agilent standard procedures and scanned using an Agilent DNA microarray 
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scanner (model G2565A). Generated scans were converted to data files with 
Agilent's Feature Extraction software (Version 9.5). DNA-microarray data were 
processed as previously described (Garcia De La Nava et al., 2003; van Hijum et al., 
2003; van Hijum et al., 2005). Differential expression tests were performed with the 
Cyber-T implementation of a variant of the t-test (Long et al., 2001). A gene was 
considered differentially expressed when p < 0.001, and an expression ratio of >3 or 
<0.33 relative to the control. The microarray data have been deposited in NCBI's 
Gene Expression Omnibus and are accessible through GEO Series accession number 
GSE47448. 
Expression and purification of RafA, MelE and MelD 
 DNA fragments containing the complete (predicted) α-galactosidase-encoding 
genes, rafA and melE, or α-glucosidase-encoding gene, melD, were generated by 
PCR amplification from chromosomal DNA of B. breve UCC2003 using Taq DNA 
polymerase and primer combinations 1869EcorVF and 1869Xba1R, 1856EcorVF 
and 1856Xba1R, or 1857Nco1F and 1857Xba1R, respectively (Table S1). NcoI or 
EcoRV, and XbaI restriction sites were incorporated at the 5’ ends of each forward 
and reverse primer combination, respectively (Table S1). In addition, an in frame 
His10-encoding sequence was incorporated into each of the forward primers to 
facilitate downstream protein purification using the Ni-NTA affinity system (Qiagen 
GmBH, Hilden, Germany). The three generated amplicons were digested with 
NcoI/EcoRV and XbaI, and ligated into NcoI/ScaI and XbaI-digested nisin-inducible 
translational fusion plasmids pNZ8048 (which contains an NcoI site) or pNZ8150 
(which contains a ScaI site), depending on the restriction sites of the amplified 
fragment (Mierau et al., 2005). The ligation mixtures were introduced into L. lactis 
NZ9000 (Table 3.1) by electrotransformation, and transformants were selected based 
151 
 
on chloramphenicol resistance. The plasmid content of a number of Cmr 
transformants were screened by restriction analysis and the integrity of positively 
identified clones, namely pNZMelE-His containing gene melE, pNZMelD-His 
containing gene melD, and pNZRafA-His containing gene rafA, were verified by 
sequencing. 
In order to achieve protein (over)expression and purification, 400 ml of M17 broth 
supplemented with 0.5 % w/v glucose was inoculated with a 2 % v/v inoculum of a 
particular L. lactis strain, followed by incubation at 30oC until an OD600 of 0.5 was 
reached, at which point protein expression was induced by the addition of purified 
nisin (5 ng ml-1) followed by continued incubation at 30oC for 90 minutes. Cells 
were harvested by centrifugation, washed and concentrated 40-fold. Protein 
purification was performed using a PrepEase® kit specialised for his-tagged protein 
purification (USB,Germany) Elution fractions were analysed by SDS 
polyacrylamide gel electrophoresis, as previously described (Laemmli, 1970) on a 
12.5 % v/v polyacrylamide gel. After electrophoresis, the gels were fixed and stained 
with Commassie Brilliant blue to identify fractions containing the purified protein. 
Rainbow prestained low molecular weight protein markers (New England Biolabs, 
Herdfordshire, UK) were used to estimate the molecular weight of the purified 
proteins. 
Biochemical characterisation of MelD, MelE and RafA 
 Determination of the putative α-glucosidase activity of MelD, and the presumed α-
galactosidase activity of RafA and MelE were performed essentially as described 
previously (Börnke et al., 2001). A 50 µl volume of each purified protein 
(concentration of 0.5 mg ml−1) was incubated with 20 mM MOPS (pH 7.0). In the 
case of RafA and MelE, 0.1 mg ml-1 w/v of α-(1 4)-galactobiose, α-(1 3)-
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galactobiose, raffinose, stachyose, melibiose, melezitose, turanose or sucrose was 
added to 20 mM MOPS buffer as the enzyme substrate in a final volume of 1 ml at 
37oC. To analyse the catalytic activities of MelD, 0.1 mg ml-1 w/v of α-(1 4)-
galactobiose, α-(1 3)-galactobiose, melezitose, maltulose, palatinose, turanose, 
leucrose, sucrose, raffinose, stachyose or melibiose was added to 20 mM MOPS 
buffer at pH 7.0 as the enzyme substrate in a final volume of 1 ml and incubated at 
37oC. Following incubation, 200 µl samples were taken at 24 hours intervals. 
Samples were filtered by membrane filtration, using Spin-Xpin-X centrifuge tube 
filters® (pore size, 0.45 μm; Costar, Corning Inc. NY), and stored at -20°C prior to 
High-Performance Anion Exchange Chromatography with Pulsed Amperometric 
Detection (HPAEC-PAD) analysis, see below.   
Kinetic constants for MelD using sucrose or turanose, and for RafA using melibiose, 
raffinose or stachyose were determined by measuring the hydrolysis rates at various 
substrate concentrations, ranging from 2.5 to 100 mM. Reactions were initiated by 
the addition of 50µl of purified protein (concentration of 0.5 mg ml−1) in 20 mM 
MOPS buffer at the optimum pH and temperature determined for each protein, and 
the reactions were stopped at different time points (up to 6 minutes) by heat 
treatment at 100°C for 15 minutes. All experiments were performed in duplicate and 
the amount of released glucose from each disaccharide substrate, namely melibiose, 
sucrose and turanose, was measured using the glucose hexokinase assay kit (Sigma-
Aldrich, Steinheim, Germany) according to the manufacturer's instructions. In the 
case of raffinose and stachyose hydrolysis, a sucrose assay kit was utilised, in which 
case enzyme activity is based on the amount of released sucrose as measured 
according to manufacturer’s instructions (Sigma-Aldrich, Steinheim, Germany). 
Sucrose/turanose or melibiose (50 mM) were used as substrates for the determination 
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of the pH (pH range of 2.5 to 9.5 was tested) and temperature (a range from 4°C to 
60°C was used) optimum. Reactions were initiated by the addition of 50 µl of 
purified protein (concentration of 0.5 mg ml−1) in 20 mM MOPS buffer at pH 7.0. 
High performance anion exchange chromatography with pulsed amperometric 
detection (hpaec-pad) analysis 
 For HPAEC-PAD analysis, a Dionex ICS-3000 system (Dionex, Sunnyvale, CA) 
was used. Carbohydrate fractions (25 μl aliquots) were separated on a CarboPac PA1 
(Dionex) analytical-exchange column with dimensions 250 mm x 4 mm with a 
CarboPac PA1 guard column (Dionex) with dimensions 50 mm x 4 mm and a pulsed 
electrochemical detector (Dionex ED40) in the pulsed amperometric detection 
(PAD) mode. Elution was performed at a constant flow-rate of 1.0 ml min-1 at 30°C 
using the following eluents for the analysis (A) 200 mM NaOH, (B) 100 mM NaOH 
plus 550 mM NaAcetate, and (C) Milli-Q water. The following linear gradient of 
sodium acetate was used: 100 mM NaOH: 0-50 min, 0 mM; 50-51 min, 16 mM; 51-
56 min, 100 mM; 56-61 min, 0 mM. Chromatographic profiles of standard 
carbohydrates were used for comparison of the results on their breakdown by 
proteins MelD, MelE and RafA. The Chromeleon software-Version 6.70 (Dionex 
Corporation) was used for the integration and evaluation of the chromatograms 
obtained. A 10 mg ml-1 stock solution of each of the carbohydrates to be used as 
reference standards was prepared by dissolving the particular sugar in deionised 
milli-Q water. The stock solution was sterilised by membrane filtration, using 
ministart filters (pore size, 0.45 μm; Sartorius AG, Göttingen, Germany), and stored 
at 4°C.  
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3.4 RESULTS & DISCUSSION 
Carbohydrate-dependent growth analysis of various B. breve strains  
Knowledge of carbohydrate metabolism by individual bifidobacterial species or 
strains is important in order to evaluate the prebiotic potential of particular 
carbohydrates from a dietary perspective. In order to determine if different strains of 
B. breve possess the ability to utilise the α-glycosidic bond-containing sugars 
raffinose, stachyose, melibiose and melezitose as sole carbohydrate sources (all of 
approximately 99 % purity), growth profiles were determined for eleven B. breve 
strains. All tested B. breve strains exhibited good growth (final OD600 > 1.0) in 
mMRS supplemented with raffinose, stachyose or melibiose (Fig. 3.1). Six strains 
exhibited good growth in mMRS supplemented with melezitose, while five strains, 
namely B. breve JCM 7017, B. breve 461, B. breve 689, B. breve NCFB 2257 , B. 
longum subsp. infantis ATCC 15697 and B. breve NCFB 2258 were not capable of 
appreciable growth (final OD600 < 0.4) on melezitose as a sole carbohydrate source 
(Fig. 3.1). 
Transcriptome analysis of B. breve UCC2003 when grown on raffinose, stachyose 
or melibiose 
 In order to identify genes involved in the metabolism of raffinose-related 
carbohydrates, we investigated differences in global gene expression upon growth of 
B. breve UCC2003 on raffinose, stachyose or melibiose, as compared with growth 
on ribose (the metabolic pathway for this carbohydrate has previously been 
characterised in B. breve UCC2003, and growth on this sugar has been shown to 
provide a suitable transcriptomic reference) (Pokusaeva et al., 2010), employing 
DNA microarray analysis (see materials and Methods). The resulting transcriptomic 
155 
 
data showed that transcription of the contiguous genes Bbr_1869, Bbr_1867, 
Bbr_1866 and Bbr_1865, designated here as rafA, rafB, rafC and rafD, respectively, 
were significantly upregulated (fold change > 4.0, P < 0.001) in B. breve UCC2003 
cultures grown on raffinose, stachyose or melibiose, relative to cultures grown on the 
control carbohydrate ribose, thus implicating this gene cluster in raffinose-related 
sugar metabolism in B. breve UCC2003 (Table 3.2). Furthermore, transcription of 
four additional genes was upregulated when B. breve UCC2003 was grown on 
raffinose (and on stachyose, although this transcriptional increase was just below the 
cut-off value of four-fold), but not on melibiose (relative to the ribose 
transcriptome), namely Bbr_0026, Bbr_0027, Bbr_0030 and Bbr_100, which are 
predicted to encode two ABC-type permeases, a hypothetical protein, and a putative 
sucrose phosphorylase, respectively. Since these four genes also exhibit increased 
transcription when B. breve UCC2003 is grown on sucrose (relative to growth on 
ribose, Table 3.2), we hypothesise that they are involved in the metabolism of this 
disaccharide, which is released upon removal of the α-galactose moieties from the 
non-reducing end of raffinose and stachyose, in contrast to melibiose hydrolysis, 
which results in galactose and glucose release. 
Our data on the raf cluster of B. breve UCC2003 and, by inference, related species 
suggests that many bifidobacteria metabolise raffinose, and the related sugars 
stachyose and melibiose, by means of a somewhat different metabolic route 
compared to that known for E. coli (Aslanidis & Schmitt, 1990). Raffinose-type 
sugar uptake in B. breve UCC2003 and other bifidobacteria apparently occurs via an 
ABC-type transporter system, which is a common way for bifidobacteria to 
internalise carbohydrates (Maze et al., 2007; O'Connell Motherway et al., 2008; 
O'Connell Motherway et al., 2011a; Pokusaeva et al., 2009; Pokusaeva et al., 2010; 
156 
 
Pokusaeva et al., 2011b; Ryan et al., 2005). Removal of the α-galactose moiety from 
raffinose and stachyose results in the release of sucrose, which in the case of E. coli 
is further metabolised via a sucrose hydrolase (Aslanidis & Schmitt, 1990), while in 
B. breve UCC2003 sucrose utilisation appears to occur by a sucrose phosphorylase, 
as a gene that is predicted to encode such an activity exhibits increased transcription 
when UCC2003 is grown on sucrose or sucrose-containing sugars (Table 3.2). 
Sucrose metabolism by sucrose phosphorylase has been characterised in other 
bifidobacteria, for example Bifidobacterium adolescentis DSM20083 (van den Broek 
et al., 2004), B. longum (Kim et al., 2003; Kwon et al., 2007) and Bifidobacterium 
animalis subsp. lactis (Trindade et al., 2003). Based on the ability of all examined B. 
breve strains to utilise raffinose-type oligosaccharides (Fig. 3.1), combined with 
other reports in the literature regarding raffinose utilisation by bifidobacteria and 
corroborated by the presented comparative genome analysis (see below, Fig. 3.2), 
raffinose-type sugar utilisation appears to be an ubiquitous property of 
bifidobacteria, supporting previous publications on the prebiotic potential of (some 
of) these sugars (Amaretti et al., 2006; Dinoto et al., 2006; Rada et al., 2002; Turroni 
et al., 2012b).  
Although transcription of the raf gene cluster of B. breve is induced in the presence 
of either raffinose, melibiose or stachyose, it has been shown that the raffinose 
system in Streptococcus pneumoniae is upregulated in the presence of raffinose, but 
not melibiose, suggesting differential regulatory mechanisms (Rosenow et al., 1999). 
Transcriptome analysis of B. breve UCC2003 when grown on melezitose 
In order to identify genes involved in melezitose utilisation by B. breve UCC2003, 
transcriptome analysis was performed upon growth of B. breve UCC2003 on this 
157 
 
trisaccharide, and compared with that obtained when grown on ribose. Analysis of 
transcriptome data obtained from two independent biological replicates revealed that 
transcription of the contiguous genes Bbr_1860 through to Bbr_1856, which are 
designated here as melA, melB, melC, melD and melE, respectively (Fig. 3.2), and 
which are located in close proximity of the raf gene cluster, were significantly 
upregulated (fold change > 4.0, P < 0.001) in B. breve UCC2003 cultures grown on 
melezitose as compared to cultures grown on ribose (Table 3.2). 
These results implicate the melABCDE gene cluster in melezitose metabolism in B. 
breve UCC2003. Interestingly, based on previously published comparative genome 
hybridisation data (O'Connell Motherway et al., 2011b), we noticed that B. breve 
strains that did not exhibit growth on melezitose lack the melABCDE gene cluster. 
Furthermore, and reminiscent of the results obtained for transcriptome analysis when 
strain UCC2003 was grown on stachyose and raffinose, transcription of four 
additional genes was upregulated when B. breve UCC2003 was grown on 
melezitose, Bbr_0026, Bbr_0027, Bbr_0030 and Bbr_0100 (Table 3.2). As 
hydrolysis of melezitose produces sucrose if the α-(1 3)-linked glucose is released, 
the transcriptional induction of these genes is believed to be correlated to sucrose 
metabolism.  
Genetic organisation of the raf and mel gene clusters, and comparison to other 
available bifidobacterial genomes  
Our presumption, based on microarray results, was that the genes of the raf gene 
cluster, schematically depicted in Figure 3.2, are involved in the metabolism of 
sugars that contain one or more α-(1 6)-linked galactose moieties (e.g. raffinose, 
stachyose and melibiose). The rafA gene, which specifies a putative α-galactosidase 
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of GH family 27, is a clear homologue of the B. breve CECT 7263 α-galactosidase-
encoding gene, with which it shares 99 % sequence identity (Jimenez et al., 2012). 
B. breve CECT 7263 also contains genes with high sequence similarity (99-100 % 
identity) to other genes in the B. breve UCC2003 raf gene cluster (Fig. 3.2). The 
rafA gene is presumed to be responsible for the breakdown of raffinose, stachyose 
and melibiose via hydrolysis of the α-(1 6)-glycosidic bond that is common to 
these carbohydrates, thereby releasing galactose. The presumptive B. breve 
UCC2003 α-galactosidase-encoding gene, rafA, is located immediately adjacent to a 
gene, Bbr_1868, designated here as rafR and predicted to encode a ROK-type 
transcriptional regulator. Members of the ROK protein family include both 
transcriptional repressors and sugar kinases (Titgemeyer et al., 1994), where ROK 
kinases possess a conserved N-terminal ATP-binding motif, while ROK repressors 
contain an N-terminal region that includes a canonical helix-turn-helix motif 
associated with DNA binding (Conejo et al., 2010). BLAST analysis and pfam 
searches revealed the presence of such a helix-turn-helix motif, thus leading to the 
prediction that the rafR gene product functions as a transcriptional regulator, which 
may, as based on its genomic location, be involved in regulating raffinose (sugar 
family)-dependent transcription of the other genes of the raf gene cluster. Close 
homologs of rafA and rafR, as well as the neighbouring genes rafB, rafC and rafD, 
which are predicted to specify a solute binding protein and two permeases, 
respectively, of a putative ABC-type sugar uptake system, are present in all other 
publicly available bifidobacterial genomes with the exception of Bifidobacterium 
asteroides PRL2011 and Bifidobacterium bifidum PRL2010 (Bottacini et al., 2012; 
Turroni et al., 2012b) (Fig. 3.2, and data not shown). Interestingly, the raf gene 
cluster does not contain a gene with a predicted ATP-binding protein, which is 
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required for energy provision of the ABC-type transport system (Schneider & 
Hunke, 1998). It is presumed that this activity is encoded by an unconnected gene, 
whose product can function as an ATP-binding component for multiple ABC 
transporters, which is similar to what has been suggested for other bifidobacterial 
ABC-type carbohydrate transport systems (O'Connell Motherway et al., 2011a; 
Pokusaeva et al., 2011b). 
The melABCDE gene cluster, whose transcription is specifically induced by growth 
on melezitose, is predicted to specify a solute binding protein (melA) and two 
permease proteins (melB and melC) (again lacking a gene predicted to encode an 
ATP-binding protein, representing a similar genetic configuration as that observed 
for the raf gene cluster, see above), an α-glucosidase (melD) belonging to GH family 
13, and an α-galactosidase/raffinose synthase (melE) of GH family 36 (Table 3.2 and 
Fig. 3.2). The DNA region between the raf and mel gene clusters contains four 
additional open reading frames: Bbr_1863 and Bbr_1864, which encode putative 
LacI-type transcriptional regulators, designated here as lacI2 and lacI1, respectively, 
and Bbr_1861 and Bbr_1862, which specify a hypothetical protein and a predicted 
solute binding protein, respectively. The mel and raf genetic loci including its 
intervening region genes share high sequence similarity (99-100 %) at the amino 
acid level and a conserved gene organisation with corresponding regions in the 
genomes of B. longum subsp. longum KACC 91563 and B. longum subsp. longum 
ATCC 55813. Interestingly, homologs of the mel gene cluster (including Bbr_1861-
Bbr_1864) are lacking in many bifidobacterial genomes, although such genomes do 
contain clear homologs of the raf gene cluster and the agl1 gene, which in the 
UCC2003 genome flank the mel cluster on either end (Fig. 3.2), suggesting that 
these bifidobacterial strains lack the (genetic) ability to metabolise melezitose. 
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Prevalence and genetic organisation of raf and mel gene clusters in other bacteria 
The genetic organisation of the bifidobacterial raf locus and the raffinose metabolic 
pathway appears to be quite different from those of various other bacterial species. In 
E. coli (Aslanidis et al., 1989), Klebsiella pneumoniae (Hama & Wilson, 1992), 
Enterobacter cloacae (Okazaki et al., 1997) and Citrobacter freundii (Shimamoto et 
al., 2001), among others, raffinose uptake is specified by a single permease-encoding 
gene, which is co-transcribed with two additional genes, that specify an α-
galactosidase and a sucrose hydrolase. As mentioned above, uptake of raffinose and 
related sugars in bifidobacteria appears to be performed by a dedicated ABC-type 
transport system, the corresponding genes of which are in close proximity of, 
although they are not co-transcribed with the α-galactosidase-specifying gene, due to 
their opposing genetic orientation (Fig. 3.2). Furthermore, the metabolic product of 
this α-galactosidase activity, i.e. sucrose, is in bifidobacteria apparently not 
metabolised by a sucrose hydrolase, but by a sucrose phosphorylase, encoded by a 
gene that is not genetically linked to the raf  locus.  
Raffinose metabolism has also been investigated in Lactobacillus plantarum ATCC 
8014, in which the putative raffinose permease-encoding gene is immediately 
followed by the α-galactosidase-specifying gene (designated melA), while preceded 
by galM, a putative microbial galactose-1-epimerase (Silvestroni et al., 2002). 
Interestingly, two genes are located downstream of melA, though on the opposite 
strand that encode the two subunits of a heterodimeric β-galactosidase, which shows 
that the genetic organisation and content of the raffinose utilisation cluster of Lb. 
plantarum differs substantially from that found in bifidobacteria. Recently it has 
been shown by transcriptome analyses that B. animalis subsp. lactis Bl-04 possesses 
a raffinose utilisation cluster including three predicted α-glycosidases, exhibiting a 
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transcription profile that is consistent with our observations for B. breve (Andersen 
et al., 2013).  
Very little information is available regarding melezitose metabolism in other 
microorganisms. Melezitose metabolism has been investigated in the yeast 
Saccharomyces cerevisiae (Hwang & Lindegren, 1964), where a melezitose 
metabolising system was identified, including an α-glucosidase or melezitase that 
was shown to be capable of hydrolysing palatinose, turanose, maltose, sucrose and 
melezitose.  
Construction and phenotypes of mutants carrying individual disruptions in the 
rafA, rafB, melA, melD and melE genes 
 In order to establish if disruption of particular genes of the raf gene cluster of B. 
breve UCC2003 affects the resulting strain’s ability to metabolise raffinose, 
stachyose and/or melibiose, insertion mutants were made in rafB, which is predicted 
to encode a solute binding protein implicated in the internalisation of the above 
mentioned α-galactose-containing sugars, and rafA, the presumed α-(1 6)-
galactosidase-encoding gene. The resulting strains were designated UCC2003-RafB 
and UCC2003-RafA, respectively (see Materials and Methods). B. breve UCC2003-
RafA and B. breve UCC2003-RafB were analysed for their ability to grow on 
mMRS supplemented with either raffinose, stachyose or melibiose as the sole carbon 
source. As expected and in contrast to the wild type, the B. breve insertion mutants 
exhibited an inability to grow on raffinose, stachyose or melibiose as the sole carbon 
source. All strains retained their ability to utilise glucose as a sole carbon source 
(Fig. 3.3A). These results not only show that the rafA gene is required for growth on 
raffinose, but also that a mutation in rafB causes this growth-deficient phenotype, 
implying that the rafBCD genes encode an ABC-type transport system responsible 
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for the internalisation of α-galactose-containing oligosaccharides. Our results 
corroborate findings of a recent study, in which a deletion in a homologue of the 
rafA gene of Bifidobacterium longum 105-A (designated agl) was shown to cause 
loss of α-galactosidic activity and a growth deficiency on raffinose or melibiose 
(Hirayama et al., 2012).  
In order to establish if disruption of particular genes from the mel cluster results in 
the loss of B. breve UCC2003’s ability to metabolise melezitose, insertion mutants 
were made in melE, which is predicted to encode an α-galactosidase, resulting in 
strain B. breve UCC2003-MelE, in melD, which is predicted to encode an α-
glucosidase, resulting in strain B. breve UCC2003-MelD and in melA, which 
encodes a predicted solute binding protein, resulting in strain B. breve UCC2003-
MelA (see Materials and Methods). These mutants, i.e. B. breve UCC2003-MelE, 
UCC2003-MelD and UCC2003-MelA, were then analysed for their ability to grow 
on mMRS supplemented with melezitose as the sole carbon source. As expected and 
in contrast to the wild type, growth of B. breve strain UCC2003-MelA on melezitose 
was severely reduced compared to that of the wild type strain, indicating that this 
gene is indeed required for melezitose catabolism. Mutant strain B. breve UCC2003-
MelD was also impaired in growth on melezitose as compared to the wild type strain 
UCC2003, though to a lesser extent than the UCC2003-MelA strain, and this growth 
defect is particularly obvious when comparing the corresponding growth profiles of 
these three strains on melezitose (Fig. 3.3B). The less severe growth deficiency (as 
compared to the MelA strain) may be due to the presence of other α-glucosidases 
produced by B. breve UCC2003 that partially compensate for the melD mutation. 
Interestingly, mutant strain UCC2003-MelE was not affected in its ability to grow on 
melezitose, indicating that MelE is not required for growth on this sugar (data not 
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shown). Wild type UCC2003 and the three mel mutants did not exhibit any 
differences in their ability to utilise glucose as a sole carbon source. 
Purification, characterisation and substrate specificity of recombinantly produced 
MelD, MelE and RafA 
In order to analyse the glycosyl hydrolase functions of MelD, MelE and RafA, we 
purified and biochemically characterised these three predicted sugar-degrading 
enzymes. All of the overproduced proteins purified well and in soluble form, and 
MelE, MelD and RafA exhibited molecular masses of approximately 68.2 kDa , 62.4 
kDa and 84.1 kDa (inclusive of the His6-tag), respectively, when analysed by SDS-
PAGE (Results not shown). 
Purified recombinant MelD protein was shown to fully hydrolyse melezitose into 
glucose and fructose (Fig. 3.4A I), thereby demonstrating that this protein has both 
α-(1 2) and α-(1 3) glucosyl hydrolase activities. This was further confirmed by 
our findings that both sucrose [α-D-Glcp-(1 2)-β-D-Fruf] and turanose [α-D-Glcp-
(1 3)-β-D-Fruf] are hydrolysed by MelD to glucose and fructose (Fig. 3.4 II and 
III, respectively). In contrast, MelD was unable, at least under the conditions tested, 
to hydrolyse leucrose [α-D-Glcp-(1 5)-β-D-Fruf], palatinose [α-D-Glcp-(1 6)-β-
D-Fruf] or maltulose [α-D-Glcp-(1 4)-β-D-Fruf] (results not shown). These results 
therefore show that MelD is an α-glucosidase that exhibits clearly different substrate 
specificities compared to the two previously characterised α-glucosidases encoded 
by B. breve UCC2003, Agl1 and Agl2, which do not possess the ability to hydrolyse 
leucrose, melezitose or sucrose, but possess such hydrolytic activity against turanose, 
maltulose and palatinose (Pokusaeva et al., 2009). The preferred substrates for Agl1 
and Agl2 are thus carbohydrates that contain either an α-(1 6) or an α-(1 1) 
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glucosidic bond (Pokusaeva et al., 2009), while MelD is an α-glucosidase with 
hydrolytic activity against α-(1 2) and α-(1 3) glucosidic bonds, which makes the 
latter enzyme different from previously characterised bifidobacterial α-glucosidases 
(Degnan & Macfarlane, 1994; Igaue, 1983; van den Broek et al., 2003). 
The putative α-galactosidase MelE failed to exhibit hydrolytic activity towards 
raffinose, stachyose or melibiose (results not shown), at least under the conditions 
tested. However, when two synthetic disaccharides, namely α-(1 4) and α-(1 3) 
galactobiose were assayed, MelE was shown to be capable of hydrolysing both 
disaccharides (Supplementary figure S3.1). The finding that the melE gene encodes 
an α-galactosidase and is present and co-transcribed in a melezitose-induced gene 
cluster suggests that this locus is also involved in the metabolism of (a) melezitose-
related carbohydrate(s), which contain(s) one or more alpha-galactose moieties 
linked through α-(1 4) and/or α-(1 3) glycosidic bonds. This sugar, like 
melezitose, may also be present in honeydew, which is secreted by aphids while 
feeding on the sugar-rich phloem of their host plants, to acquire the amino acids they 
need for growth and reproduction (Wool et al., 2006). Such honeydew 
oligosaccharides, which contain large amounts of melezitose and erlose, have been 
shown to possess prebiotic potential as they increase bifidobacterial and lactobacilli 
numbers in an in vitro fermentation system (Sanz et al., 2005).  
Purified RafA was shown to hydrolyse stachyose, raffinose and melibiose (Fig. 3.4B 
I, II and III), to produce sucrose and galactose, and cleaving melibiose to its 
monosaccharide constituents glucose and galactose, thereby confirming that RafA 
functions as an α-galactosidase. RafA was also tested for its ability to hydrolyse 
melezitose, sucrose, and a range of sucrose isomers, but did not exhibit hydrolytic 
activity against any of these carbohydrates (results not shown). However, it did show 
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hydrolytic activity against synthetic α-(1 4) and α-(1 3) galactobiose, showing 
that RafA exhibits a rather broad substrate specificity (Supplementary table S3.2). 
Previously, an α-galactosidase from B. bifidum JCM 1254 was shown to be capable 
of hydrolysing α-(1 3)-linked galactose in a branched blood group B antigen 
trisaccharide, however, this α-galactosidase did not possess the ability to hydrolyse 
α-(1 4)-galactosidic linkages (Wakinaka et al., 2013). Analysis of currently 
sequenced bifidobacterial genomes shows that most of the bifidobacterial strains 
encode at least one α-galactosidase-encoding gene (Pokusaeva et al., 2011a). 
Various α-galactosidases, capable of catalysing hydrolysis of various α-galacto-
oligosaccharides, have been studied in four bifidobacterial species to date (Garro et 
al., 1994; Goulas et al., 2009; Leder et al., 1999; Van Laere et al., 1999; Wakinaka 
et al., 2013; Zhao et al., 2008). For example, in the case of B. adolescentis, it was 
shown that the α-galactosidase hydrolyses α-(1 6)-galactosidic bonds from 
raffinose and stachyose, but also the α-(1 4) and α-(1 3) bonds of two 
galactobiose substrates (Leder et al., 1999; Van Laere et al., 1999), which is 
consistent with our findings for B. breve UCC2003. Interestingly, the α-
galactosidase of B. breve 203 was shown to have the ability to synthesise a 
trisaccharide (Gal-α-(1 4)-Gal-α-(1 6)-Glc) using melibiose as a substrate (Zhao 
et al., 2008). Furthermore, the α-galactosidase encoded by B. bifidum JCM 1254 was 
observed to be capable of hydrolysing α-(1 3)-linked galactose in a branched blood 
group B antigen trisaccharide, although this enzyme cannot hydrolyse α-(1 4)-
galactosidic linkages (Wakinaka et al., 2013).  
The obtained MelD, MelE and RafA-mediated carbohydrate hydrolysis results and 
presumed degradation pathways have been summarised in supplementary Figure 
S3.2. 
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Determination of kinetic details of MelD and RafA 
 In order to determine the kinetic parameters of the MelD and RafA enzymes, we 
characterised these two glycosyl hydrolases using the substrates against which they 
had shown hydrolytic activity (with the exception of α-(1 4) and α-(1 3) 
galactobiose, for which we did not have sufficient amounts to perform such studies). 
When sucrose and turanose were used as substrates, the optimum temperature and 
pH values for MelD activity were determined to be 30°C and 7.5, respectively, while 
in the case of RafA in combination with either of the substrates raffinose, stachyose 
or melibiose the optima were 42°C and 6.0, respectively.    
Kinetic studies were performed to determine Vmax and Km values, as well as the rate 
constants (kcat) and catalytic efficiencies (kcat/Km), for MelD using sucrose and 
turanose as substrates, and for RafA employing raffinose, stachyose and melibiose as 
substrates (Table 3.3). MelD, as shown above, exhibits hydrolytic activity against 
both α-(1 3) and α-(1 2) glucosidic linkages. In order to investigate if MelD 
exhibited any hydrolytic preference for either of these linkages, we looked at the 
ability of MelD to hydrolyse sucrose and turanose. The obtained data indicate that 
the preferred bond cleaved by MelD is the α-(1 2) linkage present in sucrose, as 
MelD hydrolyses this bond with a higher efficacy compared to the α-(1 3) linkage 
present in turanose (Table 3.3). In order to investigate the preferred substrate of 
RafA we determined the kinetic parameters of this enzyme related to its hydrolytic 
activity towards melibiose, raffinose and stachyose. The preferred substrate was 
melibiose, followed by raffinose. However, it is important to note that stachyose 
contains two α-(1 6) linkages with one of these present between two galactose 
moieties, while the other being present between galactose and glucose. The 
hydrolysis of stachyose by RafA is likely to lead to the generation of galactose and 
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raffinose, the latter again representing a substrate for RafA, as demonstrated by us 
and previously reported (Garro et al., 1999). In our kinetic experiments we assessed 
stachyose hydrolysis by measuring the release of sucrose, which would be generated 
directly by hydrolysis of stachyose to sucrose and a galacto-disaccharide and 
indirectly by initial hydrolysis of stachyose to galactose and raffinose, followed by 
hydrolysis of the raffinose to sucrose and galactose. The presence of multiple 
substrates means that the use of standard kinetic techniques to measure stachyose 
hydrolysis is not absolutely correct. However, the kinetic values calculated provide a 
reasonably accurate representation of the substrate preference of the enzyme.  
A previously published kinetic study of the E. coli K12 α-galactosidase (Schmid & 
Schmitt, 1976) revealed that this enzyme at an optimal pH 7.2 exhibits Km values of 
3.2 mM for melibiose and 60 mM for raffinose. Since we observed Km values of 
8.15 for melibiose and 14.55 for raffinose at an optimal pH of 6.0 for the B. breve 
RafA, it is clear that individual α-galactosidases, despite having the same substrate 
specificities, may still exhibit varying kinetic properties. 
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3.5 CONCLUDING REMARKS  
Bifidobacteria are believed to play an important role in the fermentation of non-
digestible carbohydrates in the lower gastrointestinal tract, and consistent with this 
notion is the prediction that a sizable proportion of the average bifidobacterial 
genome is dedicated to carbohydrate metabolism (Ventura et al., 2007a; Ventura et 
al., 2007b). Over 50 bifidobacterial carbohydrases have been studied to date, and 
various carbohydrate utilisation pathways have been characterised in B. breve 
UCC2003, such as those dedicated to the metabolism of fructose, galactan, starch, 
ribose, palatinose, cellodextrin, and fructo-oligosaccharides (Leahy et al., 2005; 
Maze et al., 2007; Mierau et al., 2005; O'Connell Motherway et al., 2011b; 
O'Riordan & Fitzgerald, 1999; Oishi et al., 2008; Pokusaeva et al., 2011b). 
The data assembled in this study provide significant information on the ability of 
various B. breve strains to grow on a number of plant-derived α-glucose and α-
galactose-containing oligosaccharides, while also identifying  the corresponding 
genes involved in the metabolism of such sugars. Two adjacent genetic loci 
dedicated to the utilisation of raffinose-containing carbohydrates and melezitose in 
B. breve UCC2003 were identified, encoding a novel α-glucosidase, specified by 
melD, and two α-galactosidases, specified by rafD and melE, as well as presumed 
ABC-type uptake systems for their corresponding carbohydrate substrates. 
Bifidobacteria appear to encode both common carbohydrate utilisation pathways 
(e.g. for the metabolism of raffinose-family sugars), as well as strain/species-specific 
pathways (e.g. melezitose metabolism). Such pathways may be a reflection of 
common elements in the diet of the host of such bacteria, while it may also allow 
certain species/strains the capacity to effectively colonise the gut or obtain higher 
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numbers when the host’s diet contains more specialised carbohydrates. In a recent 
study (van Zanten et al., 2012) B. animalis subsp. lactis Bl-04 was shown to be 
selectively increased in a model system of the human colon 10 to 100-fold on 
melibiose, xylobiose, raffinose and maltotriose, indicating that these carbohydrates 
have the potential to serve as a prebiotic.   
It is possible that the ability to lose or acquire a carbohydrate utilisation system is 
similar to that of Lb. plantarum, an organism which appears to acquire, shuffle, 
substitute or delete carbohydrate utilisation systems in response to niche 
requirements, and which makes it a “natural metabolic engineer” (Siezen & van 
Hylckama Vlieg, 2011). Further investigations will be required to determine how 
and to what extent specific carbohydrate utilisation abilities facilitate certain 
bifidobacterial species and strains to colonise and persist in the gastrointestinal tract 
of their host, and the importance of host diet in this regard.  
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3.7 TABLES AND FIGURES 
Table 3.1 Bacterial strains and plasmids used in this study 
Strain/ plasmid Relevant characteristics Reference or source 
E.coli strains 
  EC101 Cloning host, repA+ kmr (Law et al., 1995) 
EC101-pNZ-
M.Bbrll+Bbr111 EC101 harbouring pNZ8048 derivative containing bbrllM and bbrlllM 
(Mary O Connell-Motherway 
et al., 2009) 
L.lactis strains 
  NZ9000 MG1363,nisin-inducible overexpression host; pepN::nisRK (de Ruyter et al., 1996) 
NZ9700 Nisin producing strain (de Ruyter et al., 1996) 
B. breve strains 
  UCC2003 Isolate from a nursling stool (Maze et al., 2007) 
NCFB 2257 Isolate from infant intestine NCFB 
NCTC 11815 Isolate from infant intestine NCTC 
NCFB 2258 Isolate from infant intestine NCFB 
NCIMB 8815 Isolate from infant faeces NCIMB 
JCM 7017 Isolate from human faeces JCM 
JCM 7019 Isolate from infant faeces JCM 
UCC2005 Isolate from nursling stool (Pokusaeva et al., 2009) 
Yakult  Isolate from nursling stool (Oishi et al., 2008) 
Nizo 658 Isolate from nursling stool Nizo 
461 Isolate from infant/adult faeces PRL 
689 Isolate from infant/adult faeces PRL 
12L Mothers milk PRL 
UCC2003-MelE pORI19-tet-1856 insertion mutant of  UCC2003 This study 
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Strain/ plasmid Relevant characteristics Reference or source 
UCC2003-MelD pORI19-tet-1857 insertion mutant of  UCC2003 This study 
UCC2003-RafB pORI19-tet-1867 insertion mutant of  UCC2003 This study 
UCC2003-RafA pORI19-tet-1869 insertion mutant of  UCC2003 This study 
UCC2003-MelA pORI19-tet-1860 insertion mutant of  UCC2003 This study 
Plasmids pORI19-tet-1857 insertion mutant of  UCC2003 This study 
pORI19 Emr , repA- , ori+ , cloning vector (Law et al., 1995) 
pORI19-tet-MelE Internal 421bp fragment of melE and tetW cloned in pORI19 This study 
pORI19-tet-MelD Internal 456bp fragment of melD and tetW cloned in pORI19 This study 
pORI19-tet-MelA Internal 331bp fragment of MelA and tetW cloned in pORI19 This study 
pORI19-tet-RafA Internal 474bp fragment of RafA and tetW cloned in pORI19 This study 
pORI19-tet-RafB Internal 394bp fragment of RafB and tetW cloned in pORI19 This study 
pAM5 pBC1-puC19-Tcr (Alvarez-Martin et al., 2007) 
pNZ8048 Cmr; nisin-inducible translational fusion vector (de Ruyter et al., 1996) 
pNZ8150 Cmr; nisin-inducible translational fusion vector (Mierau et al., 2005) 
pNZMelE-His 
MelE with his tag cloned downstream of nisin inducible promoter on 
pNZ8048 This study 
pNZMelD-His 
MelD with his tag cloned downstream of nisin inducible promoter on 
pNZ8048 This study 
pNZRafA-His 
RafA with his tag cloned downstream of nisin inducible promoter on 
pNZ8150 This study 
JCM: Japan Collection of Microorganisms; NIZO: Nizo Food Research; NCFB: National Collection of Food Bacteria; NCIMB: National 
Collection of Industrial and Marine Bacteria; NCTC: National Collection of Type Cultures; PRL: Culture collection of probiogenomics 
University of Parma.
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Figure 3.1 Final OD600 values following 16 hours of growth of various wild type B. 
breve strains grown on 1 % raffinose, 1 % stachyose, 1 % melibiose and 1 % 
melezitose. The results are mean values obtained from three separate experiments. 
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Table 3.2 Carbohydrate-dependent transcriptional upregulation of specific genes as based on transcriptome comparative analysis using B. breve 
UCC2003 grown on 1% raffinose, stachyose and melibiose as compared to growth on ribose. Microarray data were obtained using B. breve 
UCC2003 grown on 1% raffinose, stachyose and melibiose, and using array data obtained when grown on ribose as control.  
Fold cut off point is 4 fold, p value < 0.001, and values below cut-off are indicated in the Table as dashes.
   Fold upregulation during growth on: 
Gene ID. 
Gene 
Name Function Stachyose  Raffinose  Melibiose  Melezitose  Sucrose  
Bbr_0026 
 
Permease protein of ABC transporter system for sugars _ 18.55 _ 4.66 23.73 
Bbr_0027 
 
Permease protein of ABC transporter system for sugars _ 13.98 _ 4.55 44.95 
Bbr_0030  Conserved hypothetical protein 28.53 145.75 _ 86.54 216.5 
Bbr_0100 SPase Sucrose phosphorylase 74.26 74.26 _ 128.18 41.71 
Bbr_1855 agl1 Alpha glucosidase _ 20.43 10.74 31.95 _ 
Bbr_1856 melE Raffinose synthase or seed inhibition protein _ _ _ 72.76 _ 
Bbr_1857 melD Alpha glucosidase _ _ _ 94.33 _ 
Bbr_1858 melC Permease protein of ABC transporter system for sugars _ _ _ 850.82 _ 
Bbr_1859 melB Permease protein of ABC transporter system for sugars _ _ _ 679.07 _ 
Bbr_1860 melA Solute binding protein of ABC transporter system for sugars _ _ _ 724.89 _ 
Bbr_1865 rafD  Raffinose transport system permease protein 21.66 98.36 105.07 _ _ 
Bbr_1866 rafC  Raffinose transport system permease protein 49.86 175.51 153.8 _ _ 
Bbr_1867 rafB Raffinose-binding protein 24.39 86.16 92.5 _ _ 
Bbr_1868 rafR Transcriptional repressor, ROK family  _ _ _ _ _ 
Bbr_1869 rafA Alpha-galactosidase  9.23 10.53 8.07 _ _ 
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 Figure 3.2 Comparison of the melezitose, raffinose and stachyose gene clusters of B. 
breve UCC2003 with corresponding putative melezitose, raffinose and stachyose 
utilisation loci from other bifidobacteria. Each solid arrow indicates an open reading 
frame (ORF). The lengths of the arrows are proportional to the length of the 
predicted ORF and the gene locus name, which is indicative of its putative function, 
is indicated above the arrow. Orthologs are marked with the same colour while the 
amino acid identity of each predicted protein is indicated as a percentage relative to 
its equivalent protein encoded by B. breve UCC2003. 
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 Figure 3.3 Panel A; Final OD600 after 16 hours UCC2003 and insertion mutants 
UCC2003-RafB (raffinose binding protein) and UCC2003-RafA (α-galactosidase) on 
1 % stachyose, raffinose, melibiose and glucose. The results are mean values 
obtained from three separate experiments. *P< 0.01, **P< 0.001. Panel B. Final 
OD600 following 16 hours of growth of B. breve UCC2003, B. breve UCC2003-
MelA (solute binding protein) and B. breve UCC2003-MelD (α-(1 3)-glucosidase) 
on 1 % melezitose and glucose. The results are mean values obtained from three 
experiments,*P<0.01.
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Figure 3.4 Panel A: HPAEC-PAD analysis indicating melezitose and turanose breakdown 0.1 mg ml-1 by the purified recombinant protein 
MelD in 20 mM MOPS buffer (pH 7.0) over 24 hours. Graph I: Melezitose incubated with MelD, where liberation of glucose and fructose is 
visible as chromatographic peaks eluted at 6.25 and 5.5 minutes, respectively; Graph II: Sucrose incubated with MelD, where liberation of 
glucose and fructose is visible as chromatographic peaks eluted at 6.25 and 5.5 minutes, respectively; graph III: Turanose incubated with MelD 
where liberation of glucose and fructose is visible as chromatographic peaks eluted at 6.25 and 5.5 minutes, respectively; Breakdown products 
indicated with black compound arrows. Chromatographic positions of carbohydrate standards are indicated by dashed arrows above the 
chromatogram. Panel B: HPAEC-PAD analysis indicating stachyose, raffinose and melibiose breakdown by the purified recombinant protein 
RafA in 20 mM MOPS buffer (ph. 7.0) over 24 hours. Graph I: Stachyose incubated with RafA, where liberation of galactose and sucrose is 
visible as chromatographic peaks eluted at 5.75 and 10.5 minutes, respectively; Graph II: Raffinose incubated with RafA, where release of 
galactose and sucrose is detected as chromatographic peaks eluted at 5.75 and 10.5, minutes respectively; Graph III: Melibiose incubated with 
RafA, where hydrolysis of this substrate to glucose and galactose is visible as a single chromatographic peak eluted at 5.75 minutes. Breakdown 
products indicated with black compound arrows. Chromatographic positions of carbohydrate standards are indicated by dashed arrows above the 
chromatogram. 
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 Table 3.3 Kinetic study of MelD and RafA, Vmax and Km values for the substrate sucrose including the rate constant (kcat) and catalytic 
efficiency (kcat/Km). 
 
 
Substrate Protein Vmax (μmol min-1mg-1) Km(Mm) Kcat(s-1) kcat/km(Mm-1s-1) 
Melibiose RafA 384.305±0.42  8.15±1.7 542.79±0.63 66.6±0.07 
Raffinose RafA 187.5±2.1 14.55±1.9 264.815±2.9 18.2±2.6 
Stachyose RafA 11.09±.55 3.045±.51 16.665±0.784 5.47±1.14 
Sucrose MelD 7.75±0.07 19.3±0.28  8.0725±0.07  0.4175±0.007 
Turanose MelD 12.66±1.59 91.93±1.07    13.16±1.61 0.14±0.01 
All values are means from two experiments ± standard errors. 
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 3.8 SUPPLEMENTARY DATA 
Table S3.1 Oligonucleotide primers used in this study 
Primer Sequence a Size 
1856fHd3 TGCGGAAAGCTTTGTACTTGGGATTCATTG 421bp 
1856rxba1 CTATGCTCTAGACGAAATCGACGCCGGCT   
1857fHd3 TGCGGAAAGCTTGAACGCGGTATCGGCATCATC 457bp 
1857rxba1 CTATGCTCTAGAGCACGGCGTCGCGGTCCCAGA   
1867fHd3 TGCGGAAAGCTTGCCGGACGTAATCACCTTC 394bp 
1867rxba1 CTATGCTCTAGACGACTCGGGAACCAGCGTAC   
1869Fhd3 TGCGGAAAGCTTCTGTTCGGCTCCTTCGGCG 474bp 
1869Rxba1 CTATGCTCTAGAGTCAGGTCGAGCACTTGC   
1857-confirm CATTCGAGCTGCCACACA 2.6bp 
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG   
1857-confirm ACTTTCACCAACAATGACTG 2.6kb 
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG   
1867-confirm CAACGCCTAGACTGAAGC 2.6kb 
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG   
1869-confirm GCGTTTCCGGTGCACTCGATG 2.6kb 
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG   
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG 2.7kb 
Tetwsal1R GCGACGGTCGACCATTACCTTCTGAAACATA   
1856EcorVF 
GACAAGGATATCATGCATCACCATCACCATCACCATCACCA
TCACATTGCCGAAACCTGTCC 1.9bp 
1856Xba1 GACAAGTCTAGAAACTGCGTTGGTGTGCCGG   
1857Nco1F 
TGCACGCCATGGCTCATCACCATCACCATCACCATCACCAT
CACACTTTCACCAACAATGACTG 1.6kb 
1857Xba1R CTATGCTCTAGATTATGCTGGCAAGGCCCAGACG   
1869EcorVF 
GACAAGGATATCATGCATCACCATCACCATCACCATCACCA
TCACGCCCAGAACACCGCCACC 2.3kb 
1869Xba1 CTATGCTCTAGATCAGCTTAACGCCACGGCCTTG   
a Sequences of restriction enzyme sites are indicated in bold 
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Figure S3.1 HPAEC-PAD analysis indicating α 1,3 and α 1,4 galactobiose  
breakdown 0.1 mg ml
-1
 by the purified recombinant proteins MelE and RafA in 20 
mM MOPS buffer (pH 7.0) over 24 hours. Graph I and Graph II: α-(1 3) and α-(1
4) galactobiose incubated with MelE, where liberation of galactose is visible as a 
chromatographic peak eluted at 5.9 minutes; Graph III and graph IV: α-(1 3) and α-
(1 4) galactobiose incubated with MelE, where liberation of galactose is visible as 
a chromatographic peak eluted at 5.9 minutes; Breakdown products indicated with 
black compound arrows. Chromatographic positions of carbohydrate standards are 
indicated by dashed arrows above the chromatogram.  
I 
II 
III 
IV 
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Figure S3.2 Proposed sugar metabolism pathways 
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Chapter IV 
 
Transcriptional regulation of the raffinose and melezitose utilisation gene 
clusters of Bifidobacterium breve UCC2003. 
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4.1 ABSTRACT 
Members of the genus Bifidobacterium are commonly found in the gastrointestinal 
tract of mammals, including humans, where their growth is presumed to be 
dependent on various diet- and/or host-derived carbohydrates. To understand 
transcriptional control of bifidobacterial carbohydrate metabolism, we investigated 
two genetic carbohydrate utilisation clusters dedicated to the metabolism of 
raffinose-type sugars and melezitose. Transcriptomic and gene inactivation 
approaches revealed that the raffinose utilisation system is positively regulated by an 
activator protein, designated RafR, while the gene cluster associated with melezitose 
metabolism is directly negatively regulated by a LacI-type transcriptional regulator, 
designated MelR1, while there appears to be indirect control by means of a second 
LacI-type regulator, MelR2. In silico analysis, DNA/protein interaction and primer 
extension studies revealed the MelR1 and MelR2 operator sequences, each of which 
is positioned just upstream of, or overlapping, the correspondingly regulated 
promoter sequences. Similar analyses identified the RafR binding operator sequence 
located upstream of the rafB promoter. Interestingly, we show that melezitose is 
preferentially utilised over raffinose, indicating a carbohydrate utilisation hierarchy 
in bifidobacteria with regards to particular oligosaccharides. 
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4.2 INTRODUCTION 
Bifidobacteria are saccharolytic, non-motile, non-sporulating, Gram-positive, 
anaerobic bacteria, which possess a high GC genome content, and belong to the 
phylum Actinobacteria. Bifidobacteria typically exhibit a forked (bifid) morphology 
and are commonly found as anaerobic commensals of the gastrointestinal tract (GIT) 
(Miyake et al., 1998; Ventura et al., 2007). Bifidobacteria were first isolated by 
Tissier (Tissier, 1900) as natural inhabitants of the gastrointestinal tract of humans 
and mammals, and he was also the first to recognise their probiotic or health-
promoting potential (H.Tissier, 1906). Consistent with Tissiers observations it is 
known that members of certain bacterial genera, such as bifidobacteria and 
lactobacilli, provide (some degree of) protection against certain types of 
gastrointestinal infections (Erdo et al., 2012; Parker et al., 2013).   
It is also becoming increasingly apparent that a ‘normal’ (or healthy) colonic 
microbiota may reduce the risk and/or pathology of gastrointestinal diseases and 
disorders, such as ulcerative colitis, bowel cancer and pseudomembranous colitis 
(Gough et al., 2011; Rohlke & Stollman, 2012; Zhu et al., 2013). Several recent 
studies have focused on the use of prebiotics, which are food ingredients that 
beneficially affect the host by selectively stimulating growth and/or activity of one or 
a limited number of beneficial bacteria in the colon (Gibson & Roberfroid, 1995), 
thereby improving host health. Several carbohydrates have been shown to exert 
prebiotic effects and include whole grain wheat, fructo-oligosaccharides, galacto-
oligosaccharides and lactulose (Bouhnik et al., 1999; Bouhnik et al., 2004; Costabile 
et al., 2008; Macfarlane et al., 2008).  
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Metagenomic analyses of the human gut microbiota have generated knowledge that 
may allow for the rational selection of novel prebiotics that maintain and/or enhance 
a healthy gut microbiota (Cecchini et al., 2013). Integral to the selection of 
carbohydrates with prebiotic potential is an in-depth understanding of carbohydrate 
metabolism by members of the gut microbiota. In this respect bifidobacteria possess 
a unique hexose metabolism, the so-called bifid-shunt, a metabolic pathway that 
employs the signature enzyme fructose-6-Phosphate phosphoketolase (F6PPK), 
converting carbohydrates to mainly acetic and lactic acid (Scardovi & Trovatelli, 
1965). 
Our recent work has established that Bifidobacterium breve UCC2003, an isolate 
from nursling stool, can metabolise a remarkable range of mono-, di-, oligo- and 
polysaccharides (Maze et al., 2007; O'Connell et al., 2013; O'Connell Motherway et 
al., 2008; O'Connell Motherway et al., 2011a; Pokusaeva et al., 2010; Pokusaeva et 
al., 2011; Ryan et al., 2005). Transcription of bifidobacterial gene clusters associated 
with carbohydrate metabolism appears to be tightly regulated and several 
observations have been made suggesting that such clusters are subject to carbon 
catabolite control (Parche et al., 2006).  
Direct transcriptional control of various gene clusters involved in bifidobacterial 
carbohydrate metabolism is achieved by LacI-type repressors, representing 
LacI/GalR family proteins that typically consist of an N-terminal helix–turn–helix 
(HTH) DNA-binding motif and a C-terminal domain for oligomerisation and effector 
binding (Fukami-Kobayashi et al., 2003; Weickert & Adhya, 1992). In contrast to 
other bacteria, the number of (predicted) phosphoenolpyruvate-phosphotransferase 
systems (PEP-PTSs) encoded by bifidobacteria is relatively low (Maze et al., 2007; 
Parche et al., 2006). Specific elements of the (glucose-specific) PEP-PTS system are 
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in many bacteria responsible for carbon catabolite control (Deutscher, 2008), 
however, this does not seem to be case in bifidobacteria as the required regulatory 
proteins appear to be absent. Therefore, the actual manner by which catabolite 
repression, if operational, is achieved by bifidobacteria is currently unknown. 
Recently, we have identified a raf gene cluster dedicated to the metabolism of the 
plant-derived melibiose/raffinose-containing carbohydrates in B. breve UCC2003 
(O'Connell et al., 2013). The raf locus in the B. breve UCC2003 genome is located 
adjacent to the mel gene cluster, which allows this strain to metabolise the 
trisaccharide melezitose [α-D-Glcp-(1 3)-β-D-Fruf-(2 1)-α-D-Glcp], found in 
honeydew and manna (Bacon & Dickinson, 1957; O'Connell et al., 2013). In the 
current work the aim was to investigate the transcriptional regulation of the gene 
clusters associated with the metabolism of the raffinose family sugars and 
melezitose.   
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4.3 MATERIALS AND METHODS 
Bacterial strains, plasmids and culture conditions. Bacterial strains and plasmids 
used in this study are detailed in Table 4.1. Bifidobacteria were routinely cultured in 
either de Mann Rogosa and Sharpe medium (MRS; Difco™, BD, Le Pont de Claix, 
France), supplemented with 0.05 % cysteine-HCl, or reinforced clostridial medium 
(RCM; Oxoid Ltd.). Carbohydrate utilisation by bifidobacterial strains was examined 
in modified de Mann Rogosa and Sharpe Medium (mMRS) prepared from first 
principles (De Man et al., 1960), and to which, prior to inoculation, cysteine-HCl 
(0.05 % w/v) and a particular carbohydrate source (1 % w/v) had been added. The 
carbohydrates used were raffinose, stachyose, melibiose, melezitose and lactose (all 
purchased from Sigma-Aldrich, Steinheim, Germany). Bifidobacterial cultures were 
incubated at 37oC under anaerobic conditions which were maintained using an 
Anaerocult oxygen depleting system (Merck, Darmstadt, Germany) in an anaerobic 
chamber. Lactococcus lactis strains were cultivated in M17 broth containing 0.5 % 
glucose (Terzaghi & Sandine, 1975) at 30oC. Escherichia coli strains were cultured 
in Luria-Bertani broth (LB) (Sambrook et al., 1989) at 37oC with agitation. Where 
appropriate, growth media contained chloramphenicol (Cm; 5 µg ml-1 for L. lactis, 
10 µg ml-1 for E. coli, and 2.5 µg ml-1 for B. breve), erythromycin (Em; 100 µg ml-1 
for E. coli), tetracycline (Tet; 10 µg ml-1 for E. coli or B. breve), kanamycin (Km; 50 
µg ml-1 for E. coli) or Ampicillin (Amp; 100 µg ml-1 for E. coli).  
In order to determine bacterial growth profiles and final optical densities, five 
millilitres of freshly prepared mMRS medium including a particular carbohydrate 
(see above) was inoculated with 50 µl (1 %) of a stationary phase culture of a 
particular B. breve strain. Un-inoculated mMRS was used as a negative control. 
Cultures were incubated anaerobically at 37oC for 16 hr, and the optical density at 
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600 nm (OD600nm) was determined at 30 min intervals using a Powerwave™ 
microplate spectrophotometer (BioTek Instruments, Inc. USA) in conjunction with 
Gen5™ Microplate Software for Windows. 
Nucleotide sequence analysis. Sequence data was obtained from the Artemis-
mediated (Rutherford et al., 2000) genome annotations of B. breve UCC2003 
(O'Connell Motherway et al., 2011b). Database searches were performed using non-
redundant sequences accessible at the National Centre for Biotechnology 
Information (http://www.ncbi.nlm.nih.gov) using Blast (Altschul et al., 1990; 
Altschul et al., 1997). Sequence verification and analysis were performed using the 
Seqman and Seqbuilder programs of the DNASTAR software package (DNASTAR, 
Madison, WI, USA v10.1.2).  
DNA manipulations. Chromosomal DNA was isolated from bifidobacteria as 
previously described (O'Riordan & Fitzgerald, 1999). Minipreparation of plasmid 
DNA from E. coli or L. lactis was achieved using the Qiaprep spin plasmid miniprep 
kit (Qiagen GmBH, Hilden, Germany). For L. lactis an initial lysis step was 
incorporated into the plasmid isolation procedure by resuspending cells in lysis 
buffer supplemented with lysozyme (30 mg ml-1) followed by incubation at 37oC for 
30 min (Sambrook et al., 1989). Procedures for DNA manipulations were performed 
essentially as described previously. Restriction enzymes and T4 DNA ligase were 
used according to the supplier’s instructions (Roche Diagnostics, Bell Lane, East 
Sussex, UK). Synthetic single stranded oligonucleotide primers used in this study, 
detailed in Table 4.S1, were synthesised by Eurofins (Ebersberg, Germany). 
Standard PCRs were performed using TaqPCR mastermix (Qiagen), while B. breve 
colony PCRs were performed as described previously (O'Connell Motherway et al., 
2009). PCR fragments were purified using the Qiagen PCR purification kit (Qiagen). 
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Electroporation of plasmid DNA into E. coli was performed as previously described 
(Sambrook et al., 1989). Electrotransformation of B. breve UCC2003 (Maze et al., 
2007) and L. lactis (Wells et al., 1993) was performed according to published 
protocols. The correct orientation and integrity of all constructs was verified by 
DNA sequencing, performed by Eurofins (Ebersberg, Germany).  
Construction of plasmids pNZ-MelR1-His, pNZ-MelR2-His and pQE30-RafR. 
DNA fragments containing the complete coding regions of Bbr_1864 (designated 
here as melR1) and Bbr_1863 (designated here as melR2) were generated by PCR 
amplification employing chromosomal DNA of B. breve UCC2003 as a template, 
employing PFU DNA polymerase (Agilent technologies) and primer combinations 
melR1EcorVF and melR1Xba1R, and melR2Nco1F and melR2Xba1R, respectively 
(Table 4.S1). NcoI or EcoRV, and XbaI restriction sites were incorporated at the 5’ 
ends of each forward and reverse primer combination, respectively, for the melR1 
and melR2-encompassing primers (Table 4.S1). In addition, an in frame His10-
encoding sequence was incorporated into each of the forward primers to facilitate 
downstream protein purification using the Ni-NTA affinity system (Qiagen). The 
melR1 and melR2-encompassing amplicons were digested with NcoI/EcoRV and 
XbaI, and ligated into the NcoI/ScaI and XbaI-digested nisin-inducible translational 
fusion plasmids pNZ8048 or pNZ8150, respectively (Mierau et al., 2005). Ligation 
mixtures were introduced into L. lactis NZ9000 (Table 4.1) by electrotransformation, 
and transformants were then selected based on chloramphenicol resistance. The 
plasmid content of a number of Cmr transformants was screened by restriction 
analysis and the integrity of positively identified recombinant melR1 or melR2-
containing plasmids was verified by sequencing, resulting in constructs pNZ-MelR1-
His or pNZ-MelR2-His, respectively.  
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The coding region of the predicted ROK-type regulator-encoding gene Bbr_1868 
(designated here as rafR) was PCR-amplified employing Taq DNA polymerase and 
chromosomal DNA of B. breve UCC2003 as a template, and primer combinations 
ROKBglIIF and ROKPst1R, which had BglII and Pst1 restriction sites incorporated 
at the 5’ ends of the forward and reverse primers, respectively (Table 4.S1). The 
generated rafR-encompassing fragment was digested with BglII and Pst1, and ligated 
to similarly digested pQE30 (Qiagen), an IPTG-inducible protein expression 
plasmid, which allows incorporation of a His-tag into the N-terminus of the 
expressed protein target. The ligation mixture was introduced into E. coli XL1 blue 
(Table 4.1) by electrotransformation, and transformants were selected based on 
ampicillin and tetracycline resistance. The plasmid content of a number of Ampr and 
Tetr transformants was screened by restriction analysis and the integrity of a 
positively identified recombinant plasmid was verified by sequencing and designated 
pQE30-RafR. 
Protein (over)production and purification. For the (over)production of MelR1 and 
MelR2 25 ml of M17 broth supplemented with 0.5 % glucose was inoculated with a 
2 % inoculum of L. lactis NZ9000 harbouring either pNZ-MelR1-His, pNZ-MelR2-
His or the empty vector pNZ8048 (used as a negative control), followed by 
incubation at 30oC until an Optical Density (OD600nm) of 0.5 was reached, at which 
point protein expression was induced by the addition of filter sterilised nisin-
containing, cell free supernatant of L. lactis NZ9700 followed by continued 
incubation at 30oC for 90 minutes. Cells were harvested, resuspended in 10 mM 
Tris-HCl buffer (pH 7.0), and disrupted with glass beads in a mini-bead beater 
(BioSpec Products, Bartlesville, OK). Cellular debris was removed by centrifugation 
at 3,000g to produce a crude cell extract. Although protein purification of MelR1-His 
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and MelR2-His was achieved using His-tag affinity chromatography, the purification 
procedure appeared to render the proteins inactive in subsequent EMSA experiments 
(results not shown). For this reason crude cell extracts, prepared in a 10 mM Tris-
HCl lysis buffer (pH 7.0), were adopted for the EMSA experiments (see below). 
In the case of RafR, a 300 ml volume of LB supplemented with tetracycline and 
ampicillin was inoculated with 6 ml of an overnight culture of E. coli XL1-Blue cells 
harbouring pQE30-RafR, and then incubated at 37°C. At an OD600 of 0.5, expression 
of RafR was induced by the addition of 1 mM IPTG (Roche Diagnostics Ltd., West 
Sussex, United Kingdom). Following 2 h of incubation in the presence of IPTG, 
cells were harvested by centrifugation and crude cell extracts for protein purification 
were prepared as described above. Subsequent protein purification was performed 
using a PrepEase® kit for His-tagged protein purification (USB, Germany). Elution 
fractions were analysed by SDS polyacrylamide gel electrophoresis, as described 
previously (Laemmli, 1970) on a 12.5 % polyacrylamide gel. Following 
electrophoresis the gels were fixed and stained with Coomassie Brilliant blue to 
identify fractions containing the purified protein. Prestained Rainbow low molecular 
weight protein marker (New England Biolabs, Herdfordshire, UK) was used to 
estimate the molecular weight of the expressed and/or purified proteins. 
Construction of B. breve insertion mutant strains. Internal fragments of rafR (528 
bp; representing codons 88 through to 264 out of the 403 codons of this gene), 
melR1 (380 bp; representing codons 107 through to 234 out of the 340 codons of this 
gene), melR2 (402 bp; representing codons 93 through to 227 out of the 343 codons 
of this gene), were amplified by PCR using B. breve UCC2003 chromosomal DNA 
as template and the oligonucleotide primer combinations rafRfHd3in and 
rafRrxbaIin, melR1fHd3in and melR1rxba1in, and melR2fHd3in and melR2rxba1in, 
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respectively (Table S4.1). The generated PCR products were ligated to pORI19, an 
Ori+ RepA- integration plasmid (Law et al., 1995), using HindIII and XbaI 
restriction sites that were incorporated into the primers for the partial rafR, melR1 
and melR2-encompassing amplicons, and introduced into E. coli EC101 by 
electroporation. Recombinant E. coli EC101 derivatives containing pORI19 
constructs were selected on LB agar containing Em, and supplemented with X-gal 
(5-bromo-4-chloro-3-indolyl-D-galactopyranoside) (40 µg ml-1) and 1 mM IPTG.  
The expected genetic structure of the recombinant plasmids, pORI19-rafR (pORI19 
containing an internal 528 bp fragment of the rafR gene), pORI19-melR1 (pORI19 
containing an internal 402 bp fragment of the melR1 gene) and pORI19-melR2 
(pORI19 containing an internal 380 bp fragment of the melR2 gene), was confirmed 
by restriction mapping prior to subcloning of the Tet resistance antibiotic cassette, 
tetW, from pAM5 (Alvarez-Martin et al., 2007) as a SacI fragment into the unique 
SacI site present on each of the pORI19 derivatives. The orientation of the 
tetracycline resistance gene in each of the resulting plasmids pORI19-tet-rafR, 
pORI19-tet-melR1 and pORI19-tet-melR2, was determined by restriction analysis. 
The plasmids were subsequently introduced into E. coli EC101 pNZ-MBbrI-MBbrII 
(O'Connell Motherway et al., 2009) (transformants were selected based on Cm and 
Tet resistance) in order to methylate the plasmid constructs before introduction into 
B. breve UCC2003. 
Methylation of the plasmid complement of the obtained transformants in EC101 
pNZ-MBbrI-MBbrII was confirmed by their observed resistance to PstI restriction 
(O'Connell Motherway et al., 2009). Plasmid preparations of methylated pORI19-
tet-rafR, pORI19-tet-melR1 and pORI19-tet-melR2 were introduced by 
electroporation into B. breve UCC2003 with subsequent selection on RCA plates 
211 
 
supplemented with Tet. Insertion mutants resulting from site-specific homologous 
recombination were initially confirmed by colony PCR targeting the tetracycline 
resistance gene tetW, followed by a second confirmatory PCR adopting a tetW-based 
primer, either forward or reverse depending on the orientation of tetW, in 
combination with a primer specific for each targeted gene to confirm integration at 
the correct chromosomal position (Table S4.1). In this case a product of a particular 
size would only be obtained if the correct gene disruption had been achieved. In this 
manner mutants were obtained carrying chromosomal insertions in either the rafR, 
melR1 or melR2 gene, resulting in strains B. breve UCC2003-rafR, B. breve 
UCC2003-melR1 and B. breve UCC2003-melR2, respectively. 
Analysis of preferential carbohydrate (raffinose ot melezitose) consumption by B. 
breve UCC2003. Filter-sterilised raffinose and melezitose solutions were added to 
mMRS medium (to obtain a final sugar concentration of 0.5 % and/or 0.1 % 
respectively). B. breve UCC2003 growth in mMRS supplemented with 
raffinose/melezitose and 0.05 % (wt/vol) cysteine-HCl was monitored every two 
hours for 13 hours followed by 2 time points at 24 and 48 hours by measuring the 
optical density at 600 nm (OD600). In addition, HPAEC-PAD analysis of heat treated 
(80oC for 2 mins) filtered, cell-free growth medium samples taken at the same time 
points was performed to analyse raffinose and/or melezitose consumption. 
Analysis of global gene expression using B. breve DNA microarrays. Global gene 
transcription was determined by microarray analysis during growth of B. breve 
UCC2003-rafR, B. breve UCC2003-melR1 and B. breve UCC2003-melR2, in mMRS 
supplemented with ribose and these transcriptomes were compared to that obtained 
from B. breve UCC2003 wild type cells that also had been grown on ribose as the 
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sole carbohydrate source. DNA-microarrays containing oligonucleotide primers 
representing each of the 1864 annotated genes on the genome of B. breve UCC2003 
were designed by and obtained from Agilent Technologies (Palo Alto, Ca., USA). 
Methods for cell disruption, RNA isolation, RNA quality control, complementary 
DNA synthesis and labelling were performed as described previously (Zomer et al., 
2009). Labelled cDNA was hybridised using the Agilent Gene Expression 
hybridisation kit (part number 5188-5242) as described in the Agilent Two-Color 
Microarray-Based Gene Expression Analysis v4.0 manual (G4140-90050). 
Following hybridisation, microarrays were washed in accordance with Agilent’s 
standard procedures and scanned using an Agilent DNA microarray scanner (model 
G2565A). Generated scans were converted to data files with Agilent's Feature 
Extraction software (Version 9.5). DNA-microarray data were processed as 
previously described (Garcia De La Nava et al., 2003; van Hijum et al., 2003; van 
Hijum et al., 2005). Differential expression tests were performed with the Cyber-T 
implementation of a variant of the t-test (Long et al., 2001). A gene was considered 
to exhibit significantly differential expression when p < 0.001, and an expression 
ratio of >3 or <0.33 relative to the control. Obtained microarray data were deposited 
in NCBI's Gene Expression Omnibus and are accessible through GEO Series 
accession number GSE50211. 
Electrophoretic mobility shift assay (EMSA). DNA fragments representing different 
portions of the promoter regions upstream the rafA, rafB, Bbr_1862 and melA genes 
were prepared by PCR using IRD800-labelled primers pairs (MWG Biotech; 
supplemental Table 4.S2). EMSAs were performed essentially as described 
previously (Hellman & Fried, 2007). In all cases, the binding reactions were 
performed in a final volume of 20 µl in the presence of poly[d(I-C)] in binding 
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buffer (20 mM Tris-HCl, 5 mM MgCl2, 0.5 mM DTT, 1 mM EDTA, 200 mM KCl, 
10 % glycerol at pH 7.0). Varying amounts of a crude cell extract containing either 
MelR1 or MelR2, or purified RafR, were mixed on ice with a fixed amount of DNA 
probe (0.1 pmol) and subsequently incubated for 30 min at 37°C. Samples were 
loaded onto a 6 % non-denaturing PAA gel prepared in TAE buffer (40 mM Tris 
acetate [pH 8.0], 2 mM EDTA) and run in a 0.5-to-2.0 x gradient of TAE at 100 V 
for 90 minutes in an Atto Mini PAGE system (Atto Bioscience and Biotechnology, 
Tokyo, Japan). Signals were detected using an Odyssey Infrared Imaging System 
(Li-Cor Biosciences UK Ltd, Cambridge, UK) and images were captured using the 
supplied Odyssey software V3.0.  
Primer extension analysis. Total RNA was isolated from exponentially growing 
cells of B. breve UCC2003 or B. breve UCC2003-melR2, cultured in mMRS 
supplemented with 1 % raffinose or melezitose for B. breve UCC2003, or in mMRS 
supplemented with 1 % ribose for B. breve UCC2003-melR2 (Kuipers et al., 1993). 
Primer extension was performed by annealing 1 pmol of an IRD800-labeled 
synthetic oligonucleotide to 20 µg of RNA as previously described (Ventura et al., 
2005) using primers rafAPERP1, rafAPERP2, rafBPERP1, rafBPERP2, 
melAPERP1, melAPERP1, 1862PERP1, 1862PERP1(Table 4.S2). Sequence ladders 
of the presumed rafA, rafB, melA and Bbr_1862 promoter regions were produced 
using the same primer as the primer extension reaction and employing the DNA 
cycle Sequencing Kit (Jena Bioscience, Loebstedter Strasse 80, Germany) and were 
run alongside the primer extension products to allow precise positioning of the 
transcriptional start site. Separation was achieved on a 6.5 % Li-Cor Matrix KB Plus 
acrylamide gel. Signal detection and image capture was performed by means of a Li-
cor sequencing instrument (Li-Cor Biosciences). 
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4.4 RESULTS AND DISCUSSION 
Metabolism of melezitose in B. breve UCC2003 is preferred over that of raffinose-
like carbohydrates 
In a previous study (O'Connell et al., 2013) we investigated the metabolism of 
raffinose-related carbohydrates, raffinose, stachyose and melibiose by B. breve 
UCC2003. This particular study allowed the identification of a gene cluster, 
comprising rafA, rafR, rafB, rafC and rafD, predicted to be involved in the 
utilisation of raffinose-related sugars, and where rafA was shown to encode an α-
galactosidase, rafR a putative ROK-type transcriptional regulator, while the adjacent 
rafBCD genes specified a putative ABC-type sugar uptake system (Fig. 4.1). This 
same study also identified a gene cluster in the B. breve UCC2003 genome, located 
in the immediate vicinity of the raf gene cluster, dedicated to melezitose metabolism 
(O'Connell et al., 2013), and comprised of the melA, melB, melC, melD and melE, 
genes, with melABC specifying a presumed ABC-type sugar uptake system, while 
melD and melE encoding an α-glucosidase and an α-galactosidase, respectively (Fig. 
4.1). Located between these afore mentioned raf and mel genes are four genes, two 
of which, designated melR1 and melR2, encode putative LacI-type transcriptional 
regulators (Fig. 4.1).  
We previously (O'Connell et al., 2013) demonstrated that transcription of the 
melABCDE and rafABCD genes is induced by the presence of melezitose and 
raffinose (or raffinose-like sugars), indicative of a substrate-specific transcriptional 
regulation. In order to investigate if B. breve UCC2003 exhibits a preference for 
either melezitose or raffinose, we determined growth profiles of this strain in the 
presence of various amounts of melezitose, raffinose or a combination of these two 
sugars, while we also determined the carbohydrate utilisation from the growth 
medium by HPAEC-PAD analysis (see Materials and Methods). Following initial 
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experiments required to determine the precise amounts of carbohydrate needed to 
clearly visualise preferential sugar utilisation (data not shown), it was found that 
when B. breve UCC2003 was grown in a combination of 0.1 % melezitose and 0.5 % 
raffinose, the former carbohydrate was utilised first, and that raffinose was being 
used only when melezitose had been exhausted from the medium (Fig. 4.2A). A 
diauxic growth curve could be observed when UCC2003 was grown on this 
melezitose/raffinose-containing medium, although the growth rate differences 
between melezitose and raffinose-supported growth were negligible under the 
growth conditions used (Fig.4.2B). These findings indicate that the genes involved in 
raffinose metabolism are not transcribed in the presence of melezitose, reminiscent 
of carbon catabolite regulatory control.  
Transcriptomes of B. breve UCC2003 mutants carrying disruptions in melR1, 
melR2 or rafR.  
In order to identify and investigate the regulatory players that control the raffinose 
and melezitose-induced genes, insertion mutants were made in the melR1, melR2 and 
rafR genes that were located within the mel-raf region and predicted to encode 
regulatory proteins (see above and Fig. 4.1), resulting in strains B. breve UCC2003-
melR1, B. breve UCC2003-melR2 and UCC2003-rafR, respectively (see Materials 
and Methods). It was hoped that if any of the putative regulatory genes encoded a 
repressor, mutation of the gene would lead to increased transcription even in the 
absence of the inducing carbohydrate. 
Altered gene expression patterns were determined by DNA microarray analysis from 
two independent biological replicates and employing B. breve UCC2003, B. breve 
UCC2003-melR1, B. breve UCC2003-melR2 or UCC2003-rafR cultures grown to 
the exponential growth phase in mMRS supplemented with ribose. The obtained 
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transcriptomes revealed that, compared to B. breve UCC2003, the melABCDE genes 
were significantly upregulated (fold change > 5.0, P<0.001) in B. breve UCC2003-
melR1, while melABCDE as well as its adjacent genes Bbr_1861 and Bbr_1862 were 
upregulated (fold change > 5.0, P<0.001) in B. breve UCC2003-melR2 (Table 4.2). 
However, the insertion mutation in melR2 appears to have a polar effect on the 
transcription of the downstream located gene, melR1, as this gene exhibited a 1.7-
fold lower level of transcription in the B. breve UCC2003-melR2 mutant (compared 
to UCC2003; P<0.001), thereby indicating that melR2 and melR1 are co-transcribed. 
The obtained data is consistent with our prediction that both LacI-type regulators act 
as typical transcriptional repressors since the mutations in B. breve UCC2003-melR1 
and UCC2003-melR2 cause transcriptional upregulation of adjacent genes, several of 
which have been associated with melezitose metabolism. However, the observed 
transcriptional increases observed for UCC2003-melR2 may be partly due to a polar 
effect of the melR2 mutation on melR1 transcription.  
The transcriptome of B. breve UCC2003-rafR did not reveal any statistically 
significant differences with that of B. breve UCC2003 that could be linked to the 
metabolism of raffinose-like sugars (results not shown), which is consistent with the 
notion that RafR is a ROK-type transcriptional activator. The three mutants were 
also investigated for their ability to utilise melezitose or raffinose-like sugars. The B. 
breve UCC2003-melR1 and UCC2003-melR2 mutants both retained the ability to 
utilise melezitose as sole carbohydrate source (Fig. 4.3A). Interestingly, the B. breve 
UCC2003-rafR was incapable of growing to a high optical density in mMRS 
supplemented with any of the raffinose-like sugars as the sole carbon source (Fig. 
4.3B), while growth of B. breve UCC2003-rafR in mMRS supplemented with 1 % 
lactose was comparable to that observed for the parent strain B. breve UCC2003. 
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These results demonstrate that rafR is required for growth on raffinose-related 
carbohydrates and suggest that the ROK-type transcriptional regulator RafA is 
required for the activation of the raffinose gene cluster.  
MelR1 and MelR2 bind to the melA and Bbr1862 promoter regions, respectively  
The transcriptome data obtained for the B. breve UCC2003-melR1 and UCC2003-
melR2 mutants (see above) suggests that melR1 and melR2 encode LacI-type 
regulators that control various genes of the mel gene cluster. In order to establish if 
the MelR1 or MelR2 proteins directly and specifically interact with presumed 
operator sequences within the promoter region(s) of the mel gene cluster, i.e. the 
Bbr_1862 and/or melA promoter regions (see below), electrophoretic mobility shift 
assays (EMSAs) were performed. For this purpose, we first cloned melR1 and melR2 
in the nisin-inducible vectors pNZ8048 and pNZ8150, respectively, with the 
introduction of a N-terminal His-tag-encoding sequence to facilitate protein 
expression and purification in L. lactis NZ9000 (and generating plasmids pNZ-
MelR1-His and pNZ-MelR2-His, respectively).  
However, although MelR1and MelR2 could be obtained as purified proteins, they 
proved unable to form DNA-protein complexes under the conditions used, which had 
been noted previously for LacI-type regulators in bifidobacteria (Pokusaeva et al., 
2011). For this reason, instead of the purified proteins, crude cell extracts of (nisin-
induced) L. lactis NZ9000 pNZ-MelR1-His or L. lactis NZ9000 pNZ-MelR2-His 
were employed to perform EMSAs. As a negative control for EMSAs we used crude 
cell extract of L. lactis NZ9000 (pNZ8048) (empty vector) incubated with various 
DNA fragments as mentioned below, which, as expected, all failed to alter 
electrophoretic behaviour of these DNA fragments. The obtained results with a crude 
cell extract containing MelR1 clearly demonstrate that this protein binds to the 
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IRD800-labelled DNA fragment M1, which encompasses the 444 bp promoter-
containing (see below) region preceding melA, while MelR1 failed to bind to the 
IRD800-labelled DNA fragment K1, encompassing the Bbr_1862 promoter region, 
or the rafA or rafB promoter regions (Fig. 4.4A and 4.4 B (i), and results not shown).  
Further dissection of the melA promoter region showed that MelR1 binding required 
an 84 bp DNA segment which is present within fragments M1- M4 [Fig. 4.4B (i) and 
Supplementary figure S4.1 (i-iii)], and which contains a 24 bp imperfect inverted 
repeat, 5’-TCATGCATAAGC><GCTTAGCAAATA-3’representing the putative 
MelR1-specific operator sequence. This was further validated by EMSAs using a 46 
bp synthetic DNA fragment that contained this MelR1 binding (motifmelAIR) (Fig. 
4.4C (i)). Furthermore, introduction of two point mutations in this presumed MelR1 
operator sequence (a G to T and a C to A mutation at positions eight and nine of the 
sequence as indicated above) were shown to prevent binding of MelR1 (mu-melAIR)  
(Fig. 4.4 C(iii)). Other mutations in bases on either side of this motif did not affect 
binding of MelR1 (results not shown; for all wild type and mutated primer sequences 
see Table S4.3). To investigate whether MelR1 interaction with its target DNA 
sequence is influenced by a carbohydrate effector molecule, as is known for other 
LacI-type regulators (reviewed by (Swint-Kruse & Matthews, 2009; Wilson et al., 
2007)), several carbohydrates were tested for their effects on MelR1–DNA complex 
formation. The results obtained show that the binding ability of MelR1 to the M1 
fragment of the melA promoter region is lost in the presence of melezitose at 
concentrations > 2.5 mM (Fig. 4.4D), whereas under the same experimental 
conditions galactose or lactose did not affect MelR1 binding to its target 
(Supplementary figure S4.2 (i) and (ii)). 
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When EMSAs were performed using a nisin-induced L. lactis NZ9000 pNZ-MelR2-
His cell extract, MelR2 was shown to bind to IRD800-labelled DNA fragment K1, 
which encompasses the 310 bp promoter-containing (see below) region preceding 
Bbr_1862, but not with similarly labelled DNA fragments containing the promoter 
regions upstream of melA (fragment M1), rafA or rafB (Fig. 4.4A and 4.4 B (ii), and 
results not shown). Further EMSAs showed that MelR2 binding required a 85 bp 
DNA segment present within fragments K1 and K2, and absent in fragments K3 and 
K4 of the Bbr_1862 promoter region (Fig. 4.4B (ii); Supplementary figure S4.3 (i-
iii). Inspection of this 85 bp fragment revealed the presence of a 24 bp imperfect 
inverted repeat, 5’-ATGTGCGTAATC><GATATCGCAAAT-3’, representing a 
putative MelR2 operator sequence. This was validated by EMSAs using a synthetic 
50 bp DNA fragment that contained this predicted operator sequence (Bbr1862IR) 
(Fig. 4.4C (ii)). Introduction of two point mutations in the putative 24 bp MelR2 
binding motif (an A to C and a T to G mutation at positions ten and eleven of this 
motif) were shown to prevent MelR2 binding (See Supplementary table S4.4) for 
IRD800 primer sequences (mu-Bbr1862IR) (Fig. 4.4 C (iv)). Other mutations were 
also made at positions one and two and also in bases surrounding this motif but none 
of these mutations was shown to affect binding under the conditions tested (results 
not shown; see Supplementary table S4.4 for relevant primer sequences used). To 
investigate if MelR2 interaction with its target DNA sequence is influenced by a 
carbohydrate effector molecule, as shown for MelR1, several carbohydrates were 
tested for their effects on MelR2–DNA complex formation. However, none of the 
carbohydrates tested (melezitose, turanose, sucrose, glucose, fructose, α-(1 3) 
galactobiose or α-(1 4) galactobiose) was shown to prevent MelR2 binding to its 
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DNA target (Supplementary figure S4.4 (i-vii)), suggesting that MelR2 binding is 
abrogated by an as yet unknown carbohydrate (O'Connell et al., 2013). 
The above binding studies, combined with the transcriptome analyses indicate that 
MelR1 is the melezitose-responsive repressor of the melABCDE gene cluster, while 
MelR2 is a LacI-type repressor controlling transcription of Bbr_1861 and Bbr_1862. 
The observation that the melR2 mutation leads to an increase in melABCDE 
transcription is most likely an indirect effect due to its negative polar effect on melR1 
transcription, leading to reduced MelR1 expression and consequently derepression of 
the melABCDE gene cluster. 
RafR binds to the rafB promoter region The presence of rafR, encoding a putative 
ROK-type regulator within the raffinose gene cluster suggests that this gene plays a 
role in the transcriptional regulation of the raf gene cluster, a notion that was 
supported by the inability of a rafR mutant to support proper growth on raffinose-
type sugars (see above). In order to establish if RafR is capable of interacting with 
specific sequences within the raffinose-induced (O'Connell et al., 2013) promoter 
regions upstream of rafA and rafB (see below), we overexpressed and purified RafR 
as a His-tagged protein (see Materials and Methods). RafR was then used to perform 
EMSAs, which clearly demonstrate that it causes a mobility shift of IRD800-labelled 
DNA fragment R1, which includes the 241 bp promoter region upstream of rafB 
(Fig. 4.5A and B (i) ). However, under the conditions used RafR was unable to bind 
to IRD800-labelled DNA fragment G1 which includes the 223 bp promoter region 
upstream of rafA (results not shown).  
Further EMSAs involving RafR and fragments R2 and R3 (Fig. 4.6 (i-ii) of the rafB 
promoter region showed that RafR binding requires an 81 bp DNA segment (Fig. 
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4.5(i) and (ii)), which contains an imperfect inverted repeat, 5’-
TTTATTGCGTT>A<ATCACAAAATA-3’, thus representing the putative RafR 
operator sequence. This was validated by EMSAs using a 38 bp DNA fragment that 
contained this sequence (rafBIR) (Fig. 4.5B (ii)). Introduction of point mutations in a 
35 bp sequence encompassing the putative RafR binding motif revealed various 
positions within this operator sequence that are crucial for RafR binding (Fig. 4.5C; 
for primer sequences used see Supplementary table S4.5). This operator binding 
sequence is very similar to the consensus operator sequence determined for two other 
members of the ROK family proteins, Mlc and NagC, in E. coli (Plumbridge, 2001, 
Titgemeyer et al., 1994).  
RafR interaction with its target DNA sequence was not affected by the presence of 
raffinose, stachyose, melibose, galactose, glucose, sucrose, α-(1 3)-galactobiose or 
α-(1 4)-galactobiose at concentrations ranging from 2.5 mM to 20 mM 
(Supplementary figure S4.5 (i-viii)). Binding of RafR to the rafA promoter region 
was also tested in the presence of these sugars; however, this did not result in 
binding of RafR to the rafA promoter region (results not shown).  
Identification of the transcription start sites of rafA, rafB, melA and Bbr_1862 
From the genetic organisation (Fig. 4.1) and the expression pattern of the raf locus 
(O'Connell et al., 2013) it was deduced that the raf cluster contained two 
raffinose/stachyose/melibiose-inducible promoters: one in front of the rafA gene and 
one in front of the rafB gene. In relation to the mel cluster potential promoter regions 
were identified based on in silico analysis of the mel locus (Fig. 4.1) coupled with 
transcriptomic data obtained during growth on melezitose (O'Connell et al., 2013), 
as well as the transcriptomes of UCC2003-melR1and UCC2003-melR2 (see above). 
It was reasoned that one melezitose-inducible, MelR1-dependent promoter was 
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located directly upstream of the melA coding sequence and one promoter 
(transcription of which is subject to MelR2 and an as yet unknown inducer molecule) 
preceding the Bbr_1862 coding sequence.  
In order to determine the transcription start site of these presumed promoters, primer 
extension analysis was performed using RNA extracted from B. breve UCC2003 
grown in mMRS containing either 1 % melezitose or raffinose as appropriate. To 
determine the transcription start site of Bbr_1862, B. breve UCC2003-melR2 (whose 
transcriptome revealed constitutive transcription of Bbr_1862) was grown in mMRS 
supplemented with ribose as the sole carbohydrate source. Single extension products 
were identified upstream melA, the Bbr_1862 gene, rafB, and rafA, and in all 
cases potential promoter recognition sequences resembling consensus −10 and −35 
hexamers could be identified upstream of these transcription start points (Fig. 4.7 A-
D). In the case of melA and Bbr_1862-associated promoters, the MelR1 and MelR2 
binding operator sequences overlap the respective −10 sequence, which would 
support our findings that MelR1 and MelR2 are LacI-type transcriptional repressors. 
For the rafB promoter region the RafR operator sequence is located upstream of the -
35 and -10 promoter recognition sequences, a location that is consistent with the 
notion that RafR functions as a transcriptional activator.  
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4.5 CONCLUDING REMARKS 
The data assembled in this study provide significant information on B. breve 
UCC2003’s ability to regulate two adjacent genetic loci dedicated to the utilisation 
of raffinose-containing carbohydrates and melezitose (O'Connell et al., 2013). We 
conclude that MelR1 is a LacI-type regulator that acts as a melezitose-responsive 
repressor of the melABCDE gene cluster, while MelR2 is also a LacI-type regulator 
that acts as a repressor of the Bbr_1861 and Bbr_1862 genes, the latter encoding a 
predicted carbohydrate binding protein of an ABC-type sugar transport system. 
Because of its vicinity and the finding that melE encodes an α-galactosidase, we 
speculate that MelR2 responds to an oligosaccharide, containing a melezitose 
backbone to which one or more α-galactose moieties are attached. This α-galactose-
containing oligosaccharide is bound by the product of Bbr_1862 and internalised by 
the melABC uptake system, after which the α-galactose moiety (or moieties) are 
removed by the action of MelE followed by further degradation by MelD. 
Unfortunately, no such substrates are currently commercially available and this 
hypothesis therefore remains to be verified.  
In a classic example by (Irwin & Ptashne, 1987) it was observed that mutating the 
catabolite activator protein (CAP) resulted in lack of transcriptional activation of the 
gal promoter. Similarly, in Corynebacterium glutamicum 13032, a deletion in the 
gene encoding the ROK-type protein, CysR, rendered this strain incapable of 
utilising sulphate or sulphonates as the sole source of sulphur leading the authors to 
speculate that CysR functions as a transcriptional activator (Ruckert et al., 2008). 
Since an insertion in rafR led to the inability of the strain to utilise raffinose-like 
carbohydrates and combined with our binding studies, where RafR, like many 
transcriptional activators binds upstream of the promoter region (Collado-Vides et 
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al., 1991; Madan Babu & Teichmann, 2003), we conclude that RafR also acts as a 
transcriptional activator of the rafBCD cluster.  
Somewhat to our surprise RafR did not bind to the rafA promoter, at least not under 
the conditions used here, although this promoter is transcriptionally induced when B. 
breve UCC2003 is grown in raffinose-like sugars (O'Connell et al., 2013). It may be 
that RafR requires an effector for binding to this promoter and future research will 
investigate the transcriptional regulation of rafA.  
Finally and interestingly, we found that B. breve UCC2003 prefers melezitose 
metabolism over that of raffinose-like sugars, indicating that this bifidobacterial 
strain engages in some form of carbon catabolite control. Although regulation of 
melezitose metabolism is established through the LacI-type repressor MelR1, while 
raffinose-like sugars are metabolised by means of the ROK-protein RafA, our 
findings clearly indicate that an additional, but so far elusive, carbohydrate detection 
and control system must be operating in B. breve UCC2003 and perhaps other 
bifidobacteria. Future research efforts will be aimed at identifying and characterising 
this regulatory mechanism.   
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Strain/ plasmid Relevant characteristics Reference or source 
E.coli strains 
  EC101 Cloning host, repA+ kmr (Law et al., 1995) 
EC101-pNZ-
M.Bbrll+Bbr111 EC101 harbouring pNZ8048 derivative containing bbrllM and bbrlllM 
 XLI blue RecA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)] Stratagene 
L. lactis strains 
  NZ9000 MG1363,nisin-inducible overexpression host; pepN::nisRK (de Ruyter et al., 1996) 
NZ9700 Nisin producing strain (de Ruyter et al., 1996) 
B. breve strains 
  UCC2003 Isolate from a nursling stool (Maze et al., 2007) 
UCC2003- melR1 pORI19-tet-mel1 insertion mutant of  UCC2003 This study 
UCC2003- melR2 pORI19-tet- melR2 insertion mutant of  UCC2003 This study 
UCC2003-rafR pORI19-tet-rafR insertion mutant of  UCC2003 This study 
Plasmids 
  pORI19 Emr , repA- , ori+ , cloning vector (Law et al., 1995) 
pORI19-tet- melR1 Internal 421bp fragment of  melR1 and tetW cloned in pORI19 This study 
pORI19-tet- melR2 Internal 456bp fragment of  melR2 and tetW cloned in pORI19 This study 
pORI19-tet-rafR Internal 331bp fragment of rafR and tetW cloned in pORI19 This study 
pAM5 pBC1-puC19-Tcr (Alvarez-Martin et al., 2007) 
pNZ8048 Cmr; nisin-inducible translational fusion vector (de Ruyter et al., 1996) 
pNZ8150 Cmr; nisin-inducible translational fusion vector (Mierau et al., 2005) 
PQE30 Ampr; IPTG-inducible vector Qiagen 
pNZ-MelR1-His MelR1 with his tag cloned downstream of nisin inducible promoter on pNZ8048 This study 
pnz-MelR2-His melR2 with his tag cloned downstream of nisin inducible promoter on pNZ8150 This study 
pQE30-RafR rafR  IPTG-inducible vector PQE30 This study 
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Figure 4.1 Representation of the raffinose and melezitose utilisation operons of B. breve UCC2003. 
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Figure 4.2 A. HPAEC-PAD analysis of B. breve UCC2003 consumption of (i) 0.1% 
melezitose (ii) 0.5% raffinose and (iii) 0.5% raffinose and 0.1% melezitose during 48 
hours of growth. B. Consumption of (i) 0.1% melezitose (ii) 0.5% raffinose (iii) 
mixture 0.5% raffinose and 0.1% melezitose up to 48 hours (iv) mixture 0.5% 
raffinose and 0.1% melezitose during 15 hours of growth in mMRS medium by B. 
breveUCC2003. 
A.
B. (i) (ii)
(iii)
(iv)
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Table 4.2 Transcriptome analysis of B. breve UCC2003- melR1 and B. breve UCC2003- melR2 as compared to B. breve UCC2003 grown on 1% 
ribose. 
   
 
 
 
 
Fold cut off point is 5 fold, p value < 0.001, and values below cut-off are indicated in the Table as a dash. 
Gene number Name Putative Function Fold up 
regulation 
melR2 
Fold up 
regulation 
melR1 
Bbr_1856 melE Alpha-galactosidase 6.60 5.51 
Bbr_1857 melD Alpha-1,4-glucosidase  10.24 8.59 
Bbr_1858 melC Permease protein of ABC transporter system for sugars  86.80 78.10 
Bbr_1859 melB Permease protein of ABC transporter system for sugars  88.56 67.90 
Bbr_1860 melA Solute binding protein of ABC transporter system for sugars 77.64 80.63 
Bbr_1861  Conserved hypothetical protein  59.43 _ 
Bbr_1862  Solute binding protein of ABC transporter system for sugars  148.62 _ 
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Figure 4.3 A Final OD600 after 16 hours of wild type strain B. breve UCC2003 and 
insertion mutants B. breve UCC2003- melR1 and B. breve UCC2003- melR2 grown 
on 1% melezitose and 1% lactose. The results are mean values obtained from three 
separate experiments, P< 0.1. B Final OD600 after 16 hours of wild type strain B. 
breve UCC2003 and insertion mutant B. breve UCC2003-rafR grown on 1% 
stachyose, 1% raffinose, 1% melibiose and 1% lactose (*P<0.01,**P<0.001). 
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 Figure 4.4 Panel A: Representation of the melezitose utilisation cluster of B. breve UCC2003 and DNA fragments used in electrophoretic 
mobility shift assays (EMSAs) for the melA and Bbr_1862 promoter regions. Plus and minus signs indicate whether or not MelR1 or MelR2 was 
able to bind to the melA or Bbr_1862 DNA fragments, respectively. Panel B: EMSAs showing (i) MelR1 interaction with DNA fragments 
encompassing fragment M1 and (ii) MelR2 interaction with DNA fragments encompassing fragment K1. Panel C: EMSAs illustrating MelR1 
interaction with (i) melAIR and (ii) mutated derivative mu-melAIR and MelR2 interaction with (iii) Bbr1862IR and (IV) mutated derivative mu-
Bbr1862IR. In each panel lane - represents a binding reaction to which no protein was added, while the remaining lanes represent binding 
reactions with the respective DNA probes incubated with increasing amounts of protein at concentrations ranging from 0.04 nM to 0.01µM. 
Each successive lane, from right to left, corresponds to a doubling in the concentration of each protein. Panel D: EMSAs showing MelR1 
interaction with the DNA fragment M1 with the addition of melezitose at concentrations ranging from 2.5-20 mM.
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Figure 4.5 Panel A: Representation of the raffinose utilisation cluster of B. breve UCC2003 and DNA fragments used in electrophoretic mobility 
shift assays (EMSAs) for the rafB and rafA promoter regions. Plus and minus signs indicate whether or not RafA was able to bind to the rafB or 
rafA DNA fragments, respectively. Panel B: EMSAs showing RafR interaction with DNA fragments encompassing fragment (i) R1 and (ii)the 
annealed oligonucleotides representing rafBIR. In each panel lane - represents a binding reaction to which no protein was added, while the 
remaining lanes represent binding reactions with the respective DNA probes incubated with increasing amounts of protein at concentrations 
ranging from 0.04 nM 0.01 µM. Each successive lane, from right to left, corresponds to a doubling in the concentration of each protein. Panel C: 
EMSAs showing RafR, interaction with mutated operator motif of the rafB promoter region. DNA fragments were obtained by PCR using 
IRD700 labelled primers. The operator sequence and incorporated mutations are shown above the image. wt and +: original promoter sequence, -
: no added protein. In grey the conserved ROK motif. Arrows depict the inverted repeat structure of the motif.  
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Figure 4.6 EMSAs showing RafR interaction with DNA fragments encompassing 
fragment R2 (panel i) or R3 (panel ii). 
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Figure 4.7 Schematic representation of the melA (panel A), Bbr_1862 (panel B), 
rafB (panel C) rafA (panel D) promoter regions. Boldface type and underlining 
indicate the −10 and −35 hexamers as deduced from the primer extension results and 
ribosomal binding site (RBS); the transcriptional start sites (TSS) are indicated by 
asterisks. Arrows under sequence in bold indicate the inverted repeat sequence that 
represents the MelR1, MelR2 or RafR binding sequences as displayed above the 
arrows.
PE C T A G
melA
Bbr_1862
rafB
rafA
A.
B.
C.
D.
MelR1
MelR2
RafR
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4.8 SUPPLEMENTARY MATERIAL 
Table S4.1 Oligonucleotide primers used in this study 
Primer Sequencea Size bp 
melR1fHd3 TGCGGAAAGCTTATTCTTTACACGGTTACC 380 
melR1rxba1 CTATGCTCTAGACGATGACCTGTTTGGCCGA 
 melR2fHd3 TGCGGAAAGCTTACTTGCTATCATACCGAC 402 
melR2rxba1 CTATGCTCTAGACCTGTACTGCGATGATGT 
 rafRfHd3 GCTAAAGCTTGCAGACCGCATT 530 
rafRrxba1 GTCATCTAGAGCACATGCCCCACTAGGC 
 melR1-confirm GCTCGCGAACGGCTGGC 2600 
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG 
 melR2-confirm TCACTGGCTGGCTGGTTC 2600 
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG 
 rafR-confirm GCATAGATCTTCTGACGCCAATGCGATTCC 2600 
Tetwsal1F TCAGCTGTCGACATGCTCATGTACGGTAAG 
 Tetwsal1R GCGACGGTCGACCATTACCTTCTGAAACATA 
 melR1EcorVF GACAAGGATATCATGCATCACCATCACCATCACCATCACCATCACAAACGCGCGACCATCAAC 1001 
melR1Xba1 GACAAGTCTAGACTATTCCCGCTCTGGCCC 
 melR2Nco1F TGCACGCCATGGGCCATCACCATCACCATCACCATCACCATCACAGCGAACCAACAATCTATG 1002 
melR2Xba1R CTATGCTCTAGATTAATCTCGAGGTGCTGG 
 rokFfbglII GCATAGATCTTCTGACGCCAATGCGATTCC 
 rokRrpst1 CGTACTGCAGCCTACCCAATATGCTTCAC 1206 
rafAPEFDNA CTGAAGTGCATGGCGGCG 
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Primer Sequencea Size bp 
rafAPERDNA GCATCATACGCAGCGAGCAAG 378 
rafBPEFDNA CATTGGCGTCAGACATACTTAAG 
 rafBPERDNA GAGAACCCGCCGACCACG 735 
melAPEFDNA AGCCTTCGAAACGTCATCC 
 melAPERDNA GGTGATGTTCGGGTACT 514 
1862PEFDNA GATTGTTGGTTCGCTCATGGG 
 1862PERDNA CTTTGATGGTGATGTTTG 471 
a Sequences of restriction enzyme sites are indicated in bold 
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Table S4.2 IRD800 primers used to generate PCR products and primer extension 
products in this study 
Name Primer 
Product size 
(bp) 
melAIRD800f AGCCTTCGAAACGTCATCC 
 melAIRD800r CAGACATCAGACCGGCAATAAC 322 
melAIRD800SET1F TCGCGAGAAGGAAGTGC 
 melAIRD800SET1R GTTGGCTTTGTTGCTGGA 312 
melAIRD800SET2F TCGGCCATTTGTTTGCG 
 melAIRD800SET2R GCCAGCGCCGTCCCACA 302 
melAIRD800SET3F TAAGCCGAGATAGCCAAG 
 melAIRD800SET3R GGTGATGTTCGGGTACT 302 
1862IRD800irdf GATTGTTGGTTCGCTCATGGG 
 1862IRD800irdr GAGCCAGGACCACATGCAGT 310 
1862IRD800SET1F GAAGTTAAAGTCGCCATTG 
 1862IRD800SET1R CTAAATCAGTGCTGACATC 300 
1862IRD800SET2F CGTAATCGATATCGCAAATG 
 1862IRD800SET2R GCGCCTCATCTACAGTCTTC 299 
1862IRD800SET3F GATGAGGGTATAAGGAGGTATC 
 1862IRD800SET3R CTTTGATGGTGATGTTTG 268 
rafBIRD800irdf CATTGGCGTCAGACATACTTAAG 
 rafBIRD800irdr GTCTAGGCGTTGAATGTG 222 
rafBIRD800SET1F AAGTGGGCTCGCTGGCG 
 rafBIRD800SET1R CACGCCACAGCAGCAGT 178 
rafBIRD800SET2F GCTGAAGCCGGAAGGAA 
 rafBIRD800SET2R AGCGTAACGGTACCTGC 172 
rafAIRD800f GACTCTCCTCAGCACGTTCTTC 
 rafAIRD800r GCCCTTAAGATCGCCGA 223 
rafAPERP1 CTCACCGCCATCTATCTTG 
 rafAPERP2 CGACGTATACGGAATGCATTG 
 rafBPERP1 CACGCCACAGCAGCAGT 
 rafBPERP2 AGCGTAACGGTACCTGC 
 melAPERP1 GTTGGCTTTGTTGCTGGA 
 melAPERP1 GCCAGCGCCGTCCCACA 
 1862PERP1 CTAAATCAGTGCTGACATC 
 1862PERP1 GCGCCTCATCTACAGTCTTC 
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                                Figure S4.1 EMSAs showing MelR1 interaction with DNA fragments encompassing fragments (i) M2 (ii) M3 (iii) M4. 
(i) (ii) (iii)M2 M3 M4
MelR1 MelR1 MelR1
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Table S4.3 IRD800 labelled annealed primers used to generate wild type sequence 
(wt) and also a series of mutated sequences (m) in relation to melA binding sequence.  
 
Red lettering indicates the mutated base as compared to the WT sequence. All 
primers were annealed to reverse complementary sequence, forward primers 
indicated in table. 
 
 
 
 
 
 
 
 
 
Wt CTCATGCATAAGCGCTTAGCAAATACGCTAAGCCGAGATAGCCAAG 
M1 CTCATGCATAAGCTATTAGCAAATACGCTAAGCCGAGATAGCCAAG 
M2 CTCATGCATAAGCGCTTAGCAAATACGAGAAGCCGAGATAGCCAAG 
M3 CTCATTAATAAGCGCTTAGCAAATACGCTAAGCCGAGATAGCCAAG 
M4 CTCATGCATAAGCGCTTAGCAAATAATCTAAGCCGAGATAGCCAAG 
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Figure S4.2 EMSAs showing MelR1 interaction with the DNA fragment M1 with the addition of (i) galactose and (ii) lactose at concentrations 
ranging from 2.5-20 mM.+ carbohydrate plus protein, + - protein no carbohydrate, -- no protein no sugar. 
Galactose Lactose
MelR1 MelR1
(i) (ii)
243 
 
  
 
                                Figure S4.3 EMSAs showing MelR2 interaction with DNA fragments encompassing fragments (i) K2 (ii) K3 and (iii) K4. 
(i) (ii) (iii)K2 K3 K4
MelR2 MelR2 MelR2
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 Table S4.4 IRD800 labelled annealed primers used to generate wild type sequence 
(wt) and also a series of mutated sequences (m) in relation to Bbr_1862 binding 
sequence.  
 
Red lettering indicates the mutated base as compared to the WT sequence. All 
primers were annealed to reverse complementary sequence, forward primers 
indicated in table. 
 
 
 
 
 
 
 
 
Wt TGACGGGTTCCGCAAAAAGATGTACGATGTGCGTAATCGATATCGCAAATG 
M1 TGACGGGTTCCGCAAAAAGATGTACGCGGTGCGTAATCGATATCGCAAATG 
M2 TGACGGGTTCCTAAAAAAGATGTACGATGTGCGTAATCGATATCGCAAATG 
M3 TGACGGGTTCCGCAAAAAGATGTACGATGTGCGTACGCGATATCGCAAATG 
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 Figure S4.4 EMSAs showing MelR2 interaction with the DNA fragment K1 with 
the addition of (i) Melezitose (ii) Turanose (iii) Sucrose (iv) Glucose (v) fructose (vi) 
α-1,3 galactobiose (vii) α-1,4 galactobiose at concentrations ranging from 2.5-
20 mM.+ carbohydrate plus protein, + - protein no carbohydrate, -- no protein no 
sugar.  
 
 
MelR2 MelR2 MelR2
MelR2 MelR2 MelR2
MelR2
Melezitose Turanose Sucrose
Glucose Fructose
α-1,3 gal
α-1,4 gal
(i) (ii) (iii)
(iv) (v) (vi)
(vii)
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Table S4.5 IRD700 labelled primers used to generate annealed wild type sequence 
(wt) in combination with reverse complementary primer, only forward primer 
indicated, and also a series of mutated sequences (m) by PCR used in combination 
with RV in relation to RafR binding sequence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Red lettering indicates the mutated base as compared to the WT sequence. 
RV  GCGATGCGTATGCTCGGATC 
WT  GCGCGGTATTTTGTGATTAACGCAATAAATAATGC 
M1  TCGCGGTATTTTGTGATTAACGCAATAAATAATGC 
M2  GAGCGGTATTTTGTGATTAACGCAATAAATAATGC 
M3  GCTCGGTATTTTGTGATTAACGCAATAAATAATGC 
M4  GCGAGGTATTTTGTGATTAACGCAATAAATAATGC 
M5  GCGCTGTATTTTGTGATTAACGCAATAAATAATGC 
M6  GCGCGTTATTTTGTGATTAACGCAATAAATAATGC 
M7  GCGCGGGATTTTGTGATTAACGCAATAAATAATGC 
M8  GCGCGGTCTTTTGTGATTAACGCAATAAATAATGC 
M9  GCGCGGTAGTTTGTGATTAACGCAATAAATAATGC 
M10 GCGCGGTATGTTGTGATTAACGCAATAAATAATGC 
M11 GCGCGGTATTGTGTGATTAACGCAATAAATAATGC 
M12 GCGCGGTATTTGGTGATTAACGCAATAAATAATGC 
M13 GCGCGGTATTTTTTGATTAACGCAATAAATAATGC 
M14 GCGCGGTATTTTGGGATTAACGCAATAAATAATGC 
M15 GCGCGGTATTTTGTTATTAACGCAATAAATAATGC 
M16 GCGCGGTATTTTGTGCTTAACGCAATAAATAATGC 
M17 GCGCGGTATTTTGTGAGTAACGCAATAAATAATGC 
M18 GCGCGGTATTTTGTGATGAACGCAATAAATAATGC 
M19 GCGCGGTATTTTGTGATTCACGCAATAAATAATGC 
M20 GCGCGGTATTTTGTGATTACCGCAATAAATAATGC 
M21 GCGCGGTATTTTGTGATTAAAGCAATAAATAATGC 
M22 GCGCGGTATTTTGTGATTAACTCAATAAATAATGC 
M23 GCGCGGTATTTTGTGATTAACGAAATAAATAATGC 
M24 GCGCGGTATTTTGTGATTAACGCCATAAATAATGC 
M25 GCGCGGTATTTTGTGATTAACGCACTAAATAATGC 
M26 GCGCGGTATTTTGTGATTAACGCAAGAAATAATGC 
M27 GCGCGGTATTTTGTGATTAACGCAATCAATAATGC 
M28 GCGCGGTATTTTGTGATTAACGCAATACATAATGC 
M29 GCGCGGTATTTTGTGATTAACGCAATAACTAATGC 
M30 GCGCGGTATTTTGTGATTAACGCAATAAAGAATGC 
M31 GCGCGGTATTTTGTGATTAACGCAATAAATCATGC 
M32 GCGCGGTATTTTGTGATTAACGCAATAAATACTGC 
M33 GCGCGGTATTTTGTGATTAACGCAATAAATAAGGC 
M34 GCGCGGTATTTTGTGATTAACGCAATAAATAATTC 
M35 GCGCGGTATTTTGTGATTAACGCAATAAATAATGA 
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Figure S4.5 EMSAs showing RafR  interaction with the DNA fragment R1 with the 
addition of (i) raffinose (ii) stachyose (iii) melibiose (iv) galactose  (v) glucose (vi) 
sucrose (vii) α-1,3 galactobiose (viii) α-1,4 galactobiose  at concentrations ranging 
from 2.5-20 mM.+ carbohydrate plus protein, + - protein no carbohydrate, -- no 
protein no sugar. 
RafR RafR RafR
RafR
RafR
RafR RafR
RafR
Raffinose Stachyose Melibiose Galactose
Glucose Sucrose
α-1,3 gal α-1,4 gal
(i) (ii) (iii) (iv)
(v) (vi) (vii) (viii)
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Chapter V 
Identification and characterisation of putative replication functions of the 
megaplasmid pBb7017 from Bifidobacterium breve JCM 7017 
 
 
 
Pulsed field gel electrophoresis was performed by Dr. Mary O’ Connell-Motherway. 
Schematic representation of pBb7017 was provided by Francesca Bottacini 
Schematic representation of neighbour joining tree provided by Amy O’ Callaghan 
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5.1 ABSTRACT 
A nursling stool isolate, Bifidobacterium breve JCM 7017 was found to harbour a 
190.34 kb megaplasmid, designated pBb7017, the first megaplasmid to be positively 
identified in bifidobacteria. Characterisation of bifidobacterial probiotic determinants 
has been hindered by the lack of effective molecular tools, including stable and 
effective cloning and shuttle vectors. Therefore, in this study we focused on the 
characterisation of the replication functions of the megaplasmid with the intention of 
creating an Escherichia coli/Bifidobacterium shuttle vector based on the 
megaplasmid replication functions. The megaplasmid was found to harbour two 
putative replication or rep7017 genes, designated repA7017 and repB7017. One of these, 
repA7017, encoding a putative 39.3 kDa replication protein RepA7017, was subject to 
an in depth characterisation. Several unsuccessful attempts were made to create an E. 
coli/bifidobacterial shuttle vector based on repA7017-based replication functions.  
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5.2 INTRODUCTION 
Members of the genus Bifidobacterium, known for their typical bifurcated (bifid) 
morphology, represent saccharolytic, non-motile, non-sporulating, Gram-positive, 
anaerobic bacteria, which possess a high GC genome content, and belong to the 
Actinobacteria phylum and Bifidobacteriaceae family. Bifidobacteria are commonly 
found as anaerobic commensals of the gastrointestinal tract (GIT) (Miyake et al., 
1998; Ventura et al., 2007). Various strains and species of the genus are considered 
probiotic bacteria, exhibiting one or more beneficial traits such as eliciting a 
protective effect against Gram negative pathogens (Fanning et al., 2012; Fukuda et 
al., 2011), alleviating lactose intolerance (Almeida et al., 2012), prevention of 
diarrhoea (H.Tissier, 1906), and reducing serum cholesterol (Bordoni et al., 2013; 
Dambekodi & Gilliland, 1998). Bifidobacteria may also be used as tumour-targeting 
vectors (Cronin et al., 2010; Cronin et al., 2012), or as a live vaccine (Ma et al., 
2012).  
Until recently, genetic tools for bifidobacteria had been scarce although in recent 
times a number of tools, for example those required for cloning, gene disruption and 
transposon mutagenesis, have been developed (O'Connell Motherway et al., 2009; 
Ruiz et al., 2013; Sun et al., 2012). Also various E. coli/Bifidobacterium shuttle 
vectors have been constructed to date (Klijn et al., 2006; Missich et al., 1994; Rossi 
et al., 1996; Rossi et al., 1998; Sangrador-Vegas et al., 2007; Shkoporov et al., 
2008). For example, the pBC1 replicon from Bifidobacterium catenulatum proved to 
be functional in several Bifidobacterium species, including Bifidobacterium 
animalis, Bifidobacterium longum, and Bifidobacterium pseudocatenulatum 
(Alvarez-Martin et al., 2007), while the pPKCM7 replication functions, originally 
from Bifidobacterium asteroides, were shown to be operating in B. animalis subsp. 
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lactis, B. longum NCIMB 8809, Bifidobacterium pseudolongum NCIMB 2244, 
Bifidobacterium pseudolongum subsp.  globosum JCM 5820, B. pseudocatenulatum 
LMG 10505 and Bifidobacterium dentium NCFB 2843 (Cronin et al., 2007).  
The presence of plasmids in bifidobacterial strains was originally reported over thirty 
years ago (Sgorbati et al., 1982), although only a minority of characterised 
bifidobacteria (approximately 20 %) appear to contain plasmids (Sgorbati et al., 
1982). A total of 36 plasmids have been completely sequenced to date in 
Bifidobacterium, including 24 plasmids from B. longum, three from B. breve, two 
from Bifidobacterium bifidum, B. asteroides and Bifidobacterium kashiwanohense, 
and just one from B. pseudolongum subsp. globosum, B. catenulatum and B. 
pseudocatenulatum (For a full list of plasmid names and references see page 8 in the 
Introduction of this thesis).  
Characterised bifidobacterial plasmids are relatively small, ranging in size from 1.5 
kb to 15 kb (Park et al., 1997; Sgorbati et al., 1982). The majority of the plasmids 
identified in members of the genus Bifidobacterium are predicted to replicate via the 
so-called rolling circle replication mechanism, although plasmids encoding proteins 
that are similar to known or predicted theta-type replication proteins have also been 
identified (Alvarez-Martin et al., 2007; Corneau et al., 2004; Lee & O'Sullivan, 
2006; Moon et al., 2009; Takahata et al., 2013).  
Commensal lactobacilli have been shown to harbour so-called megaplasmids, i.e. 
extra-chromosomal genetic elements with a size of 100 kb and larger, one of which, 
pMP118 from Lactobacillus salivarius UCC118, was shown to harbour genes that 
specify proteins involved in contingency amino acid metabolism, carbohydrate 
utilisation, Abp118 bacteriocin production and immunity, as well as genes encoding 
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a bile salt hydrolase and a putative conjugation locus (Claesson et al., 2006; Li et al., 
2007; O’ Shea et al., 2011). The existence of megaplasmids has previously been 
suggested for porcine isolates of B. pseudolongum subsp. globosum, though never 
conclusively proven (Simpson et al., 2003). Here we report on the replication 
functions of the 190.34 kb megaplasmid pBb7017 of B. breve JCM 7017.  
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5.3 MATERIALS AND METHODS 
Bacterial strains, plasmids and culture conditions  
Bacterial strains and plasmids used in this study are detailed in Table 5.1. 
Bifidobacterial strains were routinely cultured in either de Mann, Rogosa and Sharpe 
medium (MRS; Difco™, BD, Le Pont de Claix, France) supplemented with 0.05 % 
cysteine-HCl, or reinforced clostridial medium (RCM; Oxoid Ltd.). Bifidobacterial 
cultures were incubated at 37oC under anaerobic conditions which were maintained 
using an Anaerocult oxygen depleting system (Merck, Darmstadt, Germany) in an 
anaerobic chamber. Lactococcus lactis strains were cultivated in M17 broth 
containing 0.5 % glucose (Terzaghi & Sandine, 1975) at 30oC. Escherichia coli 
strains were cultured in Luria-Bertani broth (LB) (Sambrook et al., 1989) at 37oC 
with agitation. Where appropriate, growth media contained chloramphenicol (Cm; 5 
µg ml-1 for L. lactis, 10 µg ml-1 for E. coli, and 2.5 µg ml-1 for B. breve), 
erythromycin, tetracycline (Tet; 10 µg ml-1 for E. coli or B. breve) or kanamycin 
(Km; 50 µg ml-1 for E. coli). 
Nucleotide sequence analysis  
Sequence data was obtained from the Artemis-mediated (Rutherford et al., 2000) 
genome annotations of B. breve JCM 7017 (Bottacini et al., unpublished data). 
Database searches were performed using non-redundant sequences accessible at the 
National Centre for Biotechnology Information (http://www.ncbi.nlm.nih.gov) using 
BLASTP or BLASTN (Altschul et al., 1990; Altschul et al., 1997). Sequence 
verification and analysis were performed using the Seqman and Seqbuilder programs 
of the DNASTAR software package (DNASTAR, Madison, WI, USA v10.1.2).  
 
266 
 
Phylogenetic analysis of the repA7017 and repB7017 genes. 
A BLAST alignment of the encoded protein products of the repA7017 and repB7017 
genes of the pBb7017 megaplasmid was performed against the NCBI non redundant 
database; the first 200 significant hits (e-value < 0.0001) were retrieved and aligned, 
using Muscle v.3.3 and the relative phylogenetic neighbour-joining tree was 
computed in Mega5 with a bootstrap analysis of 100 re-samplings. 
Pulsed field Gel Electrophoresis (PFGE) 
PFGE plug preparation, S1 nuclease treatment, and PFGE were performed as 
described previously (Li et al., 2007). It is believed that S1 nuclease treatment first 
introduces a single strand break into a covalently closed plasmid, thereby converting 
superhelical molecules into an open circle form, after which a second break is 
introduced at the same site in the complementary strand to produce the linear form of 
the plasmid (Bai et al., 2003; Beard et al., 1973; Germond et al., 1974),  
DNA manipulations  
Genomic DNA was isolated from bifidobacteria as previously described (O'Riordan 
& Fitzgerald, 1999). Minipreparation of plasmid DNA from E. coli, B. breve or L. 
lactis was achieved using the Qiaprep spin plasmid miniprep kit (Qiagen GmBH, 
Hilden, Germany). For B. breve or L. lactis an initial lysis step was incorporated into 
the plasmid isolation procedure by re-suspending cells in lysis buffer supplemented 
with lysozyme (30 mg ml-1) followed by incubation at 37oC for 30 min (Sambrook et 
al., 1989). Procedures for DNA manipulations were performed essentially as 
described previously (Sambrook et al., 1989). Restriction enzymes and T4 DNA 
ligase were used according to the supplier’s instructions (Roche Diagnostics, Bell 
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Lane, East Sussex, UK). Synthetic single stranded oligonucleotide primers used in 
this study are detailed in supplementary Table S5.1, were synthesised by Eurofins 
(Ebersberg, Germany). Standard PCRs were performed using TaqPCR mastermix 
(Qiagen), while B. breve colony PCR analysis was performed as described 
previously (O'Connell Motherway et al., 2009). PCR fragments were purified using 
the Qiagen PCR purification kit (Qiagen). Electroporation of plasmid DNA into E. 
coli was performed as previously described (Sambrook et al., 1989). 
Electrotransformation of B. breve UCC2003 (Maze et al., 2007) and L. lactis (Wells 
et al., 1993) was performed according to published protocols. The correct orientation 
and integrity of all constructs was verified by DNA sequencing, performed by 
Eurofins (Ebersberg, Germany).  
Plasmid constructions 
For heterologous expression of one of the predicted replication proteins of pBb7017, 
the gene pl7017_0124 (designated here as repA7017), was amplified by PCR 
employing genomic DNA of B. breve JCM 7017 as a template, and using Taq DNA 
polymerase and primer combination repANco1F and repAXba1R (Supplementary 
Table S5.1). NcoI and XbaI restriction sites were incorporated at the 5’ end of each 
forward and reverse primer combination, respectively, for the repA7017-
encompassing primers (Supplementary Table S5.1). In addition, an in frame His10-
encoding sequence was incorporated into each of the forward primers to facilitate 
downstream protein purification using the Ni-NTA affinity system (Qiagen). The 
repA7017-encompassing amplicon was digested with NcoI and XbaI, and ligated into 
the NcoI and XbaI-digested, nisin-inducible plasmid pNZ8048 (Mierau et al., 2005). 
The ligation mixture was introduced into L. lactis NZ9000 (Table 5.1) by 
electrotransformation, and transformants were then selected based on 
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chloramphenicol resistance. The plasmid content of a number of Cmr transformants 
was screened by restriction analysis and the integrity of positively identified clones 
was verified by sequencing, resulting in the construct pNZ-RepA-His. 
In order to clone the repA7017 promoter region (termed here as repAp), this region 
which included 321bp upstream of repA7017 (promoter region) and 218bp of repA7017  
(total 539 bp) was cloned in an E. coli/Bifidobacterium shuttle vector pAM5 (for 
primer extension analysis of this promoter), the relevant fragment was amplified by 
PCR employing genomic DNA of B. breve JCM 7017 as a template, and using Taq 
DNA polymerase and primer combination repApXba1F and repApSph1R 
(Supplementary Table S5.1). SphI and XbaI restriction sites were incorporated at the 
5’ end of each forward and reverse primer combination, respectively (Supplementary 
Table S5.1). The generated 539 bp repAp-encompassing amplicon was digested with 
SphI and XbaI, and ligated into SphI and XbaI-digested pAM5 (Alvarez-Martin et 
al., 2007). The ligation mixture was introduced into E. coli EC101 (Table 5.1) by 
electrotransformation, and transformants were then selected based on tetracycline 
resistance. The plasmid content of a number of Tetr transformants was screened by 
restriction analysis and the integrity of positively identified clones was verified by 
sequencing, resulting in plasmid pAM5-repAp.  
DNA fragments containing repA7017, repA7017 plus pl7017_0123 (designated here as 
repA7017+1), and repA7017 plus pl7017_0123 plus pl7017_0122 (designated here as 
repA7017+2), all including the repA7017-upstream, and in the case of repA7017+2 also 
some downstream region of the cloned genes, were generated by PCR amplification 
(Fig. 5.1). This was achieved employing chromosomal DNA of B. breve JCM 7017 
as a template, and using Taq DNA polymerase and primer combinations 124fsph1-
rep,124rsph1-rep, 123+124fsph1-rep and 123+124rsph1-rep, and 122-124fsph1-rep 
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and 22-124rsph1-rep, respectively, in which SphI restriction sites had been 
incorporated at the 5’ end of each primer (Supplementary table S5.1). The generated 
amplicons were digested with SphI, and ligated into SphI-digested pBif (Table 5.1). 
The individual ligation mixtures were introduced into E. coli Xl1 blue (Table 5.1) by 
electrotransformation, and transformants were then selected based on 
chloramphenicol and kanamycin resistance. The plasmid content of a number of Cmr 
and Knr transformants was screened by restriction analysis and the integrity of 
positively identified clones was verified by sequencing. Resulting constructs (for 
names, see Table 5.1) were transformed into B. breve UCC2003, B. breve JCM 7017 
and B. breve NCFB 2258 in order to test if replication of these constructs was 
possible in bifidobacteria. 
In order to determine if the observed non-replicative phenotype was due to 
restriction modification barriers, the constructs were passed through an E. coli 
methylating strain EC101-pNZ-M.Bbrll+Bbr111 (O'Connell Motherway et al., 
2009). Due to the fact that pBif contained a chloramphenicol marker as did the 
methylase strain EC101-pNZ-M.Bbrll+Bbr111 a new tet-resistant plasmid backbone, 
named pWSK29-tetW, was generated using the following primers Pwsk29Fsph1 and 
Pwsk29Rnco1, in the case of the plasmid backbone, and tetwAFL3F, tetwsph1R, 
tetwsph1F and tetwAFL3R incorporating tetW in both the forward and reverse 
orientation (constructs labelled S and A, respectively) (Supplementary Table S5.1). 
The individual DNA fragments encompassing repA7017, repA7017+1 and repA7017+2 
were removed by Sph1 restriction from pBif constructs, respectively, and ligated 
into SphI digested pWSK29-tetW. The ligation mixture was introduced into EC101 
(Table 5.1) by electrotransformation, and transformants were then selected based on 
tetracycline and kanamycin resistance. The plasmid content of a number of Tetr and 
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knr transformants was screened by restriction analysis and the integrity of positively 
identified clones was verified by sequencing. Following introduction of the resulting 
constructs into EC101-pNZ-M.Bbrll+Bbr111 to allow methylation of the plasmid 
DNA (Table 5.1) (O'Connell Motherway et al., 2009), methylated plasmid DNA was 
obtained and used for transformation of B. breve UCC2003, B. breve JCM 7017 and 
B. breve NCFB 2258 in order to test if these constructs were capable of autonomous 
replication in Bifidobacteria. 
Heterologous RepA7017 (over)production  
A 2 % inoculum of L. lactis NZ9000 harbouring plasmid pNZ-RepA-His in 25 ml of 
M17 broth supplemented with 0.5 % glucose was prepared, followed by incubation 
at 30oC until an Optical Density (O.D. at wavelength 600 nm) of 0.5 was reached, at 
which point protein expression was induced by the addition of purified nisin (5 ng 
ml-1) followed by continued incubation at 30oC for 90 minutes. Cells were harvested, 
re-suspended in 10 mM Tris-HCl, and disrupted with glass beads in a mini-bead 
beater (BioSpec Products, Bartlesville, OK). Cellular debris was removed by 
centrifugation to produce a crude cell extract containing RepA-His.  
Electrophoretic mobility shift assay (EMSA) 
A DNA fragment, designated REP, representing repA7017 and 702 bp of DNA 
immediately upstream of repA7017 and including the promoter region, was prepared 
by PCR generating a 1752 bp product using an IRD800-labelled primer pair 124-
repF and 124-repR (Supplementary table S5.2). EMSAs were performed essentially 
as described previously (Hamoen et al., 1998). In all cases, the binding reactions 
were carried out in a final volume of 20 µl in the presence of poly[d(I-C)] in binding 
buffer (20 mM Tris-HCl [pH 7.0], 5 mM MgCl2, 0.5 mM DTT, 1 mM EDTA, 200 
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mM KCl, 10 % glycerol). Varying amounts of crude cell extract of L. lactis NZ9000 
harbouring plasmid pNZ-RepA-His (and expressing the RepA7017 protein following 
nisin induction) and a fixed amount of DNA probe (0.1 pmol) were mixed on ice and 
subsequently incubated for 30 min at 37°C. Samples were loaded onto a 6 % non-
denaturing Polyacrylamide (PAA) gel prepared in TAE buffer (40 mM Tris acetate 
[pH 8.0], 2 mM EDTA) and run in a 0.5-to-2.0 x gradient of TAE at 100 V for 90 
minutes in an Atto Mini PAGE system (Atto Bioscience and Biotechnology, Tokyo, 
Japan). Signals were detected using Odyssey Infrared Imaging System (Li-Cor 
Biosciences UK Ltd, Cambridge, UK) and captured using the supplied software 
(Odyssey V3.0).  
Primer extension analysis  
Total RNA was isolated from B. breve UCC2003 pAM5-repAp, grown in mMRS 
supplemented with 1 % ribose to early exponential phase, using the Macaloid 
method (Kuipers et al., 1993). RNA samples were treated with RNase-free DNase 
(Ambion). Primer extension was performed by annealing 1 pmol of IRD800 
synthetic 18-mer oligonucleotides to 20 µg of RNA as previously described (Ventura 
et al., 2005) using primers 124-REP-PE-R1 and 124-REP-PE-R2 (Supplementary 
Table S5.2). Sequence ladders of the presumed repA7017 promoter region, which 
were run alongside the primer extension products, were produced using primers PE-
DNA-F-124 and PE-DNA-R-124 (Supplementary Table S5.1) and employing the 
DNA cycle Sequencing Kit (Jena Bioscience, Loebstedter Strasse 80, Germany). 
Separation was achieved on a 6.5 % Li-Cor Matrix KB Plus acrylamide gel. Signal 
detection and image capture was performed by means of a Li-cor sequencing 
instrument (Li-Cor Biosciences). 
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5.4 RESULTS AND DISCUSSION 
Identification of the bifidobacterial megaplasmid 
We recently conducted a comparative genome analysis of representative members of 
the B. breve species, which revealed that B. breve JCM 7017 harbours a 
megaplasmid, designated pBb7017, with a size of over 190 Kb (Bottacini et al., 
unpublished results). The presence and size of this plasmid in B. breve JCM 7017 
was confirmed by pulsed field gel electrophoresis (Fig. 5.2). Sequence analysis of 
this plasmid identified two genes, pl7017_0124 and pl7017_0146, designated here as 
repA7017 and repB7017, respectively, whose encoded products represent putative 
replication proteins (see below), suggesting that the pBb7017 plasmid is a co-
integrate of two smaller plasmids. Further evidence for this apparent co-integration 
event can be derived from the evidently unevenly distributed GC content across the 
plasmid sequence. The plasmid is composed of two segments of differing GC 
content, where one segment, encompassing co-ordinates 119,440 through to 
230,439, possesses an average GC-content of 60.1 %, while the other segment, 
encompassing the remainder of the plasmid, possesses an average GC-content of 
55.3 % (Fig.5.3). Since this plasmid encodes functions that sustain stable replication 
of a very large piece of DNA, we wanted to identify and characterise these 
replication functions in order to create an E. coli-bifidobacterial shuttle and cloning 
vector for large DNA fragments.  
In silico analysis of the repA7017 and repB7017 DNA regions 
The sequences of the predicted replication proteins encoded by repA7017 and repB7017 
were used to construct a neighbour joining phylogenetic tree (Saitou & Nei, 1987) 
displaying sequence similarities between RepA7017 and RepB7017, and a number of 
selected and mostly putative replication proteins (Fig. 5.4). Due to the paucity of 
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information regarding the majority of plasmid replication proteins we were not able 
to show direct and significant similarity to a characterised replication protein known 
to support either theta-type or rolling circle-type replication. However, the results of 
the phylogenetic tree showed that RepA7017 and RepB7017 both exhibit similarity to 
replication proteins that are predicted to replicate via the theta-type mode. Such 
replication proteins include those encoded by pCRY4, a 48 Kb plasmid isolated from 
Corynebacterium glutamicum (Tauch et al., 2002; Tauch et al., 2003), the 29 Kb 
plasmid pET44827 harboured by Corynebacterium aurimucosum ATCC 700975 
(Trost et al., 2010) and pCIBA089, a 2.1 Kb plasmid isolated from Bifidobacterium 
asteroides (Cronin et al., 2007) (Fig.5.4).  
It is generally accepted that rolling circle-type plasmids are small in size, ranging 
approximately from 1.3 Kb to 10 Kb (Khan, 1997). However, plasmids that replicate 
by means of theta-type replication functions can represent both large and small 
plasmids, for example the 3.8 kb plasmid pWV02 from L. lactis replicates via the 
theta-type mechanism (Kiewiet et al., 1993), and the 13 kb plasmid pRV500, 
isolated from Lactobacillus sakei RV332 (Alpert et al., 2003). The putative 
replication protein RepA7017 displays significant similarity to deduced replication 
proteins of a series of very large, uncharacterised plasmids, for example the 86.2 Kb 
pCHA1 plasmid from Corynebacterium halotolerans (Ruckert et al., 2012), plasmid 
pRMAR01 (NC_013502) from Rhodothermus marinus DSM 4252 with a size of 
125.133 Kb, and the 14.3 Kb plasmid pKW4 from Corynebacterium jeikeium K411 
(Tauch et al., 2005).  
Analysis of the DNA region preceding repA7017 (schematically depicted in Fig. 5.5) 
allowed the detection of a high A+T rich region of 72.2 %, consisting of three 
imperfect direct repeats (Fig. 5.6A), a set of putative iterons (see below) and an 
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imperfect inverted repeat, features that have frequently been identified within the 
origin region of other theta-replicating plasmids (del Solar et al., 1998). The putative 
iterons are represented by 8 nearly perfect, direct repeat sequences (Fig. 5.6B), 
which may be required for plasmid replication as such sequences are known to play a 
crucial role in initiation of replication. No sequences were detected which match the 
consensus sequence of the DnaA box (5’-TTATCCACA-3’) (Weigel et al., 1997), 
and which are commonly found within the origin of replication of theta-replicating 
plasmids (del Solar et al., 1998). The presumed origin of replication structure 
upstream of repA7017 resembles that, among others, of the putative theta-replicating 
bifidobacterial plasmid pCIBA089 (Cronin et al., 2007) and that of the pSymb 
megaplasmid of Rhizobium meliloti (Margolin & Long, 1993). Upon investigation of 
the region preceding the replication gene repB7017 we noticed that DNA sequences 
commonly associated with such replicons, such as direct and indirect repeats, were 
absent (data not shown). Therefore it is possible that repB7017 is non-functional as a 
replication protein, and it may thus be that replication of pBb7017 is solely 
dependent on the replication functionalities provided by repA7017 and associated 
sequences. For this reason we chose to further characterise repA7017.  
RepA7017 binds to the repA7017 promoter region  
Bifidobacterial and other plasmid-encoded replication proteins have been shown to 
bind to repeat sequences upstream of their corresponding coding region; for 
example, Rep89 binds to direct repeats in the putative origin of replication of the 
putative theta-replicating plasmid pCIAB089 from B. asteroides (Cronin et al., 
2007). Examples in other bacteria would be that of predicted theta-replicating 
plasmids pPS10 from Pseudomonas savastanoi (de Viedma et al., 1995), R2K from 
E. coli (Toukdarian et al., 1996) and pSK41 from Staphylococcus aureus (Liu et al., 
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2012). In order to establish if RepA7017 can interact with the identified repeat 
sequences within the presumed promoter region upstream of the repA7017 gene we 
first cloned the repA7017 gene in the nisin-inducible vector pNZ8048 resulting in 
plasmid pNZ-repA7017-His (see Materials and Methods). Following nisin induction 
of L. lactis NZ9000 pNZ-repA7017-His, the recombinant protein was purified from 
the cell extract using metal affinity chromatography. However, purified RepA7017 
protein did not exhibit any binding activity, which is not uncommon when 
(replication) proteins of bifidobacterial origin are expressed in and purified from a 
heterologous host (Cronin et al., 2007; O'Connell Motherway et al., 2011; 
Pokusaeva et al., 2011).  
Therefore, instead of using the purified RepA7017 protein, a crude cell extract of L. 
lactis NZ9000 pNZ-repA7017-His was used for EMSA experiments. This approach 
allowed us to clearly demonstrate that RepA7017 binds to the IRD800-labelled DNA 
fragment REP which encompasses a 1752 bp promoter-containing region (see 
below) upstream of repA7017 and the repA7017 gene (Fig. 5.7 (i)). Since crude cell 
extract of pNZ8048 (empty vector not expressing RepA7017) did not exhibit binding 
towards the REP fragment mentioned above we conclude that RepA7017 binds to 
sequences within the repA7017 promoter region (Fig. 5.7(ii)). DNA fragments that 
contained eight direct repeats present in the promoter region  split into two sections 
were not affected in their mobility by RepA7017 indicating that this protein seems to 
require all four for binding (results not shown). This result is in agreement with a 
previous report whereby the presumed replication protein Rep89 associated with the 
B. asteroides plasmid pCIBA089 was unable to bind to individual direct repeat 
sequences (Cronin et al., 2007). 
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Identification of the repA7017 transcription start site  
In order to determine the transcription start site of the presumed repA7017 promoter, 
primer extension analysis was performed using RNA extracted from pAM5-repAp 
(pAM5 containing the presumed promoter region preceding repA7017) from B. breve 
UCC2003 grown in Modified Rogosa medium containing 1 % ribose as the sole 
carbohydrate source. A single extension product was identified for the promoter 
region, corresponding to a position which is 71 nucleotides 5′ to the predicted 
translational start site for the repA7017 gene (Fig. 5.8). Analysis of the sequences 
upstream of this transcriptional start point within the promoter region of repA7017 
revealed potential promoter recognition sequences resembling consensus −10 and 
−35 hexamers (Fig. 5.8). Interestingly, primer extension attempts using the wild type 
B. breve JCM 7017 strain which naturally harbours the mega plasmid proved 
unsuccessful. This may be due to low transcriptional levels of repA7017 as a result of 
negative transcriptional autoregulation by RepA7017, a common phenomenon, which 
for example is found in pPS10 (de Viedma et al., 1995). The experimental set-up we 
took for the primer extension experiment uncoupled such negative autoregulation of 
the repA7017 promoter (as this promoter was cloned separate from the repA7017 gene). 
 
Attempts to construct shuttle vectors pbif-repA7017, pbif-repA7017+1 and pbif- 
repA7017+2 
Our presumption was that repA7017 and surrounding sequences are required for 
replication of the B. breve JCM 7017 megaplasmid pBb7017. In order to determine 
if repA7017 under the control of its own promoter and presumed origin of replication, 
could support replication in bifidobacteria a series of constructs were made using the 
pBif vector (Table 5.1). This vector was chosen as it replicates via a pSC101 E. coli 
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low copy number replicon and allows the cloning of large fragments in E. coli 
(Cohen & Chang, 1977). Our objective was to use this vector to clone the 
presumptive replication functions of the pBb7017 megaplasmid in order to create an 
E. coli/Bifidobacterium shuttle vector that would be suitable for cloning of large 
DNA fragments in order to express complex functions, for example those required 
for surface polysaccharide production (Fanning et al., 2012; Tao & Zhang, 1998). 
Plasmids pbif-repA7017, pbif-repA7017+1 and pbif-repA7017+2 were first 
constructed in E. coli (see Materials and Methods). These constructs were then 
methylated using the EC101-pNZ-M.Bbrll+Bbr111 methylation strain (Table 5.1) 
(O'Connell Motherway et al., 2009) in order to overcome possible restriction 
modification systems, and attempts were then made to introduce these plasmids into 
B. breve UCC2003, B. breve JCM 7017 or B. breve NCFB 2258 by electroporation. 
Unfortunately, no transformants were obtained for any of these strain-plasmid 
combinations. Electroporation with the pBC1.2-control plasmid (Table 5.1) 
demonstrated that the prepared cells for each strain were indeed competent. These 
results demonstrate that apparently not all replication functions were present on the 
three pBif derivatives or that these replication functions were dysfunctional.  
Further cloning attempts will have to be made in order to determine if additional 
sequences are required for replication using the pBb7017 replication function (or at 
least those associated with repA7017). Previously, bifidobacterial replication functions 
have been cloned and have been used successfully to construct E.coli/bifidobacterial 
shuttle vectors (Klijn et al., 2006; Missich et al., 1994; Rossi et al., 1996; Rossi et 
al., 1998; Sangrador-Vegas et al., 2007; Shkoporov et al., 2008). The use of a 
megaplasmid has been described for the creation of an E. coli /Rhizobium meliloti 
shuttle vector mini-pSym-b (Margolin & Long, 1993). In this particular study a 4 Kb 
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DNA fragment active as an autonomously replicating sequence from the Rhizobium 
meliloti megaplasmid designated pSym-b was isolated by selecting for sequences 
that allowed a normally non-replicative pBR322 derivative to replicate in R. meliloti. 
The 4kb fragment contained several sequence motifs common to other replication 
origins, such as an AT-rich region, three potential DnaA binding sites, a potential 13-
mer sequence, and several groups of short direct repeats. The resulting E. coli/R. 
meliloti shuttle vector mini-pSym-b also replicated in the closely related strain 
Agrobacterium tumefaciens, but only in strains carrying the pSym-b megaplasmid, 
suggesting that a megaplasmid-encoded trans-acting factor is required for 
replication. 
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5.5 CONCLUDING REMARKS 
This is the first study regarding the dissection of a megaplamid from a 
Bifidobacterium strain of human origin. Although the precise replication functions 
associated with megaplasmid pBb7017 from B. breve JCM 7017 have yet to be 
deciphered, this study provides significant data as regards the regulation of the 
repA7017 promoter, and interactions between the RepA7017 and its promoter region. 
Based on the in silico analysis presented in this study it is likely that pBb7017 
replicates via a theta-type mechanism. One may further speculate that pBb7017 
replicates in a manner that is similar to that of the E. coli chromosome (Bramhill & 
Kornberg, 1988). In the latter case the replication or Rep protein, binds to a series of 
direct repeats also known as iterons to form an initiation complex at the origin. In the 
case of E. coli chromosomal replication, this complex, in association with DnaA, 
allows the transfer of DnaB-DnaC to the replication origin, resulting in the opening 
of an AT-rich region, thereby initiating leading strand synthesis. The iteron-
containing region (or even the complete plasmid sequence) of pBb7017 does not 
appear to contain DnaA boxes, and it is therefore possible that DnaB-DnaC loading 
to the replication origin requires other factors, perhaps aided by some of the 
sequence features that were identified in close proximity of the RepA7017-recognised 
iterons. Further studies will have to be performed in order to pinpoint the precise 
mode of replication for the megaplasmid pBb7017.  
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Strain/ plasmid Relevant characteristics Reference or source 
E.coli strains 
  EC101 Cloning host, repA+ kmr (Law et al., 1995) 
EC101-pNZ-M.Bbrll+Bbr111 EC101 harbouring pNZ8048 derivative containing bbrllM and bbrlllM 
(O'Connell 
Motherway et al., 
2009) 
E. coli XL1-blue 
(supE44 hsdR17 recA1 gyrA96 thi relA1 lac F′ [proAB+ laclq lacZΔM15 
Tn10(Tetr)]) Stratagene 
   
L. lactis strains 
  
NZ9000 MG1363 derivative, nisin-inducible overexpression host; pepN::nisRK 
(de Ruyter et al., 
1996) 
NZ9700 Nisin producing strain 
(de Ruyter et al., 
1996) 
   
B.breve strains 
  UCC2003 Isolate from a nursling stool UCC 
NCFB 2258 Isolate from infant intestine NCFB 
JCM 7017 Isolate from human faeces JCM 
   
Plasmids 
  
pNZ-RepA-His 
repA7017 with his tag cloned downstream of nisin inducible promoter on 
pNZ8048 This study 
pAM5-repAp7017 repA7017 promoter region cloned in PAM5 (pBC1-puC19-Tcr) This study 
pBif-repA7017 repA7017 cloned in pBif This study 
pBif-repA7017 +1 repA7017 +1cloned in pBif This study 
pBif-repA7017 +2 repA7017 +2 cloned in pBif This study 
5.7 TABLES AND FIGURES 
 
TABLE 5.1 Bacterial strains and plasmids used in this study 
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  Strain/ plasmid Relevant characteristics Reference or source 
pwsk29-tetwAFL Tetr, αlacZ,low copy number This study 
pwsk29-tetwSPH Tetr, αlacZ,low copy number This study 
pwsk29-tetw(a)-repA7017 124 cloned in pwsk29-tetwAFL This study 
pwsk29-tetw(a)- repA7017 +1 123+124 cloned in pwsk29-tetwAFL This study 
pwsk29-tetw(a)- repA7017 +2 122-124 cloned in pwsk29-tetwAFL This study 
pwsk29-tetw(s)- repA7017 124 cloned in pwsk29-tetwSPH This study 
pwsk29-tetw(s)- repA7017 +1 123+124 cloned in pwsk29-tetwSPH This study 
pwsk29-tetw(s)- repA7017 +2 122-124 cloned in pwsk29-tetwSPH This study 
pAM5 pBC1-puC19-Tcr  
(Alvarez-Martin et 
al., 2007) 
pNZ8048 Cmr; nisin-inducible translational fusion vector 
(de Ruyter et al., 
1996) 
pBif Apr, Cmr , 6.5 kbp 
APC-University 
College Cork 
pBc1.2  pBC1 cloned in in pBif Cmr 
(Alvarez-Martin et 
al., 2007) 
pWSK29 Apr αlacZ,b low copy number 
(Wang & Kushner, 
1991) 
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Figure 5.1 Schematic representation of cloned DNA fragments containing repA7017, repA7017+1, and repA7017+2 including upstream and, in the 
case of repA7017+2, downstream regions. Cloned fragments indicated by corresponding black line.
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Figure 5.2 Pulse field gel electrophoresis of pBb7017, size represented at 190.34kb 
(both lanes). Dash type arrow indicates the S1 nuclease linearised megaplasmid 
band. Black compound type arrows indicate DNA size standards. Slight smearing 
indicates degradation due to S1 nuclease.  
 
 
 
 
 
 
 
48.5kb 
97kb 
145.5kb 
194kb 
190.34kb 
285 
 
  
 
 
 
 
 
 
 
Figure 5.3 Schematic representation of pBb7017 plasmid, the inner to the outer 
circles represent GC skew, GC content, Replication genes (in red) and base position 
on the outer most circle. Dashed blue line represents putative dissection points of 
plasmid co-integration. 
 
 
repA
p17017_0124
repB
p17017_0146
p17017_0025-26 = hypothetical protein
p17017_0027= gp60
p17017_0021-24 = sortase dependent pili
Section size= 93924 bp
60.1 G+C mol% 
Section size= 96415 bp
55.3 G+C mol% 
190339 bp
286 
 
  
287 
 
Figure 5.4 Neighbour joining phylogenetic tree of replication genes repA7017 and 
repB7017 from pBb7017 as compared to other bacteria. Red indicates most related, 
these are indicated by a blue box. Green text represents the outlier.  
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Figure 5.5 Structural features of pBb7017 representing the high A+T rich region, and inverted repeat (IR) and eight direct repeats (DR) followed 
by the repA7017 protein gene. See also Figure 5.8 for further sequence details. 
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Figure 5.6 Web logo representation of predicted consensus repeat sequences; Panel A: Comparison of three direct repeats in the high A+T rich 
region; Panel B: Consensus derived from the eight direct repeat sequences present in the repA7017 promoter sequence. 
 
A. 
B. 
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 Figure 5.7 EMSAs showing interaction of crude cell extract of nisin induced NZ9000 (i) pNZ-RepA-His or (ii) pNZ8048 with DNA fragment 
encompassing promoter region preceding repA7017. 
RepA pNZ8048
REP(i) (ii) REP
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 GAACGGATTGCATCCCTGTAAGTCGCAGGTCGAAGTATGAGGGAGATT
AAGAGAGAGATTGTAAAGTCACTTGTAATATCACTTGTATATTCACTT
GGGGGTGCCTCTTAGCCCTACTGCCATAAGGGCTGAGAGGCCATGTCG
GTGTCAAAATTCTAAGAGTGGGTGTCAGAATTCTAAGCGAGGGTGTCA
AAATTCTATAAACCGGTGTCAAAATTCTAAGAAAAAAACGCTCCGTTT
TGCGACTTAATGGGGTGGAATATTCGATTCCGTCAAAAGGGTGTCAGA
ATTCTAAGGAAAGCGTCAAAATTCTAAGATAGGTGTCAATATTCTAAA
TTTGGTGTCAGAATTCTAAGAAAACGAGGTAGGATAGCAGAGTCGAAA
AAAAGAAGATACCCGCACCGTTTGCGCCGGCCGGGTATCTGGCAATCG
CTGAAAGGTAGCGACCGCATG
-35 -10 +1
*
C   T   A  G   PE
RBS
+40
+60
+20
-40
-60-80
-100-120
-140-160-180
-200-220
-240-260-280
-300-320
-340-360
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Figure 5.8 Boldface type and underlining indicate the −10 and −35 hexamers as deduced from the primer extension results and ribosomal 
binding site (RBS); the transcriptional start sites (TSS) are indicated by asterisks; Blue arrows three imperfect direct repeats which represent 
high A+T rich region; Red arrows indicate eight near perfect direct repeats associated with RepA7017 binding; Black compound arrows represent 
an imperfect inverted repeat. 
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5.8 SUPPLEMENTARY MATERIAL 
Table S5.1 Oligonucleotide primers used in this study 
Name Sequence 
Product 
(bp) 
124CTERMFNCO1 TGCACGCCATGGCCACCAATAATAACGCCATCGC 
 124 CTERMRXBA1 CTATGCTCTAGATCAGTGATGGTGATGGTGATGGTGATGGTGATGACCCAACAAAACCCGAGAC 1047 
repApXba1F CTATGCTCTAGATGAGAGGCCATGTCGGTG 
 repApSph1R CAGTCAGCATGCCGAATCATGGACTGCACGT 539 
Pwsk29Fsph1 TAACAAGCATGCGCATGGTCTATCAGGGCG 
 Pwsk29Rnco1 AAAGGACCATGGCTCATATATATACTTTAGATTG 2624 
tetwAFL3F TCAGCTACATGTATGCTCATGTACGGTAAG 
 tetwsph1R GCGACGGCATGCCCGACTGTTACTTTTTACAGTCGGTTTTCTAATGTCACCATTACCTTCTGAAACATA 2574 
tetwsph1F TCAGCTGCATGCATGCTCATGTACGGTAAG 
 tetwAFL3R GCGACGACATGTCCGACTGTACTTTTTACAGTCGGTTTTCTAATGTCACCATTACCTTCTGAAACATA 2574 
124FSPH1-REP CCGTCAGCATGCCTGCTAGTTCTTCTTCGTGCCATAC 
 124RSPH1-REP CAGTCAGCATGCCGAGGGTTTTCATGATGGC 1829 
123+124FSPH1-REP CCGTCAGCATGCCTGCTAGTTCTTCTTCGTGCCATAC 
 123+124RSPH1-REP CCGTCAGCATGCGTTGACCGTGATGTACTGGCTC 2730 
122-124FSPH1-REP CCGTCAGCATGCCTGCTAGTTCTTCTTCGTGCCATAC 
 122-124RSPH1-REP CTGTCAGCATGCGACTTTGAAGTTGATGATG 3560 
aRestriction sequence is indicated in bold 
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Table S5.2 IRD800 labelled primers used in this study 
Name IRD800 labelled Primer Product (bp) 
124-rep F CTGCTAGTTCTTCTTCGTGCCATAC 
 124-rep R TCAACCCAACAAAACCCGAGAC 1752 
PE-DNA-F-124 TGAGAGGCCATGTCGGTG  
PE-DNA-R-124 CATTCCTCGGGCCGGCT 485 
124-REP-PE-R1 GCGATGGCGTTATTATTGGT 
 124-REP-PE-R2 CGAGGTACTGGGTTTTGACA 
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Bifidobacterial genome sequence analysis has progressed significantly in recent 
years. There are currently 43 draft bifidobacterial genome sequences at different 
stages of completion in the database of National Centre of Biotechnology 
Information (NCBI; www.ncbi.nlm.nih.gov). This bifidobacterial genome sequence 
analysis has provided a wealth of primary information that has facilitated a better 
understanding as to how these bacteria survive in the gastro intestinal tract (GIT) and 
how they elicit purported beneficial activities towards their host (For a review see 
(Ventura et al., 2014)). There has also been a steady rise in the number of scientific 
papers that reported on the sequencing and analysis of bifidobacterial plasmids. The 
majority of tested bifidobacteria do not appear to harbour plasmids (less than 20% of 
the strains analysed have been shown to harbour such extrachromosomally 
replicating entities) (Sgorbati et al., 1982), and it is probably for this reason that 
there are fewer plasmids sequenced as compared to the number of sequenced 
genomes (See Chapter I, Table 1.2). 
Bifidobacterial plasmid sequence analysis and subsequent functional characterisation 
of their corresponding replication functions has allowed the construction of novel 
genetic tools for use in this group of gut commensals (Hirayama et al., 2012; 
O'Connell Motherway et al., 2009; Ruiz et al., 2013; Alvarez-Martin et al., 2008; 
Cronin et al., 2007). Such tools, when combined with bifidobacterial genome 
sequencing projects, facilitate functional genomics approaches that are central to 
further our understanding on how these bacteria colonise and persist in the highly 
competitive environment of the gastrointestinal tract (GIT).  
Glycosyl hydrolases (GHs) are essential for bifidobacteria in order to enzymatically 
access complex diet- or host-derived carbohydrates that are present in the GIT 
environment. Tables 1.4-1.8 in Chapter I presents a compilation of predicted 
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bifidobacterial GHs as based on Cazy website information (which hosts information 
on carbohydrate active enzymes (http://www.cazy.org/)). Compared to a previously 
published compilation (Pokusaeva et al., 2009), a significant increase is notable in 
the number of putative GHs, which is not surprising as it corresponds to the rise in 
completely sequenced bifidobacterial genomes. It is important to understand how 
these GHs function in bifidobacteria so that novel bifidogenic prebiotics can be 
discovered. The first step in discovering such prebiotics is to elucidate the 
saccharidic substrates associated with the identified GH-encoding genes, and to 
discover the metabolic functions and regulation of these genes. Chapters III and IV 
of this thesis outline research on the function and regulation of two gene clusters 
involved in the metabolism of raffinose-like sugars and melezitose. The obtained 
data can be used to select potential prebiotics, which will still require further in vivo 
evaluation with regards to their efficacy and selectivity as bifidogenic compounds. In 
addition, the acquired information on the enzymatic activity and specificity of the 
characterised GHs may allow the production of novel prebiotics through 
transglycosylation. Transglycosylation is the ability of so-called retaining GHs to 
catalyse carbohydrate condensation reactions by the double displacement mechanism 
with retention of configuration at the anomeric centre to yield elongated 
oligosaccharides with new glycosidic linkages (Withers, 2001).   
In Chapter II of this thesis, the ability of bifidobacteria to produce conjugated 
linoleic acid (CLA) from linoleic acid (LA; a dienoic unsaturated fatty acid) was 
investigated so as to characterise the enzymatic activity which allows certain 
bifidobacterial strains to produce this compound (O'Connell et al., 2013a; Rosberg-
Cody et al., 2004). CLA is claimed to promote to host health, for example due to its 
perceived action in anti-obesity (Chen et al., 2012), its anti-carcinogenesis activity 
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(Pierre et al., 2013), its immunomodulatory role (Bassaganya-Riera et al., 2012) and 
its involvement in bone formation (Park et al., 2013).  
The precise mechanism by which CLA is produced by certain bacteria is as yet 
unknown, although several hypotheses have been put forward to explain this 
phenomenon. For example, in Lactobacillus acidophilus AKU 1137 it is speculated 
that hydroxy fatty acid formation from linoleic acid is the first step in CLA 
formation (Ogawa et al., 2001). These authors found that when hydroxy fatty acids 
were introduced to washed Lb. acidophilus AKU 1137 cells, these hydroxy fatty 
acids are transformed to CLA isomers via an LA isomerase (LAI). 
It has been shown previously that myosin cross reactive antigen (MCRA)-like 
proteins from various microorganisms, including bifidobacteria, show over 50 % 
sequence similarity to the primary sequence of LAI proteins from Lb. acidophilus 
and Lactobacillus reuteri PYR8 (Rosson et al., 2001). These latter enzymes are 
believed to catalyse the conversion of LA to cis-9 trans-11 (c9,t11) CLA. However, 
in Chapter II of this thesis it is shown that the MCRA-encoding gene of B. breve 
NCFB 2258 is not responsible for CLA production, since an insertion mutation in 
the MCRA-encoding gene, does not affect the CLA-producing abilities of this B. 
breve strain. Instead, we found that the MCRA-encoded gene product functions as an 
oleate hydratase, which is involved in the production of 10-hydroxy fatty acids from 
oleic acid (O'Connell et al., 2013a). This finding supports previously reported data 
(Rosberg-Cody et al., 2011), in which it was shown that the MCRA protein encoded 
by B. breve NCFB 2258, when heterologously expressed in Lactococcus lactis and 
Corynebacterium glutamicum, possesses hydratase activity (catalysing the 
production of 10-hydroxy fatty acids from oleic acid). Despite suggestive data 
(Ogawa et al., 2001), which would imply the presumed bifidobacterial MCRA 
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protein and its associated linoleic acid isomerase activity in the formation of CLA 
from LA, our findings show that this enzyme is not involved in CLA production. 
Therefore, the actual metabolic pathway of CLA production in bifidobacteria is still 
elusive. 
Previous findings (Rosberg-Cody et al., 2011), which were corroborated by our data 
(Chapter II of this thesis), have shown that the MCRA protein of B. breve NCFB 
2258 is involved in the provision of increased tolerance to particular solvents, such 
as ethanol. Ethanol is a short chain alcohol and ethanol exposure results in changes 
in membrane fatty acid composition, structure and membrane fluidity in bacteria 
(Liu & Qureshi, 2009). In a previous study deletion of the MCRA-encoding gene in 
Lactobacillus acidophilus NCFM resulted in a strain that exhibited reduced growth 
in the presence of lactate, acetate and salt (O'Flaherty & Klaenhammer, 2010). The 
mechanisms by which Gram positive bacteria tolerate organic solvents have yet to be 
elucidated (Torres et al., 2011), but tolerance may be provided by the induction of a 
general stress regulon (Sardessai & Bhosle, 2002), production of organic solvent-
emulsifying or deactivating enzymes (Moriya et al., 1995) and/or an active solvent 
efflux pump (Inoue & Horikoshi, 1991; Moriya et al., 1995). Based on a previous 
study (Rosberg-Cody et al., 2011) and our own findings it may thus be concluded 
that the bifidobacterial MCRA-like protein is involved in the adjustment of the fatty 
acid composition of the lipid bi-layer in order to provide increased tolerance to 
solvents such as ethanol. 
Due to the reported health-promoting properties of CLA it is desirable to develop 
functional foods which contain high levels of these bioactive compounds in order to 
elicit a beneficial effect on human health. LA is naturally present in relatively low 
amounts in milk and dairy products, meat and meat products of ruminant animals 
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(Bhattacharya et al., 2006). The average dose of CLA reached per day in the human 
diet is 650 mg (Jutzeler van Wijlen & Colombani, 2010) and this level is not high 
enough to confer any beneficial effects on the host. For example, in order to achieve 
beneficial effects in terms of body fat reduction, daily doses of 3-4 g are advised 
(Bhattacharya et al., 2006). Ways of increasing CLA in meat and dairy products may 
be possible by means of addition of oilseeds, vegetable or fish oil to animal feed 
(Duckett & Gillis, 2010). The ability of certain gut commensals to produce CLA 
presents another route by which CLA demands can be met and thus can be 
considered an important probiotic characteristic of such bacteria (O'Shea et al., 
2012). 
Several bifidobacterial strains have been associated with probiotic activities, and 
have been used as live microbial food ingredients that, when ingested, have a 
beneficial effect on human health (Salminen et al., 1998). There are many health 
benefits associated with bifidobacteria, such as inhibition of pathogens (Fanning et 
al., 2012; Fukuda et al., 2011), alleviating lactose intolerance (Almeida et al., 2012) 
and reducing serum cholesterol (Bordoni et al., 2013). The health-promoting 
activities of probiotic bacteria may be stimulated by prebiotics, which for this reason 
are defined as non-digestible (by the human host) food ingredients that beneficially 
affect the host by selectively stimulating the growth and/or activity of one or a 
limited number of probiotic bacteria in the colon (Gibson & Roberfroid, 1995). It has 
been shown that microbiota changes with age, with bifidobacteria being predominant 
during the stage when (breast) milk is the main food source, while their relative 
numbers will decline following weaning (Yatsunenko et al., 2012). Microbiota 
composition has been shown to influence general health and it has been shown that 
particular alterations in intestinal microbiota composition are associated with several 
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chronic conditions, including obesity and inflammatory diseases in the elderly 
(Claesson et al., 2012). This study has linked diet, microbiota and health status, and 
therefore has highlighted a specific and very promising role for prebiotics in 
modulating the microbiota.  
In order to gain an insight into how potential prebiotic compounds affect host 
microbiota composition and subsequently host health, we must first investigate how 
these prebiotics are metabolised by the targeted probiotic bacteria. Chapter III of this 
thesis describes the identification and characterisation of two gene clusters 
responsible for the metabolism of the saccharidic compounds raffinose and raffinose-
like carbohydrates, and melezitose, all of which have prebiotic potential, in B. breve 
UCC2003. Stachyose and raffinose are present in a wide variety of plants (French, 
1954), while the related sugar melibiose (though not a member of the raffinose 
family) is also found in many plants and is particularly abundant in soybean roots 
and stems (Rehms & Barz, 1995). Melezitose is found in honeydew and manna, 
which are sugar-rich liquid and solid deposits, respectively, associated with leaves 
and branches of various trees and shrubs (Bacon & Dickinson, 1957).  
In this study we identified gene clusters involved in the uptake and catabolism of 
raffinose-containing carbohydrates and melezitose in B. breve UCC2003. In silico 
analyses, insertion mutagenesis, protein purification and enzyme kinetics allowed a 
detailed characterisation of the functionality of various genes and corresponding 
protein products of these clusters (O'Connell et al., 2013b). An α-galactosidase 
(encoded by rafA) and a putative solute binding protein (encoded by rafB) were 
shown to be specified by the raffinose-utilisation gene cluster. The purified RafA 
was shown to hydrolyse stachyose, raffinose and melibiose to produce sucrose and 
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galactose, while also cleaving melibiose to its monosaccharide constituents glucose 
and galactose. Kinetic studies identified that the preferred bond cleaved by RafA was 
melibiose, followed by raffinose (O'Connell et al., 2013b). Our findings indicate that 
many bifidobacteria metabolise raffinose-like sugars by means of a metabolic route, 
which is different to that known for E. coli (Aslanidis & Schmitt, 1990). Raffinose 
metabolism has previously been investigated in Lactobacillus plantarum ATCC 
8014 (Silvestroni et al., 2002), and from these and our data it is evident that the 
raffinose utilisation cluster of Lb. plantarum differs substantially from that found in 
bifidobacteria.   
In the case of the melezitose utilisation cluster, an α-galactosidase (specified by 
melE) and α-glucosidase (specified by melD) were shown to be specified by the 
melezitose utilisation gene cluster. Purified recombinant MelD protein was used to 
demonstrate that this protein has both α-(1 2) and α-(1 3) glucosyl hydrolase 
activities. MelE was shown not to exhibit hydrolytic activity towards raffinose, 
stachyose or melibiose, yet this protein as well as RafA were demonstrated to exhibit 
hydrolytic activity towards synthetic α-(1 4)- and α-(1 3)-galactobiose. Kinetic 
studies identified that the preferred bond cleaved by MelD is the α-(1 2)-glucosidic 
linkage present in sucrose (O'Connell et al., 2013b). In terms of melezitose 
metabolism in other bacteria there is a paucity of information. Melezitose 
metabolism has only been investigated in the yeast Saccharomyces cerevisiae 
(Hwang & Lindegren, 1964), revealing a melezitose metabolising system employing 
an α-glucosidase or melezitase.  
Other carbohydrate metabolising systems have been studied in B. breve UCC2003 
(Maze et al., 2007; O'Connell et al., 2013b; O'Connell Motherway et al., 2008; 
O'Connell Motherway et al., 2011; Pokusaeva et al., 2010; Pokusaeva et al., 2011; 
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Ryan et al., 2005). The study presented in Chapter III of this thesis thus provides 
relevant information as to how bifidobacteria metabolise raffinose-containing 
carbohydrates and melezitose. These pathways dedicated to the uptake and 
metabolism of potential prebiotics may represent common elements in the diet of the 
host of such bacteria, while it may also allow certain species/strains to colonise the 
gut or obtain higher numbers in the presence of these carbohydrates (van Zanten et 
al., 2012). 
It has to be realised that the study presented here is based on in vitro assays and were 
intended to gain more insight into the prebiotic potential of these carbohydrates. The 
obtained information are therefore a prelude to in vivo trials using animal models 
that may be followed by human clinical trials. Such studies will provide more 
realistic information regarding food ingredients, perhaps in combination with 
selective probiotics, to be incorporated into our diet in order to influence microbiota 
and, ultimately, host health.  
The fourth chapter of this thesis is a follow on from Chapter III and describes 
investigations that were aimed to achieve a better understanding of how B. breve 
UCC2003 regulates the transcription of the gene clusters involved in raffinose and 
melezitose metabolism. From the observed findings we deduce that the gene cluster 
associated with melezitose metabolism is negatively regulated by a LacI-type 
transcriptional regulator designated MelR1. A second LacI-type regulator, MelR2, 
which is encoded by a gene adjacent to the melR1 gene, was shown to regulate two 
genes thought to be responsible for the uptake of a melezitose-like carbohydrate 
which contains an α-galactose moiety. We were unable to test this theory as such 
carbohydrates are not commercially available. Furthermore, a ROK-type protein, 
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RafR, was shown to act as a transcriptional activator of the rafBCD cluster, the first 
such activity described for bifidobacteria. A ROK-type protein has previously been 
linked to positive transcriptional control in Corynebacterium glutamicum 13032 
(Ruckert et al., 2008), since a deletion in the gene encoding the ROK-type protein, 
CysR, rendered this strain incapable of utilising sulphate or sulphonates as sole 
source of sulphur.  
In Chapter IV we also report that melezitose is preferentially utilised over raffinose, 
indicating a form of carbohydrate utilisation hierarchy in bifidobacteria. Specific 
elements of the PEP-PTS system are in many bacteria responsible for carbon 
catabolite control (Deutscher, 2008), however, this does not seem to be case in 
bifidobacteria as regulatory proteins which are essential for this system appear to be 
absent. Therefore, the manner by which catabolite repression is achieved by 
bifidobacteria is yet to be elucidated. Transcription of bifidobacterial gene clusters 
involved in carbohydrate metabolism seems to be tightly regulated by dedicated 
regulators, in many cases LacI-type repressors, yet several observations have been 
made which suggest that these clusters are also subject to a higher order control 
system that possibly enforces global regulation (Parche et al., 2006). Further studies 
will need to be done in order to elucidate this system. 
Finally, Chapter V describes the characterisation of the replication functions 
associated with a novel bifidobacterial megaplasmid and attempts to create an E. 
coli/bifidobacterial shuttle vector as a novel genetic tool to genetically manipulate 
bifidobacteria. Bifidobacteria are known to be genetically recalcitrant, while the 
arsenal of genetic tools, such as cloning, conditionally replicating and (inducible) 
expression vectors, is limited or non-existent. Various studies have been dedicated to 
overcome the barrier imposed by restriction/modification systems in achieving 
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higher levels of transformation (Hirayama et al., 2012; O'Connell Motherway et al., 
2009; Ruiz et al., 2013). In addition, quite a number of papers have been published 
on the identification of bifidobacterial plasmids and the construction of vectors that 
can shuttle between E. coli and particular bifidobacterial species/strains (Alvarez-
Martin et al., 2008; Cronin et al., 2007; Klijn et al., 2006; Lee & O'Sullivan, 2006; 
Matsumura et al., 1997; Missich et al., 1994; Rossi et al., 1996; Rossi et al., 1998; 
Sangrador-Vegas et al., 2007; Shkoporov et al., 2008).  
In the latter context, the discovery of a megaplasmid in B. breve JCM 7017 provided 
opportunities to expand the currently available genetic tool box for bifidobacteria 
with vectors that would allow the cloning and stable maintenance of large DNA 
fragments. In order to study the replication functions of the megaplasmid, in silico 
analyses were performed which identified two genes, repA7017 and repB7017, 
encoding putative replication proteins. The RepA7017 protein was shown to bind the 
upstream region of its encoding gene, which was shown to contain a series of direct 
repeats as well as its promoter. Attempts to utilise this information for the 
construction of a bifidobacterial/E. coli shuttle vector unfortunately failed. This 
could be due to the fact that not all replication functions were present in our 
constructs or that these replication functions were present but were dysfunctional.  
The work presented in this thesis has provided novel information not only on how 
bifidobacteria utilise various carbohydrates with potential prebiotic activity, but also 
how they regulate the genes necessary for the metabolism of these saccharides, while 
also showing promising results for the production of future genetic tools for the 
genetic manipulation of bifidobacteria. In terms of CLA production our research has 
provided some further insights into fatty acid metabolism, however, the precise 
mechanism of CLA production by bifidobacteria is still a mystery. 
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